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Interactions between the innate and adaptive immune systems have pivotal roles in the 
generation of effector and memory lymphocyte responses. This thesis focuses on the 
costimulatory pathways that regulate CD4 T cells development, specifically OX40:OX40L as 
the critical mechanism downstream of CD28 signalling. Whilst it is clear that CD4 T cell 
responses require signals through OX40 pathway, its role in T cell function as well as the 
cellular sources of its ligand in vivo and how its expression is regulated are poorly defined.  
Here we reveal our studies across various in vivo immune response models, including 
attenuated Listeria and Salmonella models and the clinically approved immunostimulant 
AS01 adjuvant. Collectively, these approaches all demonstrated that OX40 signals were 
particularly important for the generation of effector CD4 T cell populations. We have shown 
that in responses to Listeria, the number of effector CD4 T cells expressing IFNg was highly 
OX40 dependent. In the context of acute bacterial infection, we discovered that OX40L is 
rapidly upregulated on DC within the first 24hrs post infection and this is controlled by the 
innate cell production of IFNg and in particular, dependent on IL-12 signals affecting the IFNg 
production by NK cells. Furthermore, using the novel OX40L conditional knockout mice we 
have successfully shown that CD11c+ DC were the critical cellular sources of OX40L during 
the primary response to Listeria and that OX40L expression by T cells, ILC3 and B cells was 
redundant. Using the AS01 model we have demonstrated that although important for optimal 
CD4 T cell responses, the rapid production of innate IFNg induced by the AS01 was not 
required for neither the upregulation of OX40L on DC nor the B cell responses generated 
post immunisation, confirming multiple mechanisms for OX40L regulation in a context 
dependent manner. Collectively, these studies highlight the importance of OX40 pathway 
across various in vivo immune responses and reveal new data on regulation of OX40L 
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CHAPTER 1: INTRODUCTION 
1.1 From innate to adaptive immunity  
Over the course of evolution, multicellular eukaryotic organisms developed a wide range of 
defence mechanisms to protect themselves from highly specialised disease-causing agents 
with which they share the environment. Due to the complex nature of their cellular 
organisation and relatively weak barriers protecting them from environmental stresses, 
multicellular organisms dedicated high number of cells to fight pathogens.  
The immune system is composed of highly compound and advanced mechanisms which 
evolved to target the immediate threats of infection in a quick and a broad response manner 
(innate immunity) followed by the more specific and thorough protective mechanism (adaptive 
immunity). The cells of the immune system work tightly together to recognise pathogens and 
activate the effector mechanisms like phagocytosis and antibody production. Although, the 
majority of mechanisms are common to many immune cells, there are some that will be only 
performed by specialised cells possessing receptors capable of binding a variety of pathogen 
associated molecules. Understanding mechanisms that mediate immune responses to 
foreign antigens will enhance our ability to develop superior approaches to combatting 
infectious disease. In particular, the development of new immune therapies and vaccines 
relies heavily upon an understanding of the interaction between the innate and adaptive 
immune cells. 
Innate immunity is often described as the first line of defence and indeed innate cells are 
clustered within the sites of entry into the body. The cells involved in innate immunity include 
the widely studied and evolutionarily ancient hematopoietic cell types: natural killer (NK) cell, 
eosinophils, basophils, mast cells, macrophages, dendritic cells (DC) and neutrophils as well 
as cells of the non-hematopoietic origin, including stromal cells (LeibundGut-Landmann et al., 




of cells, crucial in maintaining tissue barrier integrity and homeostasis. These cells are 
electively known as Innate Lymphoid Cells (ILCs) and include NK cells. They have been 
shown to be key producers of cytokines within tissues such as the intestine, lung and skin. In 
turn these cells are directly regulated by a wide range of locally produced cytokines in tissues 
(Artis and Spits, 2015). Although some of the functional aspects still require further 
assessment in vivo, there is a growing evidence supporting the involvement of ILCs in both 
the regulation of the innate immunity as well as modulation of the adaptive responses. Thus 
beyond controlling tissue homeostasis these cells are most likely important regulators of 
adaptive immunity (Hepworth and Sonnenberg, 2014a).  
 
1.1.1 Innate immune recognition strategies  
Cells of the innate immune system augment protection provided by barrier sites, relying on a 
limited number of recognition strategies. These strategies enable detection of conserved 
components of a pathogen which are crucial for its viability and virulence and therefore less 
prone to change in case of rapid pathogen evolution.  
Unlike cells of the adaptive immune system, cells described as part of the innate immune 
system lack receptors formed by RAG-mediated combinatorial gene rearrangements. 
However, they do clearly respond to signals, possessing a discrimination system which allows 
them to differentiate between the self and non-self molecules (Akira et al., 2006; Medzhitov 
and Janeway, 2000). These structures of bacterial, fungal or viral origin are referred to as 
pathogen associated molecular patterns (PAMPs). PAMPs include peptidoglycan, 
lipopolysaccharide (LPS), flagellin, lipoteichoic acid as well as bacterial and viral genetic 
material including the dsRNA, CpG-DNA and unmethylated CpG (Janeway and Medzhitov, 
2002). Innate cells can also detect immunological damage caused by an infection, including 
endogenous alarmins and heat-shock proteins. These are often referred to as damage-




through the pattern recognition receptors (PRRs). PRRs are highly primitive and include Toll-
like receptors (TLR), C-type lectin receptors, cytoplasmic RIG-I-like receptors and NOD like 
receptors. TLRs are well studied PRRs, able to recognise limited but very specific range of 
microbial products, for instance TLR4 is able to detect LPS while the TLR9 readily binds to 
the CpG DNA. TLRs were discovered in mid-1990s, when the findings of Drosophila research 
highlighted the importance of Toll protein in protecting the fruit fly against fungal infections 
(Lemaitre et al., 1996). TLRs act through initiation of signal transduction pathways that trigger 
gene expression and the subsequent upregulation of the innate immunity (Hoffmann, 2003). 
Understanding TLR function and identifying their potential ligands contributed greatly to the 
development of more efficient vaccine adjuvants. For instance, monophosphoryl lipid A 
(MPLA) have been used in both Adjuvant Systems 01 (AS01) and 04 (AS04) as a much less 
toxic ligand of the TLR4 inducing efficient innate immune responses (Casella and Mitchell, 
2008; A. M. Didierlaurent et al., 2014; McKeage and Romanowski, 2011).  
Although PRRs are classically considered as innate like recognition receptors, several 
studies have identified their expression levels on T lymphocytes or T cells and B lymphocytes 
or B cells. It has been shown that particularly TLR1, TLR2, TLR3, TLR6 were expressed by 
both CD4 and CD8 T cells (Caramalho et al., 2003; Rahman et al., 2009). B cells localised to 
the peritoneal and plural cavities, were found to express TLR1-9 while the marginal B cells 
demonstrated prevalence for expression of TLR2, TLR6 and TLR7 (Barr et al., 2007).  
 
1.1.2 Interaction of innate and adaptive immunity 
PRR signalling has two important consequences: the generation of innate responses in the 
form of cytokine production and induction of antigen presentation. The ability to induce 
adaptive responses along with several other features of the innate defences are especially 
well developed in DC. They represent a group of Antigen Presenting Cells (APCs) and are 




Zanvil Cohn who using a phase-contrast microscopy found a small group of very motile and 
branched cells colocalised with macrophages (Steinman and Cohn, 1973).  
Murine DC can be divided into 5 groups: plasmacytoid DC, XC chemokine receptor 1 
(XCR1)+ DC, CD11b+ DC, monocyte-derived DC and Langerhans cells (Crozat et al., 2010; 
Guilliams et al., 2010; Shortman and Liu, 2002). DC originate in bone marrow from DC 
precursors and circulate between blood and lymphoid and non-lymphoid tissues. Upon their 
maturation, which will be described in detail in later sections, DC are known to deliver three 
types of signals to induce activation of naive T cells: 1. Presentation of antigen to naive T 
cells; 2. Stimulation via the costimulatory molecules; 3. Initiation of differentiation via the 
cytokine secretion (Burnet, 1959; Cunningham and Lafferty, 1977; Curtsinger et al., 1999; 
Keppler et al., 2012; Linsley et al., 1990; Zinkernagel, 1974). The antigen presentation and 
provision of stimulatory signals by DCs marks the transition between the innate and adaptive 
immunity. The recognition of antigen by majority T cells is only possible when the antigen in 
presented as a part of Major Histocompatibility Complex (MHC) (Doherty and Zinkernagel, 
1975). This interaction activates naive T cells via the T cell receptor (TCR) mediated signalling 
process which ultimately results in the activation of key transcription factors. The activation 
of T cells results in their subsequent differentiation, a process known as clonal expansion 
during which cells proliferate at the highest rate, producing great number of antigen specific 
subtypes of T cells, each with specific effector cytokine profiles (Goldrath and Bevan, 1999).  
 
1.2. The adaptive immune system  
The evolution of adaptive immune system occurred much later in the development of 
multicellular organisms and has specifically been found in all jawed fish and higher 
vertebrates (Schluter et al., 1999). Cells of the adaptive immunity are commonly defined as 
the cells expressing antigen specific receptors able to identify and act upon wide range of 




generated through the process of somatic gene rearrangements. T and B lymphocytes are 
the primary members of the adaptive immunity. They work very closely with the cells of the 
innate immune system to orchestrate the best type of defence to a particular threat.  
Unlike the very rapid responses of the innate immune system, adaptive immunity has been 
characterised by slow but very specific process of organised events which usually take 
several days to develop (Chaplin, 2010). This is due to the relatively low number of adaptive 
immune cells that recognise a given peptide. Upon recognition of their cognate antigen enter 
the cycle of proliferation and differentiation before acquiring their effector functions.  
The fundamental difference between innate and adaptive immunity lies in the formation of 
long-lived cells which are able to act upon secondary encounters with the specific antigen. 
This is often referred to as immune memory. In recent years, however, there have been 
reports of a NK cell derived innate memory. It has been observed that C57BL/6 mice were 
able to generate mouse cytomegalovirus (MCMV) specific long-lived innate memory cells. In 
these mice, approximately half of the NK cell population expresses Ly49H, activating receptor 
linked to resistance to MCMV infection. The adoptive transfer of Ly49H
+
 NK cells into DAP12 
deficient mice (defective in Ly49H function) and the their subsequent challenge with the 
MCMV virus, resulted in a rapid cell expansion and increased effector functions of the NK cell 
population (Sun et al., 2009). Thus, like CD8
+
 T cells, the NK cells can also be subjected to 
viral antigen driven activation, expansion and generation of memory cells. Although 
compelling and potentially beneficial, the NK innate memory constitutes a small portion of the 
highly efficient memory responses driven by the cells of the adaptive immune system.     
 
1.2.1 T cell receptors and their repertoire 
As stated previously, the T cell receptors, or TCRs are heterodimers found on the surface of 
T cells where they recognise antigens presented as a part of the MHC. Both human and 




descriptions of TCRs related more to the similarities with immunoglobulins but since then their 
structure and function have been a subject to many research. 
TCRs are classed according to the type of T cells they are expressed on, the TCRab and 
TCRgd (Davis and Bjorkman, 1988). The TCRab are noticeably more abundant with majority 
of conventional T cells belonging to the ab lineage. The TCR a and g chains contain variable 
(V), joining (J) and constant (C) regions. These regions are also present in TCR b and d 
chains with an additional diversity (D) region. The variable regions are the main site of gene 
rearrangements which involve differential assembly of the V, D, J segments and additions or 
deletions of individual nucleotides before the final completion of the exon. 
The constant region, situated proximally to the cell membrane, determines the effector 
properties and types of chains, while the distal variable region plays a predominant role in 
antigen recognition as it contains exceptionally variable complementarity-determining regions 
(CDR), CDR1, CDR2 and CDR3. The CDR3, contained among the J and D segments, is the 
most variable and it has the most interaction with the antigen. The other two CDRs are known 
for interacting with the MHC complex (Wu, 1970). As naive T cells require interaction with the 
MHC, mutations within the CDR3 hypervariable region are therefore particularly important 
and can contribute to stronger affinity for specific antigen (Xu and Davis, 2000).  
Next to the V, D, J segments lies the main regulator of the gene rearrangements, the 
recombination signal sequence (RSS). The enzymes RAG-1 and RAG-2 act directly on the 
RSS and initiate gene rearrangements (Berg et al., 2002). The two enzymes are expressed 
by both B and T cells, with very limited evidence for expression on any other hematopoietic 
cells (Borghesi et al., 2004; Månsson et al., 2007). RAG-1 and RAG-2 pair together and are 
both required to cleave double stranded DNA of all TCR genes while the DNA repair 
machinery completes the recombination (McBlane et al., 1995). 
The gene rearrangements occur at random, resulting in a population of highly diverse T cells 




of the TCRs generated in the murine thymus could reach 10
15
 of TCR clonotypes (Casrouge 
et al., 2000). This range is however unrealistic due to the limited overall number of cells within 
one mouse. Therefore, the process of gene rearrangement contributes mainly to a differential 
distribution of the TCR frequencies, with some of the TCRs being more common and often 
shared between individuals and species (Miles et al., 2011; Venturi et al., 2008). The actual 
size of TCR repertoire for humans and mice is still unknown. 
 
1.2.2 Development of T lymphocytes 
The development of T cells starts in the bone marrow, where haematopoietic stem cells give 
rise to haematopoietic progenitors that populate the thymus and begin the process of their 
maturation (Germain, 2002). The thymus is a primary lymphoid organ that is crucial for 
maintaining a stable microenvironment and conditions required for development of T cells. It 
is present in all jawed vertebrates and is located in the superior mediastinum of the thorax, 
above the heart and behind the sternum. Functionally, the thymus is most active during the 
neonatal stages of life and after the puberty it begins to decrease in size, undergoing an 
atrophy which affects further development of thymocytes (Shanley et al., 2009).  
The developing T cells undergo several important events with the initial stages of their 
development involving changes in the expression of cell surface markers as well as genetic 
mutations. 
At the beginning of their development, thymocytes lack CD4 and CD8 expression and are 
known as ‘double- negative’ cells. Those cells undergo gene segment rearrangement within 
the TCR coding region which is essential to diversify its specificity, ultimately generating an 
enormous range of TCRs. The double negative thymocytes give rise to two distinct lineages: 
αβ and gδ T cells (Robey and Fowlkes, 1994). The majority of T cells express αβ TCRs. The 
gδ T cells comprise a minority and their numbers steadily decrease as the formation of αβ T 




al., 2014). The gδ T cells reside in distinct anatomical compartments, particularly the mucosa 
of the gut and express a distinct set of TCRs that have entirely different antigen biding 
properties than those of the αβ T cells. The gδ T cells are able to recognize antigens without 
the requirement for the MHC molecules, relying on the complementarity of the antigen and 
the biding site (Vantourout and Hayday, 2013). 
As the result of rearrangements within the β chain, thymocytes become double positive, 
expressing both CD4 and CD8 cell surface markers and are tested for their affinity towards 
the MHC complexes, in a process known as positive selection. They enter the subcapsular 
region of the thymus and are presented with self-MHC molecules bound to self-peptides in a 
process mediated by the cortical thymic epithelial cells (cTEC) (Nitta et al., 2008). The 
surviving cells, which express a TCR able to bind MHCI or MHCII and peptide become single 












 T cells are able to recognize 




 are able to interact with the MHCII. 
The rearrangements within α chain enhance the process known as the negative selection 
which takes place in the medulla. Thymocytes interact there with medullary thymic epithelial 
cells (mTECs) which present them with MHC:self-antigen complexes. The expression of self-
antigens is regulated by Autoimmune regulator (AIRE) (Anderson and Su, 2011; Shi and Zhu, 
2013). This allows to eliminate any T cells that might have developed strong affinity for the 
self-antigens and may therefore be involved in autoimmunity.  
Following the selection process, thymocytes emigrate from the thymus via the sphingosine-1 
phosphate receptor (S1P1) (Carlson et al., 2006; Matloubian et al., 2004). Mice deficient in 
the S1P1 lack peripheral populations of T cells caused by retention of mature T cells within 
the thymus (Matloubian et al., 2004).  






1.2.3 T cell migration and secondary lymphoid tissues 
First reports of lymphocytes recirculation can be traced back to 1960s when Gowans and 
others showed that cannulation of the thoracic duct in rats induced loss of lymphocytes which 
was subsequently rescued by intravenous injections of the collected lymph. Moreover, lymph 
collected from the thoracic duct, incubated in vitro with tritiated adenosine for RNA and DNA 
labelling, and transfused back into the blood, could later be recovered from the thoracic duct 
(Gowans, 1957; Gowans and Knight, 1964; Mann and Higgins, 1950). This clearly indicated 
the recirculating nature of lymphocytes. Further in vivo research in sheep characterised the 
circulating lymphocytes (Smith et al., 1970).  
High motility of lymphocytes is key to immunosurveillance and scanning for foreign antigens. 
Evolution of the immune system has optimised this process by forming highly organised 
structures, located at strategic locations allowing capturing of antigens and interaction 
between migrating antigen experienced DC, B cells and T cells. These finely designed 
structures are referred to as the secondary lymphoid tissues and they include lymph nodes 
(LNs), spleen and mucosal associated lymphoid tissue (MALT).    
 
1.2.3.1 Lymph nodes 
The LNs are organised lymphoid tissues that filter the lymph for signs of infection. They 
consist of discrete B-cell areas termed follicles (found in the cortex), T cell areas (found within 
the paracortex) and medullary cords, rich in plasma cells.  
Afferent lymphatics draining the peripheral tissues merge into LNs, and circulating 
lymphocytes enter the LNs via the high endothelial venules (HEV). DC and antigen enter the 
subcapsular sinus and using cortical and medullary sinuses they pass through the cortex, 
paracortex and medullary cords (Gretz et al., 1997).  
The entry of lymphocytes is highly regulated by a number of adhesion molecules, selectins, 




1994; Stamper and Woodruff, 1976). The migration of T and B cells into the LNs is dependent 
on CD62L and CCR7 (Cyster, 1999; Debes et al., 2005; Springer, 1994). The L-selectin 
CD62L allows for recognition of GlyCAM-1 and CD34 (vascular addressins) found on 
endothelium of HEVs inducing cell arrest. The chemokine signalling of CCL19 and CCL21 
induces the action of integrins, like LFA-1 which binds to the ICAM-1 and -2 that are found 
on endothelial cells, and promotes the entry of the lymphocyte into the LN (Masopust and 
Schenkel, 2013). Within the LN, T cells expressing CCR7 use fibroblastic reticular cell (FRC) 
networks which directs them as well as DC to the paracortex via expressions of CCL19 and 
CCL21.  
B cells migrate into B cell follicles via the network of follicular DC, a non-migratory population 
found within the B cell areas of secondary lymphoid tissues. These cells are known to produce 
high levels of CXCL13, an attractant chemokine for the CXCR5 expressing B cells. 
Lymphocytes leave the LN via efferent lymphatics in a sphingosine-1-phosphate receptor 1 
(S1P1) dependent manner. The importance of S1P1 signalling was characterised in early 
studies on Fingolimod (FTY720) action (Fujita et al., 1994; Yanagawa et al., 1998). FTY720 
is a drug made by changing the structure of the fungal Myriocin and it modulates the egress 
of lymphocytes from the LN. It becomes phosphorylated by the sphingosine kinase and acts 
as a agonist, activating the S1P1 (Brinkmann et al., 2002). Its immunomodulating 
characteristics have classed FTY720 as a possible therapeutic agent which has proven 
valuable in transplantation and multiple sclerosis treatments (Brinkmann et al., 2002, 2001; 
Cohen et al., 2010).   
  
1.2.3.2 Spleen 
Spleen is the largest organ of the immune system. Interposed within the blood stream, spleen 
plays an important role in filtering of blood and thereby monitoring for invading disease-




The importance of spleen was first recognised in animal studies involving a splenectomy. It 
was observed that the animals could survive the surgery and recover, however they were 
more prone to developing diseases later on, particularly parasitaemia (Morris and Bullock, 
1919; Yadava et al., 1996). Similar observations apply to human individuals who had their 
spleens surgically removed. Postsurgical infection is most likely to occur within the first couple 
of years after surgery and usually poses a 5% lifetime risk. One of the rare but also most 
serious complications of the splenectomy is the overwhelming post splenectomy infection 
(OPSI) which is usually caused by Streptococcus pneumoniae, Haemophilus influenzae and 
Neisseria meningitidis (Chong et al., 2017; Okabayashi and Hanazaki, 2008). The OPSI leads 
to sepsis, which unfortunately, despite aggressive treatments is associated with high mortality 
rates.  
The spleen is organised into three main areas, the white and red pulps and the marginal zone 
(MZ) separating the two. Structurally, splenic white pulp is very similar to LN, as it contains T 
and B cell zones being involved in initiation of immune responses. On the other hand, the red 
pulp, rich in macrophages, is involved in blood filtering and recycling.  
Blood enters the spleen via afferent splenic artery and filters through trabecular arteries 
entering the splenic parenchyma. Branching arterioles of the trabecular arteries enter red 
pulp and form central arterioles which branch further to deliver blood to the white pulp (Groom 
et al., 1991). Early studies on spleen function, proposed two circulatory systems, closed and 
open (Schmidt et al., 1993). In closed circulation, some of the arterioles branch out to the 
marginal zones, allowing blood to travel through the adjacent venous sinuses, completely 
bypassing the red pulp. Open circulation is characterised by the blood entering and filtering 
through a meshwork of the red pulp.  
The red pulp and marginal zones, rich in macrophages form the first line of defence. The 
marginal zone macrophages (MZM) are particularly important for trapping antigens being 
equipped with various scavenger receptors including macrophage receptor with collagenous 




mice deficient in MZMs were unable to control early infection to lymphocytic choriomeningitis 
virus (LCMV) and Listeria monocytogenes (Aichele et al., 2003; Seiler et al., 1997). 
Antigen-experienced DCs and other lymphocytes pass through the marginal zones before 
entering the white pulp and the T cell rich periarteriolar lymphatic sheaths (PALS). Similarly 
to LNs, the stromal cells within the spleen, particularly the FRCs mediate the migration of 
cells into the white pulp by expressing CCL19 and CCL21 which interact with CCR7 receptor 
expressed on T cells (Förster et al., 1999). Migration of B cells into the B cell follicles is 
CXCL13 and CXCR5 dependent (Allen et al., 2004). Following the antigen exposure, T and 
B cells downregulate their homing receptors and exit the white pulp via the bloodstream. 
In both circulations, blood continues to flow through the sinuses which merge into trabecular 
veins, which in turn form a splenic vein allowing the blood to exit into the hepatic circulation.  
 
1.2.3.3 Mucosal associated lymphoid tissue 
MALTs are located at the sites of mucosal tissues and are often referred to as the inductive 
sites for mucosal immunity. MALTs are involved in IgA class switching in antigen specific 
manner (Gormley et al., 1998). They include for instance the gut-associated lymphoid tissue 
(GALT) and bronchus-associated lymphoid tissue (BALT). GALTs consist of Payer’s 
Patches and isolated lymphoid follicles (ILFs) in which majority of the lymphocytes are 
contained. They are important for immune tolerance as well as defence against pathogens 
(Jung et al., 2010). 
 
1.2.4 Antigen recognition and TCR signalling  
The pioneering work by Doherty and Zinkernagel highlighted the importance of MHC and 
TCR interactions in recognising and generating pathogen specific T cell responses. Their 
initial experiments involved infecting the mice with meningitis virus, isolating the T killer cells 




Zinkernagel and Doherty, 1997). They concluded that in order for the T cells to attack the 
infected cells, they had to recognize not only the antigen but also the specific MHC molecule. 
This dual-recognition model has been used since then and inspired further research into the 
T cell-mediated immunity. 
As mentioned previously, DCs are thought to be main players in the initiation and progress of 
T cell mediated responses. Their exceptional design combines the ability to intake, process 
and present foreign antigens with the expression of costimulatory molecules, secretion of 
cytokines and migration into various tissues. As shown by many in vitro studies, other APCs, 
like for instance B cells, are much less efficient in activating T cells than DC (Cassell and 
Schwartz, 1994; M. Croft et al., 1992).   
Function of DC as immunoregulators is dependent on their state of maturation which is 
induced by various environmental factors. Pathogen induced inflammation recruits DC to the 
site of infection, where they begin the process of antigen uptake. Chemotaxis is key to their 
recruitment, with majority of DC expressing chemokine receptors like CCR1, CCR2, CCR3, 
CCR5 and CCR6 and CXCR1. These receptors are predominantly stimulated by macrophage 
derived proinflammatory chemokines, the CCL3 (MIP-1 alpha), CCL7 (or MCP-3), CCL5 
(RANTES), CCL20 (MIP-3 alpha), and CCL23 (or MPIF-1) (Sallusto et al., 1998; Sozzani et 
al., 1995). 
Immature DC are able to recognize the antigen and other PAMPs expressed by 
microorganisms by the PRR receptors found on their surface. Among those receptors, C-type 
or calcium dependent lectins (CLR) play a particularly important role in DC function (Soilleux 
et al., 2002). For instance, one of the mostly studied receptors, the DC-SIGN is capable of 
recognising glycosylated residues found on the surface of many pathogens (Curtis et al., 
1992). The immature DC have been shown to express very weak affinity towards the T cells 
but great capacity for endocytosis. The interaction between antigen and CLR stimulates the 
DCs to take up the pathogen derived molecules and internalise them into phagosomes. 




subunit of NADPH oxidase is recruited into the phagosome to alkalise the environment 
(Savina et al., 2006). This leads to an arrest of further degradation process, ensuring that 
antigens remain intact and ready for presentation. Inside the Endoplasmic Reticulum (ER), 
the MHCII associates with invariant chain (li) to form abli3 complex. This complex is then 
transported via the trans-Golgi network into the endosomes, which assemble with the foreign 
peptides containing phagosomes. This results in li degradation and exchange of li subunit 
CLIP for foreign antigen (Bénaroch et al., 1995; Landsverk et al., 2009; Watts, 2004). The 
exchange of CLIP requires chaperone HLA-DM (Mosyak et al., 1998). The fully assembled 
MHCII peptide complex is then transported onto the surface of the DC.  
Presentation of self-antigens follows the same principles however the process here is more 
simplistic. Following the proteolytic degradation, the peptides are translocated into the ER by 
the action of transporter associated with antigen processing (TAP). The assembly of peptide, 
MHCI, calreticulin and ERp57 is mediated by Tapasin (Williams et al., 2002). The complex is 
then transported via the Golgi apparatus to the plasma membrane. Upon their maturation, 
antigen experienced DC migrate into the secondary lymphoid organs, towards the T cell 
areas. They downregulate their chemokine receptors, apart from the CXCR4, becoming 
unresponsive to further proinflammatory signals, while upregulating CCR7 associated with 
cell migration and LN entry (Yanagihara et al., 1998). Cell surface proteins expressed on the 
surface of DC and T cells facilitate clustering between the two cells. For instance, ICAM-3 
receptor, one of DC-SIGN, has a strong affinity for ICAM-3 expressed on T cells promoting 
DC/T cell primary interactions (Geijtenbeek et al., 2000). Upon establishing the pMHC/TCR 
contact, DC provide further support for T cells in the form of additional direct interaction via 
the CD40 signalling or by secretion of soluble cytokines which can determine T cell fate (Caux 






1.2.4.1 TCR signalling 
TCR signalling process is very complex and it begins when a TCR engages with its cognate 
pMHC. TCR lacks intracellular domains but can still interact with CDde, CD3ge and CD3zz 
subunits, which express immunoreceptor tyrosine-based activation motifs (ITAMs). 
Engagement with the pMHC recruits the Lck kinase to the TCR where it phosphorylates 
immunoreceptor ITAM motifs of two TCR components, the associated invariant CD3 and z 
chains. The colocalization of CD4 or CD8 molecules and the pMHC allows for Lck recruitment 
to the TCR (Bell et al., 1991; Shaw et al., 1990).  Mice deficient in Lck have their T cell 
development impaired at early stages (Molina et al., 1992). The phosphorylated tyrosines of 
ITAM motifs form a binding site for Zap70 kinase. After being recruited to the plasma 
membrane, ZAP70 binds via SH2 domain. Lck phosphorylates ZAP70, leading to its 
activation and subsequent phosphorylation of two adaptor proteins: linker for activation of T 
cells (LAT) and cytosolic protein SH2 (Wardenburg et al., 1996). Together these proteins form 
a complex which directs activation of further signalling events. Phosphorylated LAT recruits 
PLCg1, p38, Grb2 and Gads. The interaction between Grb2 and Son of Sevenless (SOS), 
guanine nucleotide exchange factors, activates the Ras-GTPs by encouraging the release of 
guanosine diphosphate (GDP) (Liu et al., 1999). Ras-GTP induced signalling cascade results 
in activation of MAPK/ERK Kinase and MAPKs kinases which act on transcription factors NF-
kB and AP-1 involved in many aspects of T cell mediated responses, like migration, 
proliferation and effector functions.  
The strength and quality of TCR signalling has a definitive impact on the differentiation of 
effector T cells, with the antigen dose playing important role. Previous studies on Leishmania 
major and L. monocytogenes infections have shown that differentiation of the CD4 effector 
populations was highly dependent on the dose of bacteria administered (Bretscher et al., 
1992; Darrah et al., 2007; Pepper et al., 2011; Tubo et al., 2013). BALB/c mice are known to 




administration of low dose of L. major results in a strong Th1 response and protects the mice 
from bacteria (Bretscher et al., 1992). In L. monocytogenes infections, low doses of bacteria 
generally cause differentiation of T helper 1 (Th1) and T follicular helper (Tfh) cells, however, 
limit the formation of germinal centres (GC). The increased of the bacterial dose corresponds 
to a reduction in Th1 population and increase in both Tfh and GC formation (Tubo et al., 
2013).    
The quality of the TCR signalling is often explained through its durability which usually 
correlates with antigen persistence. For instance, in Tfh differentiation, the presence of 
increasing and persisting pMHCII enhances Tfh proliferation and induces CG formation 
(Baumjohann et al., 2013). While in the Th1 responses, although high levels of pMHCII 
increase proliferation, their persistence often results in cell death (Kallies et al., 2006).    
 
1.2.5 T cell subsets  
T cells can be divided into two large general groups according to their differential functions 
and properties: helper CD4
 
and cytotoxic CD8 T cells. Third smaller group consists of gd T 
cells and Natural Killer T (NKT) cell which, as previously stated, are classed as cells of the 
innate immune system. Invariant NKT (iNKT) cells are thought to be mediators between 
innate and adaptive immunity. Although, they express TCRs generated through 
rearrangement events, they can only recognise a limited number of glycolipid antigens (Van 
Kaer et al., 2011). Upon their activation, iNKT cells elicit very rapid responses and like 
majority of innate cells, fail to generate memory populations. 
One of the first evidences for the separation of CD4 and CD8 T cells on a phenotypic and 
functional basis advanced from experimental data showing that depletion of Ly-2 (CD8a) and 
Ly-3 (CD8b) expressing lymphocytes by using antisera and compliment resulted in cell 





1.2.5.1 Cytotoxic CD8 T cells 
The function of CD8 T cells is mainly focused on eradication of infected cells by the use of 
their cytotoxic properties (Cantor and Boyse, 1975; Cerottini et al., 1970). Similar to one of 
the subclass of CD4 T cells, CD8 cell differentiation is T-box transcription factor (T-bet) 
dependent and as demonstrated previously IL-12 can promote its expression (Curtsinger et 
al., 2003; Takemoto et al., 2006). Another transcription factor, Eomesodermin (EOMES) also 
assists CD8 differentiation (Pearce et al., 2003).  
Naive CD8 T cells recirculate through secondary lymphoid and non-lymphoid tissues, until 
they encounter cognate antigen (Cose et al., 2006; Weninger et al., 2001). They recognise 
endogenous antigens of viral or microbial origin present in the cytosol and expressed as part 
of MHCI (Pamer and Cresswell, 1998).  
Once activated, CD8 T cells differentiate and initially were classed into two main groups, the 
preferential Interferon g (IFNg) and Tumour necrosis factor a (TNFa) producing Tc1 cells, and 
the IL-4, IL-5, IL-6 and IL-10 producing Tc2 cells (Mosmann et al., 1997). Tc1 CD8 T cells 
are involved in cell lysis, releasing secretory vesicles containing perforins and granzymes.  
Further studies have described a third group Tc17, characterised by production of IL-17 (Yen 
et al., 2009).  
Therapeutically, they represent a very powerful group of cells capable of highly destructive 
functions which are of great benefit to tumours treatments as well as control of responses 
during the chronic infections. However, the same properties can be the cause of major 
difficulties, particularly in transplantology and autoimmunity treatments (Delfs et al., 2001; 
Fazou et al., 2001; Jacobsen et al., 2002).    
CD8 T cell responses result in formation of long-lived and antigen-specific memory 
populations which express memory-like phenotype and persist in the absence of antigen 





1.2.5.2 Helper CD4 T cells and their subsets  
Helper CD4 T cells are highly important modulators of the immune responses, particularly to 
intracellular and extracellular bacteria, parasites and fungi. They aid in generation of effective 
responses by producing cytokines that can act directly or indirectly upon the infection, 
targeting pathogens or stimulating the proliferation of B cells. They provide help for B cells in 
production of antigen specific antibodies and are involved in activation of macrophages, 
recruitment of neutrophils, eosinophils, basophils, as well as produce vast range of cytokines 
and chemokines which influence the course of immune responses (Carside et al., 1998; 
MacLennan et al., 1997). This group of T cells also contains regulatory cells which ensure 
minimal tissue damage as well as the memory cells which induce a rapid response to any 
reoccurring infections. The basis for different ‘subtypes’ of CD4 T cells comes from distinct 
cytokine profiles. 
The fundamental research conducted by Mossman and Coffman in 1986 confirmed the ability 
of CD4
 
T cell lines to differentiate into two groups of cells, that could be characterised by two 
different sets of cytokines they were producing, the IFNg and IL-4 (Coffman et al., 1986). Later 
on, those cells were named as T helper 1 (Th1) and T helper 2 (Th2) cells. To date, we 
understand that CD4
 
T cells can take on many different functions. They have been classified 
into several types according to such functions, including Th1, Th2, Th9, Th17, Th22, 
regulatory T (Treg) cells and Tfh cells. Moreover, plasticity between the subtypes has been 
reported.  
Differentiation of each of the CD4 T cell subsets requires several important factors, namely 
the transcription factors and cytokines produced in response to the infection that together 





Figure 1. 1 CD4 T cell differentiation. 
 
1.2.5.2.1 Th1 cells 
Th1 cells are involved in proinflammatory responses to intracellular bacterial and viral 
infections. Alongside IL-2, those cells produce high levels of INFg and TNFa which play 
important role in phagocyte responses by activating macrophages and stimulating cell-
mediated immunity. The interaction with macrophages via CD40 and IFN-g has a mutual 
effect. In vitro studies showed that activation of macrophages induces them to secrete high 
levels of IL-12 which in turn regulates Stat4 signal transducer which induces IFN-g secretion 
without TCR stimulation (C S Hsieh et al., 1993; W.-R. Park et al., 2004). Increase in the IFNg 
production upregulates T-bet transcription factor strengthening Th1 fate and administration 
of anti-IFNg results in inhibition of the Th1 cell type differentiation yet having no effect on the 
proliferation rate of CD4
 









































mediated activation of Stat1. The conserved T-box domain contained within the T-bet binds 
specifically to the promoter as well as the enhancer of IFNg gene, inducing its transcription 
and mediating IFNg production in Th1 responses. This process is then amplified by Stat4 
activation triggered by IL-12 (Thierfelder et al., 1996).   
Studies have shown that, sustained expression of T-bet in differentiated Th2 cells can redirect 
their fate programme and polarise them towards a Th1 cell-like phenotype. This is ultimately 
caused by the reduction in IL-4 expression (Lametschwandtner et al., 2004; Szabo et al., 
2000; Zhuang et al., 2009). Moreover, the CD4 T cell responses in T-bet deficient mice are 
much more biased towards a Th2 type immunity, leading to a higher expression of GATA3 
(Finotto et al., 2002; Nakamura et al., 1999). These mice however are able to maintain 
relatively normal Th1 differentiation in the absence of IL-4 pathway (Usui et al., 2006). T-bet 
also has been shown to play an important role in generating effector Th1 T cells and 
promoting development of experimental autoimmune encephalomyelitis (EAE), as this 
autoimmune disease was prevented in T-bet deficient mice (Bettelli et al., 2004; Nath et al., 
2006; O’Connor et al., 2013). 
 
1.2.5.2.2 Th2 cells 
Th2 cells are main effector helper cells found during responses to parasites like helminths. 
They are known to produce high levels of IL-4, IL-5 and IL-13 and have positive effect on the 
activation of eosinophils and B cell stimulation followed by strong antibody production 
(Coffman et al., 1986). The cytokine induced production of IgE and IgA specific to the antigen 
enables neutralisation of parasites during the possible re-challenge.  
Th2 differentiation is highly dependent on high levels of both IL-2 and IL-4. Similarly, to the 
IFNg in Th1 responses, the concept of IL-4 involvement is particularly interesting due to the 
formation of feedback loop in which the main product of Th2 immunity is also a crucial fate 




differentiation using three proposed mechanisms: 1. Increased proliferation; 2. Increased 
cytokine production; 3. Prevention of T-bet expression (Zhu et al., 2006, 2001). In mouse 
studies, the absence of GATA3 led to an abolishment of Th2 differentiation and a shift in the 
cell fate towards the Th1 phenotype without IL-12 or IFNg stimulation (Pai et al., 2004; Zhu et 
al., 2006, 2004). 
Th2 responses have also been studies with regards to asthma due to the highly important 
role of their effector product IL-4. Abrogation of IL-4 responses with the use of monoclonal 
antibodies or mice deficient in IL-4 pathway resulted in reduced airway hyperactivity to an 
antigen (Corry et al., 1996; Coyle et al., 1995).   
 
1.2.5.2.3 Th17 cells 
Th17 population of CD4 T cells have been found to be involved in infections caused by 
extracellular bacteria, fungi and viruses at mucosal sites. They were first identified as one of 
the main factors contributing to the EAE. Early studies by Cua et al. showed that EAE 
development was abrogated in mice lacking IL-23, but no IL-12. By producing knockout mice 
for the IL-23p19 subunit, targeting only IL-23 or the IL-12p40 subunit, targeting both IL-23 
and IL-12, they were able to show that both genotypes gave similar results, remaining 
unaffected by the EAE, while mice lacking IL-12p35 and deficient only in IL-12 showed 
significant progression of the disease (Cua et al., 2003).     
Further studies linked the expression of IL-23 with an increase in the IL-17 producing 
population of CD4 T cells which in turn correlated with an increase in the severity of EAE 
(Langrish, 2005; Murphy et al., 2003).  
Th17 cells secrete IL-17A, IL-17F, IL-21 and IL-22 which promote recruitment of neutrophils 
and production of antimicrobial agents and other proinflammatory cytokines like IL-1 and IL-




Differentiation of Th17 cells is highly dependent on the expression of RORgt transcription 
factor which is reinforced by optimal levels of IL-6, IL-21, IL-23 and Transforming growth 
factor β (TGF-β) (Manel et al., 2008; Veldhoen et al., 2006). IL-6 and IL-21 activate Stat3 and 
its suppressor SOCS3. TGF-β plays the critical role, enhancing activation of Stat3 by 
inhibiting SOCS3 action (Qin et al., 2009). Stat3 in turn, regulates expression of RORgt, which 
orchestrates further differentiation and its absence results in the Th17 deficiency (Ivanov et 
al., 2006; Yang et al., 2007). Although RORgt is crucial for Th17 differentiation, another 
member of the ROR family, the RORa can also be involved. Deletion of both RORgt and 
RORa have been shown to exacerbate the impairment in the differentiation of Th17 (Yang et 
al., 2008).     
 
1.2.5.2.4 Regulatory T cells 
Tregs were first identified in the 1990s and are critical regulators of the immune system, 
orchestrating tolerance towards self-antigens and commensal microbiota. Sakaguchi et al. 
have shown their importance by transferring CD4 T cells depleted of Tregs into the BALB/c 
athymic nude mice. The results showed a dramatic impairment in the immune tolerance 
characterised by development of autoimmune diseases, including thyroiditis and gastritis as 
well as wasting disease. The autoimmunity was however prevented when Treg sufficient CD4 
T cells and not CD8 T cells were transferred shortly after (Sakaguchi et al., 1995).  
Tregs act on both T cells, regulating the antigen-specific responses, and at the same time 
remodelling the function of DCs. The two types include natural (nTreg) and induced (iTreg) 
Tregs which differ in their origin. The nTregs are produced during the selection process within 
the thymus while the iTregs are differentiated due to the proinflammatory cytokines (Chen et 
al., 2003).  Both the TGF- β and Forkhead box p3 (Foxp3) play crucial role in the development 
and function of Tregs (Chen et al., 2003; Fontenot et al., 2003; Fu et al., 2004; Hori et al., 




affinity for self-antigens than other conventional T cells (Jordan et al., 2001; Kawahata et al., 
2002). The lack of FoxP3 expression has severe effects on the functionality of immune 
system, causing fatal autoimmune diseases in both humans and mice (C. L. Bennett et al., 
2001; Brunkow et al., 2001; Wildin et al., 2001). Mice that lack this crucial transcription factor 
do not survive for more than 5 weeks. TGFβ can upregulate Foxp3 expression, stimulating 
naive CD4
 
T cells to become Tregs. As a result, Tregs have been of main focus to 
transplantation studies which specified the high number of Treg could be beneficial in 
preventing allograft rejections (Dai et al., 2004).   
Differentiation of Tregs is proportional to the level of stimuli received by the T cells from 
antigen-activated DCs. Very low level may not reach the threshold and prevent Treg 
differentiation, leading to autoimmunity. In contrast, a very strong stimulus increases their 
differentiation and may result in immunosuppression. The function of Tregs is highly 
dependent on IL-2 cytokine levels, produced by naive T cells during the antigen encounter 
(Malek et al., 2002). The lack of IL-2 stimuli results in Bim mediated apoptosis.  
 
1.2.5.2.5 T follicular helper cells 
Tfh cells are crucial for survival and development of B cells, being involved in guiding the 
class switching and maintenance of the GCs. They provide an activation signal through the 
CD40L molecule which is essential for sustained GC formation (Breitfeld et al., 2000; Elgueta 
et al., 2013; King et al., 2008). GCs are the primary sites for B cell production of high affinity 
antibodies (Tas et al., 2016).  
There are reports of IL-6, IL-2 and ICOS driven Tfh. Signalling through the IL-6 receptor 
stimulates expression of Bcl-6 which in turn induces early expression of CXCR5 chemokine 
(Choi et al., 2011). As shown with the use of IL-6 deficient mice, absence of IL-6 has a 
profound impact of the Tfh differentiation (Choi et al., 2013). On the other hand, ICOS and IL-




action of IL-2 during priming induces strong Tfh phenotype and GC formation (Ballesteros-
Tato et al., 2012; Vogel et al., 2013).  
 
1.2.6 Costimulatory signals  
As discussed in previous sections, activation of naive T cells and their transition into effector 
populations is highly depended on their interaction with APCs. Although, specific recognition 
of antigens presented as a part of MHCII initiates signalling through the TCR receptor and 
activates signalling cascade, it is the costimulatory signals that stabilise the interaction and 
direct T cells function.  
The classical two-signal model introduced in late 1970s by Lafferty and colleagues proposed 
that efficient T cell activation required two types of signals, including the TCR engagement 
as well as other stimuli (Lafferty et al., 1980). The pioneering in vitro studies by Schwartz 
group identified APCs as main providers of costimulatory signals and defined these signals 
as crucial for full T cell activation (Jenkins and Schwartz, 1987). They compared the 
stimulatory potential of live versus fixed antigen-activated APCs, assessing T cell proliferation 
and production of IL-2. Despite the TCR:MHCII engagement, fixed APCs were unable to drive 
efficient T cell responses and the interaction resulted in T cell anergy. Further reports of T 
cell anergy and limited function of TCR:MHCII complexes have also been shown (Brunet et 
al., 1987; Harding et al., 1992; June et al., 1990). 
Costimulatory molecules functionally define a number of receptor:ligand interactions that 
typically occur between the T cells and APCs (Figure 1.2). T cells express broad repertoire 
of costimulatory receptors which can transduce vast number of cell specific signalling 















Figure 1. 2 Costimulatory interactions in T cells. 
 
1.2.6.1 The B7-CD28 superfamily  
Early studies identified the critical role of two costimulatory molecules belonging to the family 
of B7 ligands. Both the B7.1 (CD80) and B7.2 (CD86) proteins are expressed on the surface 
of APCs and have been shown to interact with the CD28 receptor that is found on majority of 
murine naive CD4 and CD8 T cells (Gross et al., 1992). The interaction between CD28 and 
B7 molecules mediates proliferation and survival of activated T cells, by enhancing the IL-2 
production (Srinivasan et al., 2001). Administration of anti-CD28 prevented T cell anergy, 
proving the importance of this costimulation in T cell responses (Harding et al., 1992). 
However, it has also been shown that in prolonged acute infections and in cases where the 
TCR signal is very strong, T cells can become activated in the absence of crucial CD28 
signalling (Kündig et al., 1996). Furthermore, the presence of functional alloreactive 
responses to skin grafts and their subsequent rejection supports the limited function of CD28 
signalling (Ha et al., 2001; Kawai et al., 1996).   
CD28 is a 44 kDa type I transmembrane glycoprotein homodimer encoded by genes found 















Lafage-Pochitaloff et al., 1990). The receptor was first identified in 1980s when its enhancing 
effect on T cell differentiation and expansion was shown (Gmünder and Lesslauer, 1984). 
The importance of CD28 signalling was supported by studies in CD28-deficient mice where 
despite seemingly normal T and  B cell development, both adaptive responses to lectins and 
vasicular stomatitis virus were significantly reduced (Shahinian et al., 1993). Furthermore, T 
cell activation was impaired due to reduced levels of IL-2. CD28 signalling has also been 
associated with increased expression on Bcl-2 and Bcl- extra large (Bcl-xL) protein, the two 
important anti-apoptotic proteins which promote cell survival (Kündig et al., 1996).   
CD28 signalling is initiated by interaction between the extracellular MYPPPY motif and CD80 
and CD86 (Harper et al., 1991). CD80 and CD86 expression is highly regulated by the 
presence of inflammatory signals, with the translation of their mRNA being enhanced 
following an antigen driven immune response (Paine et al., 2012; Subauste et al., 1998). The 
affinities of the two interactions differ with a stronger affinity for the CD86 which proved to be 
particularly important in transplant rejection studies (Collins et al., 2002; Weaver et al., 2008).  
The resulting interactions form an immunological synapse between T cell and the APC which 
induces recruitment of phosphoinositide 3-kinase (PI3K). This in turn enhances the signalling 
of AKT pathway which promotes T cell survival and differentiation (Lee et al., 2010; Wu et al., 
2005). CD28 costimulation also initiates activation of Lck and Fyn protein tyrosine kinases  
and guanosine exchange factor VAV1 which are important for the nuclear factor NF-kB 
involved in enhanced expression of Bcl-xL (Khoshnan et al., 2000; Takeda et al., 2008).  
Activation of naive T cells induces expression of cytotoxic lymphocyte-associated antigen-4 
(CTLA4) molecule which is a homolog of the CD28. Like its family member, CTLA4 binds the 
CD80 and CD86 but acts as a negative regulator, whereby it inhibits proliferation of overactive 
T cells. It binds the two B7 molecules with much higher affinity and therefore its dysfunction 
has been linked to the development of autoimmune diseases (Karandikar, 1996). Deficiency 




cells (Tivol et al., 1995). Similar results were shown in tumour studies, where CTLA4 blockade 
with monoclonal antibodies enhanced the antitumor T cell activity (Leach et al., 1996). 
Additionally, in human studies, treatment with anti-CTLA4 increased survival of patients 
suffering from advanced melanoma (Hodi et al., 2010). Interestingly, the increased survival 
was associated with increase in ICOS expression on T cells (Carthon et al., 2010). 
ICOS is another member of the CD28 family, and it has also been shown to have a 
costimulatory function in T cell activation. It interacts with the ICOS ligand (ICOSL) that is 
expressed on majority of DC, macrophages and B cells (Steven K. Yoshinaga et al., 1999). 
Unlike the CD28, expression of ICOS is induced on the surface of active T cells upon 
stimulation through the TCR and CD28 (Coyle et al., 2000; A Hutloff et al., 1999; McAdam et 
al., 2000; S K Yoshinaga et al., 1999). 
ICOS signalling may be considered as a type of reassurance for T cell activation and 
subsequent proliferation and differentiation. It enhances low level IL-2 production by the CD4 
T cell which stabilises the initial proliferation (Riley et al., 2001). It is important for regulating 
effector T cells responses, particularly the cytokine production including IL-4, IL-5, IL-10, 
Granulocyte-macrophage colony-stimulating factor (GM-CSF), IFNg and TNFa as well as 
generation of Tfh with the provision of ICOSL by B cells being critical (Bauquet et al., 2009; 
Andreas Hutloff et al., 1999).  
The last member of the CD28 superfamily is the Programmed cell death 1 (PD1) receptor 
which binds homologues of the B7 molecules, namely PD-L1 (B7-H1) and PD-L2 (B7-DC). 
Those ligands are very specific and expressed on the lymphoid and non-lymphoid tissues as 
well as in some tumours. The PD1 receptor is expressed on the surface of activated T cells, 
B cells, DCs and NKT cells. Signalling through the PD-1 receptor inhibits CD28 induced 
activation of AKT pathway which results in an overall suppression of TCR signal transduction 




autoimmunity as C57BL/6 mice deficient in this inhibitory receptor develop an arthritis-like 
autoimmune condition (Nishimura et al., 1999).   
The cells of many tumours express high levels of PD-L1 ligand, preventing the development 
of effector T cell responses and thereby impairing patient outcomes. Blocking the interaction 
via the PD-L1 ligand has been shown to be paramount to the immunotherapy treatment of 
many types of cancer, including the glioblastomas, melanomas, breast and kidney cancers 
(Nomi et al., 2007; Thompson et al., 2007).  
 
1.2.6.2 Tumour Necrosis Factor Receptor Superfamily  
Tumour Necrosis Factor Receptor Superfamily (TNFRSF) consists of a set of receptors and 
their cognate ligands which provide an essential signalling network for many aspects of 
immune cell functions (Gravestein and Borst, 1998). Tumour Necrosis Factor Receptors 
(TNFRs) are involved in modulating the antigen-specific T cell responses, including 
production of cytokines as well as T cell survival. 
The founding member of the TNFRSF, TNF ligand, was identified four decades ago as one 
of the agents produced by activated monocytes and macrophages and it had detrimental 
effects on tumour cells in vitro causing them to undergo necrosis (Carswell et al., 1975). 
Further reports showed that it had potential in controlling the tumour growth in both in vitro 
and in vivo models (Haranaka et al., 1984; Matthews, 1979). TNF exists in two forms, as a 
transmembrane protein and as a soluble factor released by the TNFa converting enzyme 
induced proteolysis. All of the ligands in the TNFRSF form a homo-trimeric structure and are 
primarily designed for cell-cell contact, however their secreted forms can have more disperse 
effects (Bodmer et al., 2002). TNF binds two receptors the TNFR1 and TNFR2. Although 
majority of the cells express TNFR1 and only some express TNFR2, the transmembrane form 




The TNFRs constitute a group of 29 type 1 transmembrane monomer receptors, which 
associate into trimeric structures upon the ligand binding. As the definition implies, they 
contain both extracellular and intracellular domains. The structure of the ectodomain, 
extending into the extracellular space, is highly conserved within the superfamily and is 
characterised by its cysteine-rich region (Locksley et al., 2001).  
The TNF receptors can be divided into two groups, according to the nature of the signal 
transduction initiated by their intracellular domain. They can be either activating, like CD40 
and induce the NF-kB and MAPK pathways, or they can act as death receptors (DRs), like 
Fas receptor, initiating apoptosis (Li et al., 2013). Fas receptor is one of the most well-known 
death receptors. It contains an intracellular death domain which becomes activated upon the 
interaction with FAS ligand and recruits caspase 8 (Carrington et al., 2006). Caspase 8 
potentiates the apoptotic signals via the release cytochrome c and activation of caspase 9 
which in turn results in apoptosis or programmed necroptosis. Hence TNFRs can provide 
both costimulatory and coinhibitory signals having a direct effect on the course of immune 
responses. However, their expression can be regulated by types of interferons, like for 
instance Interferon g (IFNg) (Aggarwal et al., 1985).  
In humans, the majority of genes encoding the costimulatory TNFRs reside within one locus 
on Chr 1p36 (Granger and Ware, 2001). These include the OX40, CD30, HVEM, DR3, GITR, 
4-1BB, TNFR2 with their corresponding ligands located within the paralogues regions among 
Chr 1, 6, 9 and 19.  
For CD4 T cell function, OX40 and CD30 are likely the key TNFRSF members required for 








1.2.6.2.1 CD30 receptor  
CD30, also known as TNFRSF8, was identified in 1980s through the analysis of Hodgkin and 
Stenberd-Reed cell lines. The large set of monoclonal and polyclonal antibodies used in the 
study enabled an in-depth analysis of the cell expression profile (Stein et al., 1982). 
CD30 receptor shares the structural characteristics with other TNFRSF members and is 
expressed on activated B and T cells (Gilfillan et al., 1998; Stein et al., 1982). In mice, T cell 
expression of CD30 is enhanced in response to CD3 and CD28 signalling, and can be 
downregulated by IFNg (Gilfillan et al., 1998). 
CD30 ligand (CD30L/TNFSF8) is also inducible and expressed on DCs including some rare 
populations of splenic CD4 DCs, as well as NK cells, B and T cells, eosinophils and mast 
cells. In vitro mouse studies revealed that CD30L expression is also highly dependent on the 
TCR engagement and is absent on resting lymphocytes (Shimozato et al., 1999).  
Costimulation via the CD30 receptor has an impact on T cell proliferation, differentiation and 
survival. The costimulatory nature of the receptor is reflected in the signalling pathways 
activated upon its engagement. The c-terminal of the cytoplasmic tail of CD30 receptor 
recruits TNFR-associated factors (TRAFs). Particularly, TRAF2 and TRAF5 have been 
shown to mediate the CD30 induced activation of NF-kB and MAPK pathways (Aizawa et al., 
1997). Activation of those pathways was diminished when dominant negative mutants of 
TRAF2 and TRAF5 were generated (Aizawa et al., 1997; Duckett and Thompson, 1997). 
TRAFs associate with E2 and E3 ligase complexes which lead to RIP1 ubiquitination and 
subsequent activation of IKK complex. This complex, in turn, phosphorylates IkB which 
enables translocation of the NF-kB/Rel into the nucleus and activates transcription of target 
genes. Alternative pathway of CD30 signalling involves TRAF2 and TRAF5 induced activation 
of MAPK cascade and the activator protein 1 (AP-1), which regulate the course of cell cycle 




Classification of CD30 as a costimulatory molecules resulted from early in vitro studies which 
identified it as one of the enhancers of T cell responses (Bowen et al., 1996; Del Prete et al., 
1995). Other studies also highlighted the fact that CD30 is expressed late in the response, 
about 3-4 days post TCR engagement and therefore can be crucial in maintaining efficient T 
cell responses and promoting T cell survival (Nakamura et al., 1997).   
Early in vivo studies focused on assessing the effects of CD30 deletion on the development 
of T cells. Mice deficient in CD30 were first shown to have an impaired thymic negative 
selection determined by an increase in the total number of thymocytes and thereby 
suggesting that CD30 was involved in promoting cell death (Amakawa et al., 1996).  This 
however proved controversial and was later disproved by DeYoung et al. who used both class 
I and class II- restricted TCR transgenic mouse strains that were crossed with CD30
-/-
 mice 
to outline the role of CD30 in negative selection (DeYoung et al., 2000). They showed that 
the lack of CD30 signals had no effect on the negative selection and that it had a minimal 
effect on thymic apoptosis. In their study, DeYoung et al. discussed the possible caveats of 
the previously published data and narrowed them down to the problems with housing and 
breeding conditions of the mice used in the study.  
Further in vivo studies demonstrated the important role of CD30 signals in particularly the 
CD4, CD8 T cell and B cell responses. Some of the key findings of bacterial infection models, 
highlighted the role of CD30/CD30L signalling in controlling pathogens and the course of 
infection, in particular generation of long-lived memory T cell populations. Across different 
types of infections, the lack of CD30/CD30L signalling was associated with an increase in 
bacterial burden, reduction in the number of memory effector CD4 T cells capable of secreting 
IFNg as well as with a significant impairment in the CD8 T cell memory (Nishimura et al., 
2005; Podack et al., 2002; Tang et al., 2008; Umeda et al., 2011). Furthermore, CD30 signals 
have been shown to be important in gd T cell mediated immunity, particularly their ability to 




In regards to the humoral responses, the absence of CD30 signals has been linked to a 
reduction in the tiers of high affinity antibodies post immunisation with NP-chicken 
gammaglobulin (NP-CgG) (Gaspal et al., 2005). Moreover, at 14 days post NP-CgG treatment, 
the CD30
-/-




 mice failed to sustain germinal centres and lost 
plasma cells.  
In clinical studies, soluble CD30 has been used as one of the markers for monitoring the 
progress of immune diseases, like for instance leishmaniasis or HIV viremia, however it has 
also been used as a readout for the efficacy of hepatitis c therapy (Ajdary et al., 2006; Biswas 
et al., 2006; Yang et al., 2006). Due to the increased CD30 expression on many lymphomas, 
the signalling pathways have been targeted in various therapeutic treatments (Ansell et al., 
2007; Bhatt et al., 2016).    
 
1.2.6.2.2 OX40 receptor 
OX40 receptor and its costimulatory potential were first identified in 1987, using monoclonal 
antibodies against rat T cell blasts (Paterson et al., 1987). The study showed that blocking 
OX40 in vitro reduced T cell proliferation. Further cloning experiments identified it as a 
member of TNFRSF (Calderhead et al., 1993). OX40, also known as TNFRSF4, is a 50kD 
transmembrane protein which shares the cysteine-rich domain with other TNFRSF members.  
Ligand for OX40, the OX40L or TNFSF4, is also a transmembrane protein which was first 
identified as gp34 molecule present on T cells carrying the human T cell leukemia virus (Miura 
et al., 1991). So far, there is no clear indication suggesting that OX40L could be an alternative 
ligand for other receptors.  
Following antigen presentation and subsequent CD28 signalling, OX40 is induced on 
activated T cells with a peak of expression at 2-3 days post stimulation (Marriott et al., 2014; 
Stüber and Strober, 1996). CD40 activated APCs and APC and T cell-derived IL-2 production 




cells is highly dependent on the strength of TCR stimulation, however other factors like IL-2 
and IL-4 can also affect it (Gramaglia et al., 1998; Rogers et al., 2001; Toennies et al., 2004).  
Following repeated signalling through the TCR , the memory T cells upregulate OX40 more 
rapidly, often within 1-4 hours of reactivation (Croft, 2010). Constitutive expression of OX40 
has only been reported on nTregs. Several groups showed that OX40 ligation reduces 
suppressive function of nTregs specifically via downregulation of FoxP3 transcription factor 
(Kitamura et al., 2009; Takeda et al., 2004; Valzasina et al., 2005; Vu et al., 2007).    
Like CD30 receptor, OX40 is activated upon engagement with its ligand and acts via the 
TRAF2 and TRAF5 to initiate NF-kB, PI3K and AKT signalling pathways and thereby 
exacerbating its pro-survival properties (So et al., 2011) (Figure 1.3).  
 
 
Figure 1. 3 OX40-OX40L signalling. 
Primary sources of OX40L include activated APCs, like DCs and B cells, where its expression 


















lymphopoietin (TSLP) and signals through the BCR. OX40L, however, has also been found 
on other cell types including macrophages, endothelial, mast and NK cells (Imura et al., 1996; 







 accessory cells known as lymphoid tissue inducer (LTi) cells, belonging to 
the group 3 of ILCs were shown to provide both OX40L and CD30L, particularly at adult 
stages of mouse development (Kim et al. 2005). The expression of those two ligands is 
absent at the neonatal stages and reaches normal levels within the first weeks of life. The 
diversity of cell types providing OX40L suggests the pathway is involved in many aspects of 
immune responses and therefore poses as a potential target for various immunotherapies. 
Studies have shown that the close evolutionary relationship and sharing of signalling 
pathways between the CD30 and OX40 receptors supports redundancy in case of deficiency 
of one of the signals (Chung et al., 2002; M.-Y. Kim et al., 2005; Locksley et al., 2001). Despite 
this synergistic function of OX40 and CD30 receptors, previous data has shown the effects 
of the OX40 signalling to be more dominant in challenge CD8 T cell responses to OVA 
(Bekiaris et al., 2009a). In FoxP3-dependent autoimmunity, the lack of OX40 more than CD30 
signals decreased the function of effector T cells and thereby delayed the onset of the disease 
(Gaspal et al., 2011).   
OX40 signals are important for expansion and survival of both CD4 and CD8 T cells, by 
maintaining the survival signals and facilitating transition through effector phases (Gramaglia 
et al., 1998; I. Gramaglia et al., 2000; Murata et al., 2000a; Weinberg et al., 1999). The lack 
of early OX40 costimulation and the subsequent reduction in T cell proliferation translates 
into an impaired generation and reactivation of memory T cells (Salek-Ardakani and Croft, 
2006; Takeda et al., 2004; Valzasina et al., 2005; Vu et al., 2007) (Figure 1.4).  
Administration of agonistic OX40 antibody can overturn the defect and augment T cell 
responses. Similar results were obtained in mice constitutively expressing OX40L on DCs, 
which showed elevated numbers of CD4 T cells present within the B cell areas in GCs 




Reports of OX40 mediated control of cytokines production describe its contribution to the T 
cell derived IL-2 (Gramaglia et al., 1998). In this in vitro study, I-EK fibroblast lines were 
transfected with murine OX40L cDNA which enabled generation of APCs expressing either 
OX40L, CD28 or OX40L and CD28, and then were used to activate CD4 T cells. The results 
at 40 and 60 hours post stimulation showed the combined effect of OX40L and CD28 
signalling which promoted significantly higher levels of IL-2 production that either of the 
molecules alone.  
Furthermore, OX40 signals have also been shown to enhance expression of CD25, also 
known as IL-2R achain (Lathrop et al., 2004). In study of peripheral self-tolerance, transgenic 
CD4 T cells transferred into mice expressing pMHC ligand under the control of MHCII 
promoter expanded and became unresponsive to the antigen in vitro (Lathrop et al., 2004). 
Interestingly, 5 days post administration of agonist anti-OX40, T cells were defined by an 
increase in cell granularity and high expression of CD25. Mice died within 12 days of 
treatment due to the profound accumulation of effector T cells and the resulting cytokine 
storm. Administration of anti-OX40 augmented T cell responsiveness to IL-2 which in turn 
resulted in enhanced production of IFNg through stimulation with IL-12 and IL-18, which 
proved more effective than treatment with phorbol 12-myristate 13-acetate (PMA) and 
Ionomycin.     
Due to its enhancing properties, OX40 has been used as an adjuvant to increase immune 
protection against various infections. For instance, treatment with OX40L.Ig fusion protein 
mediated clearance of Cryptococcus neoformans (Humphreys et al., 2003). Moreover, OX40 
is also highly important in a poxvirus vaccine, where along with 4-1BB enhanced priming in 
vivo of both CD4 and CD8 T cells (Munks et al., 2004). Cancer therapy studies have focused 
on OX40 signalling, because of reports of OX40 expression on T cells infiltrating tumours and 




carcinomas (Weinberg et al., 2000). Anti-OX40 enhanced tumour specific priming as well as 
generation of memory T cells. The enhancing effect was however dose dependent.  
The Th2 infection models outlined the role of OX40 signalling in mediating the T cell specific 
in asthmatic patients and increasing airway sensitivity (Di et al., 2015; Hong et al., 2015; 
Siddiqui et al., 2010).  
 
Figure 1. 4 The role of OX40 signals in CD4 T cells responses. 
 
1.2.7 CD4 T cell memory 
Typical antigen-specific T cell responses are characterised by distinct phases during which 
they become activated (priming), proliferate (expansion), undergo apoptosis (contraction) 
with the remaining cells being maintained as a quiescent population (memory). T cell 
responses usually peak at day 7-15 post antigen encounter and after that initial phase, 
effector cells enter a long contraction phase during which the majority of them die through 
apoptosis (Krammer et al., 2007). This phase is characterized by an increased action of Fas 
signalling which is responsible for inducing apoptosis in the T lymphocytes (Nagata, 1997). 
Although, Fas receptor is found on both effector and naive T cells, only the active cells are 
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subjected to its negative effects due to the absence of the protective FLIP molecule (Tschopp 
et al., 1998). The effector cells capable of escaping the process survive and become memory 
cells. The T memory cells are residual and quiescent cells and can survive for many years 
after the infection has been cleared. In mice, the half-life of memory T cells fluctuate around 
40 days (Pepper et al., 2010). In this study the use of MHCII tetramers enabled tracking of 





 effector T cells were both found to survive and enter 
the memory pool.  
Memory T cells are often divided into two groups: the effector memory (Tem) and central 
memory (Tcm) cells. This classification is based on the expression of CCR7 and CD62L which 
characterise their migratory capabilities. Tcm express both CCR7 and CD62L which enables 
them to move via the lymphoid tissue (Pepper and Jenkins, 2011). They secrete more IL-2 
which results in increased proliferative potential. In comparison Tem are thought to move via 
the nonlymphoid tissue or blood and are secreting effector cytokines. Tem upregulate other 
adhesion molecules which allow the entry to the nonlymphoid tissues, for instance CCR4, E-
selectin and a4b1 which allows entry to the skin (Gehad et al., 2012). 
Memory and secondary responses have been described for all subsets of CD4 T cells. 
Generation of memory T cells in Th1 type of responses is well understood, unlike the 
generation of Th2 and Th17 memory which still proves problematic, primarily due to the lack 
of good antigen specific models. Moreover, the plasticity between the populations makes the 
research even more challenging. There have also been reports of Treg memory showing 
similar phases of activation, contraction and persistence in viral infections (Sanchez et al., 
2012).    
The factors responsible for promoting the CD4 memory T cell generation are still being 
established, due to the low abundance of those cells compared to the CD8
 
T cells. There are 




controversies arising from the use of TCR transgenic mice to assess the influence of 
TCR:pMHC interaction on generation of memory T cells, it has been shown that this 
association could play a significant role (Gray and Matzinger, 1991; Purton et al., 2007; Swain 
et al., 1999). The determining factor is the heterogeneity of the memory cells resulting from 
the asymmetric division which may affect their dependence on the TCR:pMHC interaction. 
This is visible in the turnover rate for the two identified populations the MHCII depended 
memory phenotype cells and MHC independent antigen-specific cells (Purton et al., 2007). 
Although the optimal TCR:pMHCII interaction is important, studies have shown that it is 
durability of the interaction of some TCR clones that gives them a competitive advantage and 
enables survival (Celli et al., 2008; Kim et al., 2013).  
Other factors like the initial size of the pool of naive T cells can regulate the expansion and 
size of the CD4
 
memory T cell population (Moon et al., 2007). Previous reports have shown 
that the number of naive CD4 T cell precursors specific for a single epitope in both mice and 
humans ranges between 1-100 cells per 10
6
 naive CD4 T cell (Kwok et al., 2012; Whitmire et 
al., 2006).  
Costimulatory signals and cytokines present during priming and expansion can also 
contribute to the establishment of memory population. The early CD28 and CD40 signals are 
particularly important as they both promote T cell expansion and minimise the non-specific T 
cell activation (Grewal et al., 1995; Jenkins et al., 2001; Pagan et al., 2012). As discussed 
before CD28 upregulates IL-2 production which in turn enhances the proliferation of effector 
T cells. Particularly, in Th1 and Th2 responses the strength of the IL-2 correlates with the 
CD4 T cell proliferation which in turn promotes survival of higher number of effector T cells 
and their entry into the memory phase (Pepper et al., 2011). Furthermore, TNFRSF plays a 
crucial role in maintaining effector T cells and promoting generation of memory T cells 
(Withers et al., 2009). 
Maintenance of CD4 T cell memory is dependent on a combination of TCR signalling, IL-7 




memory cells, specifically their responsiveness to IL-7 signals (Bushar et al., 2010). Similar 
to the CD8 memory T cells, under normal conditions, maintenance of CD4 memory T cells is 
IL-15 dependent (Purton et al., 2007). IL-7 and IL-15 are mainly produced by stromal tissues 
in secondary lymphoid organs, bone marrow, epithelial cells and antigen presenting cells 
(Fehniger and Caligiuri, 2001; Mazzucchelli et al., 2009).   
Developed memory T cells move throughout the body and upon encounter of a cognate 
antigen they drive a more rapid and specific secondary response, which results in a greater 
number of antigen-specific cells as well as greater responsiveness to the antigen. 
 
1.3 Adjuvants and their role in enhancing immune responses  
Development of successful vaccination systems requires many years of research, studying 
different aspects of immune responses. It is crucial to understand the mechanisms behind 
the development of highly efficient immunity and generation of memory T cell and B cells 
which will guard an individual against reoccurring infections. Interaction between innate and 
adaptive immunity including cell activation and recruitment, cytokine secretion and 
upregulation of costimulatory molecules are all key parameters which collectively influence 
the course of the immune response and the establishment of immune memory. Previous 
studies have shown that priming of CD4
 
T cells can be affected by many factors including the 
cytokine milieu surrounding the cells as well as the components and types of vaccines (Jelley-
Gibbs et al., 2008; Lanzavecchia and Sallusto, 2005).  
Vaccination involves administration of an immunologic agent which leads to the development 
of long-term immunity. It was first described in 1796 when Edward Jenner conducted his 
pioneering experiment. He inoculated 8-year-old boy, James Phipps with the matter from a 
cowpox lesion found on a dairymaid’s arm. He observed that James developed signs of mild 
infection which begun resolving after 10 days. Approximately 2 months later James received 




James did not develop smallpox as a result of treatment, which led to a conclusion that 
exposure to the cowpox virus provided protection against the smallpox virus. Since Jenner’s 
discovery, further advances in biological and immunological research led to establishment of 
worldwide immunisation programs which aimed to control the spread of infectious diseases. 
In 1980, following global immunisation campaign led by the World Health Organisation 
(WHO), smallpox was declared eradicated.  
Although we have been able to controls the vast majority of infections, we are still faced with 
several challenged like rapid evolution of disease-causing organisms, cancer, the 
complications of past diseases as well as public, social and financial challenges. All of those 
make the development of new vaccines that much more difficult. 
One of the most important stages in the history of vaccination was the transition between the 
live-attenuated and the more advanced inactivated vaccines as well as discovery of 
recombinant DNA technology which enabled formation of subunit vaccines. Although still in 
use, some of the early vaccines have been associated with insufficient bacterial inactivation 
which may be dangerous for recipients (Zepp, 2010). With the discovery of 
immunostimulatory effects of bacterial molecules and other antigen stability enhancing 
agents, inactivated vaccines became the main focus. In these vaccines microorganisms and 
viral particles are subjected to treatments with heat, chemicals or radiation and are therefore 
more safe for use (Pasquale et al., 2015). However, the absence of strong stimulation from 
living organisms makes those vaccines relatively inefficient and therefore they are heavily 
depended on either large doses which are not desired or more commonly are supported by 
adjuvants. 
Adjuvants were first discovered in 1920s, when observations of coinjection of diphtheria 
toxoid with unknown substances showed significantly higher rates of antibody production 
(Glenny and Südmersen, 1921). Shortly after this, it was found that both aluminium salts and 




Administration of antigen/adjuvant complexes has been shown to increase the expansion of 
CD4
 
T cells and production of proinflammatory cytokines (Curtsinger et al., 1999; Pape et al., 
1997). In studies on the responses to pigeon cytochrome c protein in B10.BR mice, the 
different adjuvants were shown as major determinants in antigen-driven CD4
 
T cell diversity 
(Baumgartner and Malherbe, 2010; Malherbe et al., 2008).    
 
1.3.1 Types of adjuvants and their mechanisms of action  
The action of majority adjuvants is based on two immune response inducing factors: 
stimulation of immune system and antigen delivery fraction. The immunostimulatory 
molecules consists of TLR, CLR and NLR ligands as well as saponins, providing co-
stimulation. The delivery systems comprise mainly the aluminium salts, which are most 
commonly used, and emulsions and lipid vessels (Reed et al., 2013).  
 
1.3.2 Aluminium salts 
Aluminium salts are far the mostly studied adjuvants. They were the first adjuvants that 
received approval to be used in human vaccines including vaccines against Hepatitis A 
(HAV), Hepatitis B (HBV), diphtheria/tetanus/pertussis (DTP) and human papillomavirus 
(HPV) (Apostólico et al., 2016). 
The mode of action of aluminium salts was first described in 1926, when precipitation of 
antigen with aluminium potassium sulphate proved effective in inducing antibody responses 
(Glenny et al., 1926). They have been shown to promote efficient antigen uptake and to 
stimulate components of the complement system (Gupta, 1998; Gupta et al., 1995). 
Aluminium salts were shown to work as terminals and bind antigens via electrostatic forces, 
allowing for their slow release rates and prolonging its effect on the immune system. This 
theory was widely accepted for many years, however in recent decade further research 




instance, removal of slow release-depot properties did not alter the immune response 
(Hutchison et al., 2011). Moreover, additional reports also demonstrated that aluminium salts 
led to a release of uric acid which acts as DAMP activating innate immune system (Kool et 
al., 2008). In addition, they can also be sensed by NOD-like receptors (NLRs) and activate 
NLRP3/NALP3 inflammasome complex (Eisenbarth et al., 2008). The key issues associated 
with aluminium adjuvants include weak responses, preferentially inducing Th2 responses, 
limited range of injection sites and possible allergic reactions (Grun and Maurer, 1989). 
Therefore, aluminium salts cannot be used in every vaccine formulation. 
 
1.3.3 Emulsions 
Emulsions are the most commonly used adjuvants. They have several classes depending on 
the dispersion phase of oil or water components (water-in-oil, oil-in-water, water-oil-water). 
They often act as antigen depot, slowing down its release yet their mechanisms are still not 
fully understood. The three representative adjuvants of this group are Freund’s Adjuvants, 
MF59 and AS03. Complete Freund’s adjuvant (CFA) is a water-in-oil emulsion, containing 
heat-killed mycobacteria. CFA induces immunogenicity and promotes primarily Th1 
responses (Yip et al., 1999). It has been used particularly in experimental induction of 
autoimmune diseases, like arthritis which could be induced through immunisation with type II 
heterologous collagen in CFA (Inglis et al., 2007). One major limitation of the use of CFA are 
the inflammatory side effects which often result in painful ulceration around the injection site 
(Billiau and Matthys, 2001).  
The Incomplete Freund’s adjuvant (IFA) is also a water-in-oil emulsion, however it does not 
contain mycobacteria. Similarly to CFA, the efficiency of IFA adjuvants is overshadowed by 
the possible side effects which for some individuals can be severe including sterile abscesses 




skewed Th2 responses (Yip et al., 1999). Alongside CFA it also enhances the antigen uptake 
by APCs through the increase in phagocytic activity (Nicol et al., 1966).  
The frequent side effect of both CFA and IFA has made them unsafe for human use and are 
progressively considered hurtful for the animals undergoing research, with some reports 
suggesting the use of analgesics to minimise the side effects (Kolstad et al., 2012).  
Another adjuvant, MF59 is a water-in-oil emulsion, containing squalene oil, and surfactants 
Tween 80 and Span85 which together induce robust cellular and humoral responses 
(Stephenson et al., 2005). It has been licensed for more than 19 years and has been used in 
influenza vaccine (Fluad™, Seqirus) which showed significant effects for adults and 
individuals over the age of 65 and adults suffering from chronic illness (O’Hagan, 2007). It 
has also been used to induce the immunogenicity of the trivalent inactivated influenza vaccine 
in 14-20 months children where it increased antibody titers and enhanced antigen-specific 
CD4 T cell responses (Nakaya et al., 2016). In PBMC cultures, MF59 induced secretion of 
chemokines, like CCL2 (MCP-1), CCL3 (MIP-1α), CCL4 (MIP-1β), and CXCL8 (IL-8) which 
act as chemoattractant for monocytes and granulocytes (Seubert et al., 2008). Similarly, it 
was also shown to promote monocyte differentiation characterised by upregulation of MHCII, 
CD86 and increased expression of CCR7. 
Finally, AS03 a GSK licensed oil-in-water adjuvant emulsion, containing a-tocopherol 
(vitamin E), squalene, and polysorbate 80, was first used in Prepandrix vaccine against avian 
influenza H5N1. Later it was also included in two other influenza vaccines, the Pandemrix 
and Arepanrix. The AS03 adjuvant has been shown to induce high antibody titers, even with 
reduced antigen dose. It has been shown to enhance the function of innate cells, particularly 
antigen presentation and increase the humoral and antigen-specific CD4 T cell responses 
(Garçon et al., 2012; Roman et al., 2011).  
As described above both MF59 and AS03 are considered safe for human use and have been 




1.3.4 Challenges of modern vaccines: Adjuvant system 01 (AS01) and its 
potential in promoting effective innate and adaptive immune responses  
The continuous evolution of disease-causing pathogens poses the biggest challenge of 
modern vaccines.  One of such organisms is the parasite from genus Plasmodium 
responsible for 212 million clinical cases of Malaria worldwide in 2015 leading to 429 000 
deaths (WHO, 2017). Recently, great focus has been placed on the development of vaccine 
targeting the deadliest P. falciparum infection. GlaxoSmithKline Biologicals (GSK), the PATH 
Malaria Vaccine Initiative (MVI), Bill & Melinda Gates Foundation and a network of African 
research centres came together to produce first efficient malaria vaccine, the RTS,S/AS01 








Figure 1. 5 Graphical depiction of circumsporozoite (CSP) and RTS,S structures 
(Kaslow and Biernaux, 2015). 
RTS,S vaccine is composed of 189 amino acids from circumsporozoite protein (CSP). This 
protein is found on the surface of the sporozoites or on infected hepatocyte (Offeddu et al., 
2012) (Figure 1.5). The Hepatitis B virus surface antigen (HBsAg) monomers are fused to 
CSP and serve as protein carriers (Bairwa et al., 2012). As RTS,S alone has been shown to 
have poor immunogenicity, the AS01 adjuvant has been added to improve the resulting 




The design of AS01 adjuvant gives this vaccine a great potential at targeting Malaria, however 
it has also been selected for development of candidate Zoster vaccine where it induced 
immunity in people over 50 years of age (Chlibek et al., 2013). The adjuvant itself began 
development more than 20 years ago and overtime has gained some excellent immune 
enhancing qualities.  
AS01 belongs to a group of liposomes-based adjuvants. This group of adjuvants combines 
two functions of being able to deliver the vaccine as well as induce immune responses. AS01 
is composed of two immuno-stimulants: MPLA and QS-21 (licensed by GSK from Antigenics 
Inc., a wholly-owned subsidiary of Agenus Inc., a Delaware, USA corporation).  
MPLA has been used as an immune stimulant for many years. It is a derivative of 
lipopolysaccharide (LPS) from Salmonella minnesota and therefore it acts on the innate 
immunity via the TLR4. It is however approximately 100-fold less toxic than LPS and therefore 
used as a preferred stimulant (Thompson et al., 2005). 
QS-21 is a saponin extract from soap bark tree Quillaja saponaria Molina. QS-21 is a water-
soluble triterpene glycoside. So far, the there is no clear understanding of the mechanisms 
and signalling pathways used by QS-21 to induce immune response, however it has been 
shown to trigger CD8
 
T cell and other antibody responses (Kashala et al., 2002; Newman et 
al., 1997). It also activates the ASC-NLRP3 inflammasome pathway inducing release of IL-
18. The cholesterol added to the liposome core removes its haemolytic activity (Didierlaurent 
et al., 2017). 
Previously, Diedierlaurent et al (2014) showed the impact AS01 had particularly on the innate 
immunity. They identified the response to be especially rapid, with the drainage from the 
muscle occurring within the first 24 hours post injections, concluding that the administration 
of antigen and adjuvant at the location and same time was pivotal to efficient establishment 
of antigen specific immunity (Arnaud M Didierlaurent et al., 2014). Flow cytometry analyses 
revealed elevated numbers of Ly6C
high
 monocytes and neutrophils within the muscle just 3 




hrs post injections (A. M. Didierlaurent et al., 2014). This suggests that AS01 promotes 
recruitment of innate cells into the site of injections and the dLNs. Specifically, the recruitment 
and activation of DCs and subsequent upregulation of costimulatory molecules is important 
to induce T cell priming and begin the process of establishing T and B cells memory 
populations. 
Recently, the group has focused on assessing the earliest stages of vaccination using the 
HBs antigen and AS01 (Coccia et al., 2017). They successfully identified cell populations 
involved in producing early production of IFNg which is well known to be highly important in 
creating Th1 polarising milieu, allowing establishment of antigen-specific CD4 T cells 
responses. They assessed the IFNg production in draining iliac LNs within the first 6 hrs of 
immunisation. The analyses revealed the main source of IFNg to include dLN resident NK 
cells and CD8 T cells which have been identified to respond in antigen-independent fashion.  
These initial findings have emphasised the potential and efficacy of the AS01 adjuvant in 
inducing immune responses against antigens.  
 
1.4 Aims 
Several hypotheses were stated prior the investigation: 
1. The CD4 T cells and their effector functions generated in response to Listeria 
monocytogenes-2W1S, Salmonella typhimurium-2W1S and AS01 adjuvant are 
dependent on OX40 signals. 
2. Cellular provision of OX40L by ILC3, T cells, DCs and B cells is crucial for the 
generation of effector CD4 T cell responses to Listeria monocytogenes-2W1S.  
3. Early cytokines produced in responses to Listeria monocytogenes-2W1S are involved 
in the regulation of OX40L expression on DC post infection.   
4. AS01 adjuvant induces early production of proinflammatory cytokines by innate 




CHAPTER 2: MATERIALS AND METHODS 
2.1 Mice 
Mice were bred at the University of Birmingham Biomedical Services Unit (BMSU) except for 
IL-12p35
-/- 
mice which were generated at
 
the University of Manchester and shipped to 
Birmingham. All mice were used in accordance with Home Office regulations. Efforts were 
made to ensure that mice were age and sex- matched for the individual experiments. The 
age of the mice ranged from 6 to 12 weeks at the start of the procedure. All genetically 
modified strains were compared to WT controls or adequate littermate controls bred in-house. 
The mice were sacrificed using a Schedule 1 technique, cervical dislocation of the neck. All 
mice used in this research were on a C57BL/6 background and their details can be found in 
Table 2.1.  
Table 2. 1 Original mice strains used in this investigation 
Mouse 
strain 









CD45.1 C57BL/6 WT BMSU 
C57BL/6  C57BL/6J 
https://www.jax.org/s
train/000664 






































CD45.2 C57BL/6 Deficient in 
expression of 
CD30 and OX40 
receptor (Gaspal 















CD45.2 C57BL/6 Deficient in 
CD80 and CD86 
costimulatory 
molecules. 











CD45.2 C57BL/6 Control strain 
expressing Cre 
recombinase 















CD45.2 C57BL/6 IFNg reporter 
mice (Price et 
al., 2012; 












CD45.2 C57BL/6 Strain has floxed 
exon 1 of the H2-
Ab1 locus, used 





















CD45.2 C57BL/6 Deficient in IFNg 










CD45.2 C57BL/6 Deficient in p35 

















CD45.2 C57BL/6 Deficient in 
CD1d, 
glycoprotein 












CD45.2 C57BL/6 Control strain 
expressing Cre 
recombinase 









































CD45.2 C57BL/6 Strain possess 
floxed Tnfsf4 
locus 
























CD45.2 C57BL/6 Deficient in T 



























CD45.2 C57BL/6 IL-17A reporter 



























CD45.2 C57BL/6 Conditional knockout mice lacking the 







CD45.2 C57BL/6 Conditional knockout mice lacking the 











CD45.2 C57BL/6 Reporter mice allowing to fatemap the 







CD45.2 C57BL/6 Conditional knockout mice lacking the 





CD45.2 C57BL/6 Reporter mice allowing to fatemap the 
expression of Cre in T cells.   
Great x 
Smart17A 









CD45.2 C57BL/6 Dual reporter mice for IFNg and IL-17A 











CD45.2 C57BL/6 Dual reporter mice for IFNg and IL-17A 
deficient in CD30 receptor and expressing one 








CD45.2 C57BL/6 Dual reporter mice for IFNg and IL-17A 
deficient in OX40 receptor and expressing one 







CD45.2 C57BL/6 Conditional knockout mice lacking the 







CD45.2 C57BL/6 Conditional knockout mice with ubiquitous 







CD45.2 C57BL/6 Conditional knockout mice lacking the 





CD45.2 C57BL/6 Reporter mice allowing to fatemap the 
expression of Cre in RORgt cells.   
 
2.2 Medium and Reagents   
2.2.1 Medium 
A list of reagents used in the research is provided below in Table 2.3  
Table 2. 3 List of reagents used in this investigation 
Medium  Reagents and concentrations 
Culture Medium RPMI-1640 with L- Glutamine (ThermoFisher), 1% Penicillin and 
Streptomycin (Sigma-Aldrich), 1% L-Glutamine (Sigma-Aldrich), 




Staining buffer (SB) Dulbecco’s Phosphate Buffered Saline (DPBS) +CaCl2 +MgCl2 
(Sigma-Aldrich), 2% Heat-inactivated foetal bovine serum (FBS) 
(Sigma-Aldrich), 2.5 M Ethylenediaminetetraacetic acid (EDTA) 
(Sigma-Aldrich) 
Staining solution for 
immunofluorescence 
microscopy 
Phosphate buffered saline (PBS) (Sigma-Aldrich), 1% Bovine 
serum albumin (Sigma-Aldrich) 
Haemolytic Gey’s 
Solution  
Solution A: 35 g NH4Cl, 1.85 g KCl, 1.5 g Na2HPO4.12H2O, 0.119 
g KH2PO4, 5.0 g Glucose, 25 g Gelatin, 1.5 mL 1% Phenol red 
Solution B: 4.2 g MgCl2.6H2O, 1.4 g MgSO4.7H2O, 3.4 g CaCl2 
Solution C: 22.5 g NaHCO5,  
distilled H2O 
Hank's Balanced 
Salt Solution (HBSS) 
with EDTA 
500 mL Calcium and Magnesium free HBSS (Sigma-Aldrich), 2.5 
M EDTA (Sigma-Aldrich) 
HBSS with FCS 500 mL Calcium and Magnesium free HBSS (Sigma-Aldrich), 2% 
FCS 
Culture media with 
Collagenase VIII 
(from C.histolyticum) 
15 mL culture media, 0.015 g Collagenase from C. histolyticum 
(Sigma-Aldrich) 
 
2.2.2 Gey’s solution 
Gey’s solution was used in preparation of spleen samples as a red blood cell lysis buffer. It 
was made from solution described in Table 2.3. Stock solutions A, B and C were prepared, 




combining 10 mL Solution A, 2.5 mL Solution B, 2.5 mL Solution C and 35 mL of distilled 
water. The buffer was kept at 4-8 °C.  
 
2.3 Cell isolation from murine tissues  
2.3.1 Preparation of cell suspension from mouse lymph nodes   
The dissected lymph nodes were placed in small petri dishes (Nunclon, ThermoScientific) 
containing 3 mL RPMI medium. The lymph nodes were cleaned under the dissecting 
microscope to remove the fat depositions around the tissues using forceps. 
Lymph nodes were teased using forceps and incubated in 3 mL RPMI with 250 μg/mL 
Collagenase/ Dispase (Roche), 25 μg/mL DNase I (Sigma-Aldrich) for 20 min at 37 °C. The 
reaction was stopped with 60 µL of 10 mM EDTA (Sigma-Aldrich). The tissues were crushed 
through a 70 μm Falcon cell strainer (Falcon, Corning) and washed thoroughly with RPMI. 
Cell suspensions were centrifuged for 6 min at 4 °C, 1500 rpm, unless stated otherwise. 
Pellets obtained from lymph node samples were then resuspended in appropriate volume of 
Staining Buffer (SB).  
 
2.3.2 Preparation of cell suspension from mouse spleen  
Spleen were dissected and placed in RPMI medium. When required, the spleens were teased 
using forceps and digested as described in section above with the digest lasting 30 min.  
The spleens were crushed through a 70 μm Falcon cell strainer and washed thoroughly with 
RPMI. The single cell suspensions were centrifuged and obtained pellets were resuspended 
in 5 mL Gey’s solution red lysis buffer. Pellets were incubated for 5 min on ice. After addition 
of 10 mL RPMI, the samples were centrifuged and pellets were resuspended in appropriate 




Cells prepared for flow cytometry took place in non-sterile conditions, whereas the 
preparation of cells for overnight culture involved the use of safety cabinets and sterile 
reagents.  
 
2.3.3 Preparation of cell suspension from mouse small intestine 
The small intestine was dissected (end of the stomach to the cecum) and the fat surrounding 
it was removed using forceps. Peyer’s Patches were excised and the small intestine was cut 
length-wise and cleaned in Hank's Balanced Salt Solution (HBSS) (Sigma-Aldrich) 2 % FCS. 
Next the intestine was cut into small fragments and placed in 50 mL falcon tube containing 
20 mL HBSS 2 % FCS. The sample was filtered through a nylon mesh and incubated in 20 
mL HBSS EDTA for 20 min at 37 °C shaking incubator. The sample was filtered and washed 
with 20 mL HBSS before incubating it for another 20 min in 20 mL HBSS EDTA in the same 
condition as above. Both HBSS EDTA and HBSS were prewarmed in 37 °C water bath prior 
the experiment.  
After second incubation, small intestine was washed 3 times with 20 mL HBSS. It was then 
placed in 15 mL of prewarmed culture media containing 1 mg/mL Collagenase VIII (Sigma-
Aldrich) and incubated for 15 min at 37 °C shaking incubator. After the initial 10 min 
incubation, the samples were shaken manually until most tissue fragments were digested, 
however at no point exceeding the 5 min. 
The digested tissue was placed on ice and then filtered through a 100 μm cell strainer 
(Greiner Bio-One) and then a 70 μm Falcon cell strainer each time washing it twice with 5 mL 
SB. Samples were centrifuged and pellets resuspended in appropriate volume of SB and 







2.3.4 Preparation of cell suspension from mouse colon 
The colons were dissected and the fat surrounding them was removed using forceps. The 
tissues were cut lengthwise and cleaned in Hank's Balanced Salt Solution (HBSS) (Sigma-
Aldrich) 2 % FCS. In general, the preparation followed similar protocol to the one used for 
small intestine, with some fundamental differences in enzyme mix used to digest the tissue. 
The enzymes used in colon and cecum preparation included: 0.85 mg/mL Collagenase V 
(sigma C9263-1G), 1.25 mg/mL Collagenase D (Roche 11088882001), 1 mg/mL Dispase 
(Gibco 17105-041), 30 µg/mL DNAse (Roche 101104159001). The enzyme mix was made 
in culture media and 10 mL was used per sample. Samples were digested between 30-40 
min at 37 °C.  
Similarly, to the small intestine preparation, the single cell suspensions were passed through 
a 100 μm cell strainer (Greiner Bio-One) and then a 70 μm Falcon cell strainer each time 
washing it twice with 5 mL SB. Samples were centrifuged and pellets resuspended in 
appropriate volume of SB and placed on ice. 
 
2.4 Cell Culture  
Cell suspensions were prepared in sterile conditions using the method described in section 
2.3.1 and 2.3.2. The cells were cultured overnight (24 hrs) at 37 °C, 5 % C02 in 24 well plate 
in 1 mL culture media. Those conditions were also true for the 48 and 72 hrs cultures. Both 
culture types involved culturing 2 x 10
6
 splenocytes/1 mL, unless stated otherwise.  
Assessment of OX40L expression on Antigen Presenting Cells, like dendritic cells and B cells 
required overnight culture with CD40 stimulation. For this purpose, purified anti-CD40 
antibody was added to at 1 µg/mL.  
To assess the expression of OX40L on T cells, 2 x 10
6
 splenocytes were cultured at 37 °C 
with 5 % C02 for 72 hrs in the presence of 10 µg/mL Abatacept and 0.5 µg/mL Functional 




In experiments assessing expression and regulation of OX40L on splenic DC, the 2x10
6 
splenocytes from uninfected or actA-deficient Listeria monocytogenes-2W1S (Lm-2W1S) 
infected mice, were cultured overnight (18-24 hrs) at 37 °C, 5 % C02 in 24 well plate in 1 mL 
culture media, either alone or with 1 µg anti-CD40 Abs or 100 ng recombinant IFNg 
(Peprotech). 
Unspecific stimulations with PMA and Inonomycin required culturing splenocytes at 37 °C in 
the presence of PMA (50 ng/mL) and Iononomycin (1.5 µM). After the initial hour, BFA (BD 
Biosciences) was added to a final concentration of 10 ug/mL and cells were incubated for 
further 3 hrs.  
In AS01 experiments, assessment of the early IFNg production involved incubation of cell 
suspensions for 3 hrs in culture media in the presence of Brefeldin A (BFA) (10 µg/mL, BD 
Biosciences) and Monensin (10 µg/mL, BD Biosciences) at 37 °C 5 % C02.  
Similarly, splenocytes or colon cells from mice infected with Lm-2W1S or Salmonella 
typhimurium respectively, were cultured for 3 hrs in culture media in the presence of BFA (10 
µg/mL, BD Biosciences) to assess IFNg production.  
 
2.5 Flow Cytometry 
List of antibodies used in flow cytometric analyses can be found in Table 2.4. 
The fraction of cells stained for specific markers was depended on the experiment and the 
population that needed to be identified. For the AS01 experiments whole pools of iliac and 
inguinal lymph nodes were stained, while in the Lm-2W1S model the staining was performed 
on 1/3 of pooled LNs (mesenteric, 2 inguinal, 2 brachial, 2 auxiliary) and 1/10 or 1/12 of 
spleen. Typically, 1/2 of mesenteric LN was stained, unless stated otherwise. When MACS 
cell separation was performed, whole enriched fraction and 1/10 of the run-through fraction 




Any samples subjected to cell culture and also gut samples were stained with APC eFluor 
780 viability dye (1:1000, eBiosciences) in PBS for 20 min on ice prior to antibody staining.  
For assessing OX40L on DC, prior to surface staining the cells were treated with 2.4G2 
antibody for 10 min to block FC receptor. 
Surface staining was performed in 96-well plates (ThermoScientific) in 50 µl or 100 µl SB for 
30 min on ice. Plates were centrifuged for 2-3 min to pellet the cells. Staining for CXCR5 was 
performed for 1 hr at room temperature (RT), usually alongside the 2W1S:IA
b
 MHCII Tetramer 
staining. Single stain controls were set up using WT splenocytes stained in 50 µl with 
individual fluorochromes used in the antibody cocktails. Staining for lineage markers involved 
the use of either individual antibodies or collection of antibodies conjugated to the same 
fluorochrome.  Following the staining, 100 µl of SB was added and the cells were centrifuged. 
Pellets were washed twice with 200 μL SB. 
Staining with biotinylated antibodies required isotype control staining to assist correct gating. 
For this type of staining, both antibody cocktails were prepared in SB containing 5 % of rat 
and 5 % mouse sera to block any non-specific avidin binding. The cells were incubated for 
30 min on ice. Detection of biotinylated antibodies was achieved using Streptavidin 
conjugated to specific fluorochrome, prepared in SB with 5 % of rat and 5 % mouse sera and 
incubating the samples for 30 min on ice. Following the staining, 100 µl of SB was added and 
the cells were centrifuged. Pellets were washed twice with 200 μL SB. 
Analysis of transcription factors and intracellular cytokines required the use of intracellular 
labelling. Following the surface staining, cells were fixed and permeabilised using either 
Foxp3 (eBioscience) or BD Cytofix (BD Bioscience) kits which were used according to the 
manufacturer’s instructions. Foxp3 (eBioscience) fixation and permeabilisation buffers were 
used for majority of transcription factor staining, with exception to experiments were reporter 
mice were used or overnight staining carried out. For those experiments as well as for majority 




buffers were used. The cells were fixed on ice for 30 min or overnight in 100 μL of 
fixation/permeabilisation solution prior to addition of 100 µL permeabilisation buffer and 
centrifugation. The cells were washed 3 times with 200 μL permeabilisation buffer. The cells 
were then stained with intracellular antibodies in 100 µL permeabilisation buffer for 40-60 min 
or overnight at RT. 100 µL of permeabilisation buffer was added before centrifuging the cells 
and washing twice with 200 µl of permeabilisation buffer. Pellets were resuspended in 200-
400 µL SB for analysis. 
The samples were transferred into fluorescence-activated cell sorting (FACS) tubes (Becton) 
and Spherotech Accucount blank particles (Spherotech) were added to each sample allowed 
calculation of total cell numbers factoring in the proportion of the samples analysed.   
Samples were analysed using LSR Fortessa X-20 with a FACS diva software (BD 
Biosciences). Compensations were set up manually using the single stain controls. The 
acquired events were first analysed using the forward and side scatter. The gate was placed 
appropriately to exclude dead cells and debris. Collected data was analysed using the FlowJo 















Table 2. 4 List of antibodies used in this investigation 
Specificity  Clone Conjugate  Dilution  Manufacturer  
B220  RA3-6B2 eFluor 450  
FITC  
PE-Cyanine7 

















Alexa Fluor 700 











eBioscience   
eBioscience  
CD4  RM4-5 Brilliant violet 510  
APC 





















CD1d PBS-57 APC 1:100 NIH 








eBioscience   
CD24 M1/69 Brilliant violet 605 1:600 Biolegend  
CD25  PC61 Brilliant Violet 650 1:200 Biolegend 




CD44  IM7 Brilliant violet 785  1:200  eBioscience  
CD45  30-F11 Brilliant violet 786 1:200 BioLegend  






CD49b DX5 FITC 1:200 eBioscence 
CD86 GL-1 FITC 





CCR6  29-2L17 Brilliant violet 605 1:100 eBioscience 
CXCR5  2G8 PE-Cyanine7 1:50  BD Biosciences  
EOMES Dan11mag PE 1:50 eBioscience 
GL7 GL-7 eFluor 450  1:100 eBioscience 
hNGFR ME20.4 PE 1:50 BioLegend 






IFN-g  XMG1.2 PE-Cyanine7 
Brilliant violet 510 




eBioscience   
BioLegend 
BioLegend 
IFN-gR  2E2 Biotin 1:100 eBioscience 
IL-2  JES6-5H4 Alexa Fluor 488  1:100  eBioscience  
Ly6c HK1.4 Brilliant Violet 711 1:800 BioLegend 
NK1.1 PK136 






NKp46 29A1.4 Brilliant Violet 605 1:100 BioLegend 
MHCII M5/114.15.2 
Brilliant Violet 510 










2.5.1 MHCII Tetramer staining 
MHC II tetramers were obtained from National Institute Health (NIH) Tetramer facility. The 
staining was performed for 1 hr at RT. Control MHC II tetramer was used regularly to stain a 
fraction of cells to assess the specificity of 2W1S:I-A
b
 tetramer binding. 
Additionally, experiments carried out to identify different memory T cell populations and T 




When performing the in vivo peptide stimulation it was important to preserve the detection of 
intracellular cytokines, therefore 1 μL of Brefieldin A (10 μg/mL) was added to each sample 
stained with 2W1S:I-A
b
 tetramer.    
The CD1d tetramer was added to the cocktail of extracellular antibodies and stained on ice 
for 30 min. 
 
Brilliant violet 421 1:20 BioLegend 
OX40L  RM134L PE 1:50 Biolegend 






SIRPa P84 PerCP-eFluor 710 1:200 eBioscience 






TCRb H57-597 Alexa Fluor 700 1:100 Biolegend 













2.5.2 MACS cell separation 
MACS cell separation was performed to identify and analyse the rare 2W1S:I-A
b
 populations 
at day 2-4 post immunization with Lm-2W1S. After 1 hr of staining with 10 μg/mL APC 
conjugated 2W1S:I-A
b
 MHC II tetramer in the dark in a RT water bath, the samples were 
incubated with 25 μL anti-APC beads (Miltenyi Biotec) for 15 min on ice. Cells were then 
washed and centrifuged and filtered through a 30 μm pre-separation filters (Miltenyi Biotec). 
The LS columns (Miltenyi Biotec) were assembled onto a magnet and washed with 3 mL 
staining buffer. The cells were passed through the columns and washed with 9 mL staining 
buffer (in 3 consecutive repeats). The magnetically labelled cells were flushed through the 
column with 5 mL SB by firmly applying the plunger. Both the enriched and ‘run-through’ 
fractions were stained to assess the efficiency of the enrichment.  
 
2.6 Immunisations and infections 
2.6.1 Growth of Listeria monocytogenes for infection  
Mice were infected with actA-deficient strain of Listeria monocytogenes-2W1S. This strain 
was engineered to express recombinant protein OVA fused to 2W1S52-68 
(EAWGALANWAVDSA). This enabled detection of antigen-specific CD4
+ 
T cell responses.  
 
2.6.1.1 Fresh stock preparation 
Bacterial cultures were plated and grown on agar with 20 μg/mL of selection antibiotic, 
chloramphenicol at 37 °C overnight. Agar plates were prepared by autoclaving agar powder 
(Sigma-Aldrich) in distilled water and adding the antibiotic once the medium has cooled to 
around 50 °C. The 20 mL of LB agar was poured into large petri dishes and were stored at 4 
°C. Single colonies of Lm-2W1S were subcultured in 10 mL LB broth containing 20 μg/mL 
chloramphenicol overnight at 37 °C in a shaking incubator. Next day the subcultures were 




original culture. Those were incubated for approximately 3 hrs to reach the optical density 
(OD)
600
 of 0.1 which was measured using a spectrophotometer (Jenway 6405). The 
spectrophotometer was calibrated using a LB medium. The culture that showed required 
OD
600
 was divided into 1 mL aliquots and centrifuged at 10000 rpm for 10 min. Pellets were 
washed with sterile PBS and centrifuged again to remove dead bacteria. The resulting pellets 
were resuspended in sterile PBS and further checks were performed to ensure the OD
600
 
remained within the limit of 0.1.  
 
2.6.1.2 Glycerol stock preparation 
Bacteria were pre-cultured in 10 mL of LB broth containing 20 μg/mL chloramphenicol from 
a single colony and grown overnight at 37 °C at 200 to 250 rpm. Next day, 1 mL of Lm-2W1S 
was seeded into 200 mL of LB broth containing 20 μg/mL chloramphenicol and grown at 37 
°C at 200 to 250 rpm until OD600 of 0.6-0.7 was reached. The liquid bacterial cultures were 
then centrifuged for 20 min at 4 °C, 4000 rpm. The supernatant was discarded and pellets 
resuspended in LB broth with 15 % glycerol. Glycerol stocks of Lm-2W1S were aliquoted into 
1 mL cryovials and stored at -80 degrees. Three randomly chosen samples were used to 
assess the viability of bacterial stocks by plating serial dilution of bacteria on agar containing 
20 μg/mL chloramphenicol. Prior administration, the 1 mL Lm-2W1S was centrifuged and 
washed with sterile PBS before resuspending in adequate volume of sterile PBS to obtain 
10
7
 bacteria per 200 µL.     
The bacteria were diluted in sterile PBS to 10
7 in 200 μL. Mice were infected with 10
7 Lm-








2.7.4 In vivo restimulation 
The mice that had been infected with Lm-2W1S received 100 μg 2W1S peptide (20 mg/1 mL) 
and 2.5 μg LPS i.v. in the tail vein. The mice were then sacrificed 4 hrs later and their spleens 
and pool of mesenteric, brachial, auxiliary and inguinal LNs were harvested for analysis.  
 
2.6.2 Growth of Salmonella typhimurium for infection  
Glycerol stocks were prepared using the same method as described in previous section. 
Streptomycin was used as a selection antibiotic. The viability of the stocks was tested by 
randomly choosing 3 samples and plating the bacteria on MacConkey agar (Sigma-Aldrich) 
containing 100 µg/mL of streptomycin (Sigma-Aldrich).  
The mice were given 20 mg of streptomycin in 100 µL sterile PBS by oral gavage 24 hrs prior 
to the administration of Salmonella.  
The glycerol stock of bacteria were centrifuged and washed with sterile PBS before 
resuspending in adequate volume of sterile PBS to obtain 10
9
 bacteria per 100 µL and 
administered by oral gavage.  
To determine the prevalence of Salmonella infection, stool sampling was carried out at 
various timepoints. To collect the stools, individual mice were placed in an isolated cage to 
allow time for stools production. The stools were weighed and resuspended in appropriate 
volume of PBS (e.g. 0.0321 g stool was resuspended in 321 μL of PBS) and left for 40 min. 
Once homogenised, the stools were pulsed in a centrifuge for 3 sec. The collected 
supernatants were used in serial dilutions, later plated on MacConkey agar (Sigma-Aldrich) 
containing 100 µg/mL of streptomycin and grown overnight at 37 °C.  
 
2.6.5 AS01 adjuvant immunizations 
To test the effectiveness of AS01 adjuvant, the injections were performed using the 2W1S 




intramuscular injections. The injections were performed in sterile conditions with mice under 
anaesthetic. The site of the injection, the gastrocnemius muscle, was shaved to allow better 
visualization of the site. Approximately 3 mm of the needle was inserted into the muscle. Mice 
were left to recover while being monitored for any signs of possible damage to the sciatic 
nerve.  
Initial experiments involved administration of 30 μL Evan Blue dye at 10 mg/ml of PBS in 
gastrocnemius muscle of one leg.   
Later experiments progressed to test the effect of AS01 on enhancing the immune response. 
The subsequent refinements involved injecting the OVA-2W1S protein with or without the 
AS01 as well as reduction of the injection volume to 10 μL administered into gastrocnemius 
muscle of both hind legs. The injections contained either 20 µg OVA-2W1S (10 mg/1 mL) and 
1/50 Human Dose (HD) AS01 or 20 µg OVA-2W1S and PBS. A pool of iliac and draining 
inguinal lymph nodes were analysed to assess the changes in immune response. Cell 
suspensions were prepared according to the protocol in section 2.3.1. 
 
2.7 Statistics 
Data were analysed using GraphPad Prism (version 6.0e). Non parametric Mann- Whitney, 
two tailed test or Non-parametric Kruskal-Wallis one-way ANOVA with post hoc Dunn’s tests 
were used to determine significance which was set at p≤0.05. Median values were calculated 










CHAPTER 3: THE ROLE OF OX40 SIGNALS IN TH1 CD4 T CELL 
RESPONSES 
3.1 Introduction  
Effective CD4 T cell responses, both primary and secondary, rely on activation and most 
importantly subsequent expansion of antigen-specific cells. In the absence of expansion, the 
insufficient numbers of activated antigen-specific cells can lead to poor immune responses 
or tolerance which often result in cells death (M. Croft et al., 1992).  
APCs play a crucial role in eliciting CD4 T cell responses, by providing essential signals that 
promote both activation and expansion. The discovery of CD28 signalling in the late 1980s 
marked an emergence of a new two-signal model of T cell activation. Although oversimplified, 
this theory described the importance of both the formation of TCR and Ag-MHCII complexes 
as well as the signalling via various costimulatory pathways (Jenkins et al., 1988; Mueller et 
al., 1989). 
The costimulatory interactions have different levels of significance, with some of them like the 
CD28 signalling being absolutely essential for T cell activation as represented by the 
constitutive expression of CD28 receptor on the surface of all naive T cells. Other 
costimulatory pathways, however, can be inducible, being expressed or regulated after the 
initial TCR and CD28 signalling. These include for instance, ICOS, a member of the CD28 
and CTLA-4 receptor family, which is similarly efficient in enhancing T cell responses like 
CD28, increasing proliferation and secretion of cytokines, except for IL-2 (A Hutloff et al., 
1999). Others include members of the TNFRSF, like OX40 and CD30, which are involved in 
potentiating and maintaining the survival of Ag-specific CD4 T cells.  
Although, it is known that co-signalling downstream of the TCR is important in all stages of T 
cell response, like the priming, effector and memory phases as well as for both CD4 and CD8   




the exact timing and contributions of individual signalling pathways impacting T cell function 
still require further understanding.  
Since its discovery in 1980s, much progress has been made in understanding the role of 
OX40 signalling pathway in various immunological models. The preferential expression of 
OX40 on activated CD4 T cells has highlighted its potential in promoting and augmenting 
immune responses as well as in generation of long-term memory. It has provided a 
particularly attractive target for cancer immunology, with many studies emphasising the 
benefits of using OX40 agonists in targeting tumours (Gough et al., 2012; Redmond et al., 
2014). Phase I clinical trials of patients with advanced form of cancer showed OX40 to be a 
potent costimulatory pathway, with a regression of metastatic lesions after just one treatment 
with monoclonal OX40 antibody (Curti et al., 2013).  
Many in vitro and in vivo studies showed OX40 to be crucial in the secondary mechanisms of 
T cells activation, maintaining proliferation and enhancing their survival by activating Bcl-xL 
and Bcl-2 molecules (Rogers et al., 2001; Soroosh et al., 2014, 2007). 
Despite early questions regarding polarisation signals and OX40, there is growing evidence 
suggesting that all effector T cell populations are indeed OX40 dependent, regardless of the 
differences in the polarisation signals.  
Initial studies suggested that OX40 was particularly important for regulating the balance 
between Th1 and Th2 immunity, particularly during T cell priming where it was shown to 
promote Th2 differentiation. For instance, activated naive T cells engaging in OX40/OX40L 
signalling were shown to produce low but stable levels of IL-4 cytokine, promoting 
development of Th2 effector cells (Ohshima et al., 1998). Moreover, disease models revealed 
that OX40 deficient mice appeared to be resistant to allergic inflammation in mouse model of 
asthma, while in WT mice blockage of OX40 signals prevented progression of Leishmania 
major induced infection which was linked to reduced Th2 responses (Akiba et al., 2000; 
Jember et al., 2002). Additionally, overexpression of OX40L acted as an adjuvant, 




described provision of OX40L by DC in vivo to be potent costimulatory signal promoting Th2 
responses, however with no effect on their optimal polarisation (Jenkins et al., 2007). On the 
other hand, studies also showed that in presence of IL-12, OX40L lost the ability to mediate 
Th2 immunity and instead increased Th1 inflammatory responses by inducing release of 
TNFa, while immunotherapy with OX40L-Fc (chimeric fusion protein) increased levels of Th1 
cytokines (Ito et al., 2005a; Zubairi et al., 2004). However, further studies are still required to 
fully understand the role of OX40/OX40L signalling in Th1 responses.    
In regard to Th17 responses, the published data is contradictory, since some reports propose 
that OX40 signals are supportive for Th17 cells in vivo, however, other studies conclude that 
OX40 signals inhibit Th17 formation through histone modifications that result in closure of 
Il17 locus (Xiao et al., 2016, 2012; Xin et al., 2014; Zhang et al., 2010).   
With all of the conflicting data, one particular study investigated the role of several 
costimulatory molecules, including OX40, in T cell differentiation, also assessing the role of 
the initial antigen dose as well as affinity of the peptide presented as a part of MHCII during 
CD4 T cell priming. They concluded that rather than one individual receptor intrinsically 
controlling differentiation of CD4 T cells, it was the combination of many costimulatory 
pathways and the peptide affinities that led to acquisition of specific T cell fate (Rogers and 
Croft, 2014). Therefore, perhaps OX40 alone functions as a regulator of T activation rather 
than one of the cell fate determinants.  
Many of the existing studies investigating the role of OX40 signals in various immune 
responses have utilised TCR transgenic T cells often at completely unphysiological precursor 
frequencies, having a profound effect on the nature of the response. Assessments of the T 
cell function in the presence and absence of OX40 have also been limited, with the analysis 
of cytokine production often relying heavily upon ex vivo restimulation. This can distort our 
understanding of where the defects really are and might explain why OX40 signals have been 




In this chapter, we aimed to further define the role of OX40 signals, particularly focusing on 
their requirement in generating functional CD4 T cell responses in a polyclonal endogenous 
response and investigate which T cell populations are impacted the most by the lack of OX40 
signalling. Using previously widely utilised 2W1S peptide, either incorporated into bacterial 
genome or conjugated to OVA protein, we were able to track antigen specific CD4 T cell 
responses to Listeria monocytogenes, Salmonella serovar typhimurium as well as adjuvanted 
vaccines. Those three very different models enabled us assessing the effects of OX40 
deletion on 2W1S-specific effector CD4 T cells in systemic and acute intestinal Th1 






















3.2.1 IFNg producing effector CD4 T cells generated in response to Listeria 
monocytogenes-2W1S are OX40 dependent   
Early studies have established the essential role of the OX40 pathway in the formation of 
robust primary CD4 T cell responses (Gaspal et al., 2005; Rogers et al., 2001). One such 
study has shown that primary responses to antigen pigeon cytochrome c, in particular the 
effector cell proliferation and functions were highly dependent on OX40 signals (I Gramaglia 
et al., 2000). However, many of the previous research investigating the antigen-specific CD4 
T cells responses used TCR transgenic models and did not explored the endogenous T cell 
populations. As monoclonal populations, having no variations in their clonal expansion, TCR 
transgenic T cells are limiting as they distort the real representation of the endogenous in vivo 
responses. Moreover, the experimental design of the TCR transgenic models often involves 
a transfer of a considerably large numbers of TCR transgenic T cells, creating not only a 
competitive environment but also further altering the effector responses due to the large 
precursor populations (Ford et al., 2007; Hataye et al., 2006; Kearney et al., 1994).  
As previously established in our laboratory, we have used a more refined method of tracking 
the antigen specific CD4 T cell responses. This method was optimised by the Jenkins 
laboratory, where they used MHCII Tetramers to an immunogenic peptide 2W1S which has 
been previously shown to be recognised by a large endogenous population of naïve CD4 T 
cells  
The immunogenic potential of the 2W1S peptide was utilised by creating an attenuated strain 
of Listeria monocytogenes with a mutation in the actA gene preventing bacterial motility, that 
was engineered to secrete an OVA-2W1S conjugate protein under the control of hly promoter 
(Ertelt et al., 2009; Portnoy et al., 2002). Infection with an attenuated Listeria monocytogenes-
2W1S (Lm-2W1S) strain has been extensively studied and has been characterised by a 





The initial studies in our laboratory have shown the significance of OX40 signals in 
establishing the antigen specific CD4 T cells responses to Lm-2W1S. In particular, previously 
published data on Lm-2W1S induced memory CD4 T cell responses have determined an 
important role for OX40 pathway, specifically in generating 2W1S effector memory T cell 
populations (Marriott et al., 2014). Interestingly, in the absence of OX40 signals, generation 
of T follicular helper cells occurred without any complications. These results provided useful 
insight into the costimulatory requirements of 2W1S specific CD4 T cells in producing efficient 
and long-term responses to Listeria infections.  
We therefore aimed to build on this existing data by investigating the primary CD4 T cell 
responses to Lm-2W1S in the absence or presence of OX40 signals using IFNg reporter mice 
to better asses the functional requirements of CD4 T cells. Furthermore, we also focused on 
expanding the investigation to include other infection models to determine if OX40 signals 
could have the same impact across different Th1 responses and tissues.  
Although CD30 and OX40 clearly control the outcome of CD4 T cell responses, 
understanding their effect within an endogenous response with survival versus function 
carefully dissected has not been done, but is crucial to really understanding exactly what 
these signals do. 
We began our investigations into the requirements for OX40 signals in establishing efficient 
CD4 T cell responses to Lm-2W1S focusing on the specific role of these signals in the function 
of CD4 T cells defined as their ability to make IFNg. For these analyses we generated mice 






) and crossed with Great x Smart17A dual 
IFNg and IL-17A reporter (GS) mice (Price et al., 2012). The two costimulatory pathways for 
CD30 and OX40 have previously been shown to have possible redundancy in their 
expression, showing a synergistic effect on the survival of Th2 cells in responses to alum-
precipitated NP-chicken gammaglobulin, thus we decided initially to use the CD30
 
and OX40 




The use of GS mice allowed for accurate and unmanipulated assessment of the impact of 
CD30 and OX40 ablation on the IFNg expression following the infection as well as cell 




 mice alongside WT controls 
were infected with Lm-2W1S and the responses assessed in the spleen at the peak of the 
response, at 7 days post infection (dpi). WT mice were used as negative controls for the eYFP 














, revealed a robust population of CD44
hi
 2W1S-specifc CD4 T 
cells characterised with the use of 2W1S tetramer (Figure 3.1 A).  
To distinguish between the effector and Tfh populations of 2W1S-specific CD4 T cells, we 
assessed the expression of eYFP and CXCR5 which were previously identified to be 
dominant in the two populations respectively (Pepper et al., 2011). The gates were set using 





 mice (Figure 3.1 B). Our analyses showed that absence of CD30 and OX40 
resulted in modest reduction (approximate two-fold) in total number of 2W1S-specific CD4 T 
cells (Figure 3.1 C). However, the most prominent contribution of OX40 signals was observed 
when assessing the eYFP expression, where the numbers and percentages of effector T 








 mice (Figure 
3.1 B, D, E). The reduction in numbers was approximately 8.7-fold comparing to the GS mice. 
Interestingly, the numbers of Tfh CXCR5
+
 cells were not affected by the lack of CD30 and 
OX40 signals (Figure 3.1 F), consistent with the previously published data on the OX40 
independent Tfh responses (Marriott et al., 2014). 
Due to the eYFP reporter expression being relatively low, we next sought to assess Th1 
effector responses using another method, namely assessment of the T-bet expression which 
was previously identified as transcription factor required for efficient Th1 responses and IFNg 


































































































Figure 3. 1 Mice deficient in CD30 and OX40 show a dramatic decrease in reporting of 
IFNg production  
To determine the requirement for CD30 and OX40 on CD4 T cell effector function without ex 
vivo manipulation, dual IFNg (eYFP) and IL-17A reporter mice (Great x Smart17A, GS) 




) were infected i.v. with Lm-
2W1S and the splenic response analysed at 7 days post infection. (A, B) Gating strategy 
showing identification of 2W1S-specific CD44
hi














 mice. Gated on 
WT cells (lacking any eYFP) used to establish eYFP gating. (C) Enumeration of 2W1S-
specific CD4 T cells. (D) Enumeration of eYFP+ 2W1S-specific CD4 T cells. (E) Percentage 
of 2W1S-specific CD4 T cells expressing eYFP. (F) Enumeration of CXCR5+ 2W1S-specific 
CD4 T cells. Data are pooled from three independent experiments, n=11. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 










These analyses ensured that all effector cells were identified regardless of their functional 














] and their expression of T-bet assessed against the expression 




 mice (Figure 3.2 A, B). Numbers of effector 




 and their percentages were significantly reduced 
(approximately 2.1-fold) in the absence of CD30 and OX40 signals (Figure 3.2 C, D). 




, where unaffected in none 
of the mouse strains assessed, again supporting the nonessential role of OX40 signals in Tfh 
formation (Figure 3.2 E). 
We aimed to determine whether the absence of IFNg-producing Th1 cells at 7 dpi, identified 
in Lm-2W1S as peak of the response, was due to the reduced survival of the effector T cells. 
We therefore performed identical assessment of the 2W1S-specific CD4 T cell responses at 




 mice, looking at both the ability to make IFNg and 
expression of T-bet.  
Consistently with the analyses conducted at 7 dpi, also in this case the number of 2W1S-




 mice (Figure 
3.3 B). Furthermore, the numbers and percentages of eYFP
+
 2W1S-specific CD4 T cells were 
heavily reduced in the absence of CD30 and OX40 signals, as oppose to no difference in the 
number of CXCR5
+
 2W1S specific T cells (Figure 3.3 A, C, D, E). This data was further 
supported by the considerable reduction of T-bet expression on 2W1S-specific effector CD4 




 mice (Figure 
3.3 F, G, H, I). Altogether, these results have highlighted the crucial role of CD30 and OX40 
signals in primary responses to Lm-2W1S, being particularly important for the function and to 
a lesser extend the number of Th1 effector CD4 T cells.  Majority of research has concluded 
the role of OX40 to be specifically important for the survival of T cells and memory responses 








































































Figure 3. 2 Generation of Th1 effector T cells, but not CXCR5+ populations is highly 
dependent on CD30 and OX40 signals  
To test the role of CD30 and OX40 signals in the generation of Th1 effector CD4 T cells, the 




 mice were infected i.v. with Lm-2W1S and the responses 
assessed at 7 days post infection. (A, B) Gating strategy showing identification of 2W1S-
specific CD44
hi










) and their expression of CXCR5 




 mice. (C) Enumeration of T-bet+ 2W1S-specific 
CD4 T cells. (D) Percentage of 2W1S-specific CD4 T cells expressing T-bet. (E) Enumeration 
of CXCR5
+ 
2W1S-specific CD4 T cells. Data are pooled from three independent experiments, 
n=11. Values on flow cytometry plots represent percentages, bars on scatter plots represents 
the median. Statistical significance was tested using an unpaired, non-parametric, Mann-




































































































































GS CD30-/- x OX40-/-






Figure 3. 3 Requirements for OX40 signals in generation of effector T cells and their 
function are evident early in the response  
To determine the requirement for CD30 and OX40 on CD4 T cell effector function without ex 
vivo manipulation, GS and GS CD30-/- x OX40-/- were infected i.v. with Lm-2W1S and the 
splenic response analysed at 4 days post infection. (A) Gating strategy showing identification 
of 2W1S-specific CD44
hi










) and their expression 




 mice. Gated on WT cells (lacking any 
eYFP) used to establish eYFP gating. (B) Enumeration of 2W1S-specific CD4 T cells. (C) 
Enumeration of eYFP
+ 
2W1S-specific CD4 T cells. (D) Percentage of 2W1S-specific CD4 T 
cells expressing eYFP. (E) Enumeration of CXCR5+ 2W1S-specific CD4 T cells. (F) 
Expression of T-bet versus CXCR5 by 2W1S-specific CD44
hi





 mice. (G) Enumeration of T-bet+ 2W1S-specific CD4 T cells. (H) Percentage 
of T-bet
+
 2W1S-specific CD4 T cells. (I) Enumeration of CXCR5+ 2W1S-specific CD4 T cells. 
Data are pooled from two independent experiments, n=7. Values on flow cytometry plots 
represent percentages, bars on scatter plots represents the median. Statistical significance 
was tested using an unpaired, non-parametric, Mann-Whitney two tailed T test: *p≤0.05, 










Here we successfully showed that responses were diminished from the very early stages and 
were maintained throughout, thereby linking the requirements of OX40 to the function of T 
cells rather than only to the expansion and survival.  
 
3.2.2 OX40 signals play the dominant role in generating functional effector 
CD4 T cells  
Having established the importance of OX40 and CD30 signalling pathways for effector T cell 
responses, we sought to determine if OX40 was indeed the dominant signal as previously 
indicated (Bekiaris et al., 2009b; Gaspal et al., 2011).  







 mice by the means of the T-bet and CXCR5 expression which were used 
as determinants of the effector and Tfh populations respectively (Figure 3.4 A). We observed 





 mice as compared to WT and OX40
-/-
 mice (Figure 3.4 B). These results were 





 mice reporter mice.  
Although, OX40
-/-
 mice showed minimal but not statistically significant defect in the total 2W1S 
response, the analyses of their 2W1S-specific CD4 effector T cells evidently indicated the 
requirement for OX40 signals represented by approximately 3-fold reduction in the number 
of T-bet expressing 2W1S-specific T cells (Figure 3.4 C). Similar defect in the effector T cell 




 mice, approximately 4.5 reduction when 
compared to the WT control mice (Figure 3.4 C), demonstrating the effector T cell responses 
to be in larger part dependent on OX40 rather than the CD30 signals. Significant defect in the 
total numbers of T-bet expressing cells were further supported by similar statistically verified 
reduction in percentage of 2W1S-specific CD4 T cells expressing T-bet at 7dpi (Figure 3.4 
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Figure 3. 4 Generation of effector T cells is dependent primarily on OX40:OX40L 
interactions in response to Lm-2W1S  
The specific contribution of OX40:OX40L interactions in the generation of Th1 effector CD4 
T cells was determined in the response at 7 days post infection with Lm-2W1S. The 2W1S 






 mice. (A) 
Expression of T-bet versus CXCR5 by 2W1S-specific CD44
hi
















 mice. (B) Enumeration of 2W1S-specific 
CD4 T cells. (C) Enumeration of T-bet+ 2W1S-specific CD4 T cells. (D) Percentage of T-bet+ 
2W1S-specific CD4 T cells. (E) Enumeration of CXCR5+ 2W1S-specific CD4 T cells. Data are 
pooled from four independent experiments, n=20 WT, n=17 OX40KO, n=20 dKO. Values on 
flow cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using Kruskal-Wallis one-way ANOVA with post hoc 















To further investigate the dominant role of OX40 in establishing effector T cell, particularly in 
their functional capabilities, we generated GS reporter mice that were deficient in either CD30 









 (sufficient in OX40 but lacking CD30 signals) were infected with Lm-2W1S 
and the responses assessed in spleens at 7 dpi. Similarly, to the previous data, we found that 
approximately 30% of 2W1S-specific CD4 T cells in GS mice expressed eYFP (proportional 
to IFNg) at 7 dpi (Figure 3.5 A). Comparisons in the single knockout mice revealed once again 
a OX40 dependent formation of effector T cell population shown by the significant reduction 
in the numbers and percentages of eYFP
+













mice (Figure 3.5 A, B, C). 
No significant differences were found in the expression of CXCR5, defining the Tfh population 
to be OX40 independent (Figure 3.5 D).  
Moreover, analyses of T-bet expression in infected GS mice further indicated the OX40 
specific, rather than CD30, generation of effector T cells post infection with Lm-2W1S (Figure 
3.6 A). In comparison to the GS control mice, the enumeration and percentages of T-bet 














3.6 A, B, C). Typically, the Tfh responses were not influenced by the differences the provision 
of OX40 and CD30 signals.  
Together these data demonstrate the dominant nature of OX40 signals and their crucial 
requirement for generating primary Th1 response in Lm-2W1S induced infection, with the 























































































Figure 3. 5 OX40 rather than CD30 is critical for the CD4 effector T cell response to 
infection with Lm-2W1S  
To dissect the individual requirement for CD30 versus OX40 in the production of IFNg by 








 mice to 









). The 2W1S-specific CD4 T cell response was assessed at 7 days post 
























 mice. (B) Enumeration of 2W1S-specific 
CD4 T cells expressing eYFP (C) Percentage of 2W1S-specific CD4 T cells expressing eYFP. 
(D) Enumeration of CXCR5+ 2W1S-specific CD4 T cells. Data are pooled from three 
independent experiments, n=8. Values on flow cytometry plots represent percentages, bars 
on scatter plots represents the median. Statistical significance was tested using an unpaired, 
non-parametric, Kruskal-Wallis one-way ANOVA with post hoc Dunn’s test: *p≤0.05, 

























































































Figure 3. 6 Dominant role of OX40 in generation of CD4 effector T cells  
To dissect the individual requirement for CD30 versus OX40 in the generation of Th1 effector 













were infected i.v. with Lm-2W1S and responses were assessed at day 7 post infection.  











); (B) Enumeration of T-bet+ 2W1S-specific CD4 T cells. (C) 
Percentage of T-bet
+
2W1S-specific CD4 T. (D) Enumeration of CXCR5+ 2W1S-specific CD4 
T cells. Data are pooled from three independent experiments, n=8. Values on flow cytometry 
plots represent percentages, bars on scatter plots represents the median. Statistical 
significance was tested using an unpaired, non-parametric, Kruskal-Wallis one-way ANOVA 
















3.2.3 The requirement for OX40 signals persists throughout the response   
Previous reports concluded the role of OX40 to be specifically important for the survival of T 
cells and memory responses (Byun et al., 2013; Gaspal et al., 2005; I. Gramaglia et al., 2000). 
Having established that T-bet expression could be used to track effector T cells responses to 
Lm-2W1S and most importantly was reflecting the OX40 requirement of 2W1S-specific CD4 
T cells to generate efficient immune responses, we aimed to investigate further time points in 
the infection to determine whether the defective primary responses could persists later on, 
having a particular impact on the memory responses upon challenge.  






 mice infected 
with Lm-2W1S and found no significant difference in the 2W1S-specific CD4 T cell response 
in all infected strains (Figure 3.7 A, B). However, despite the initial observations, analyses of 
T-bet versus CXCR5 expression identified a persisting defect in the effector T cell population 
in mice that lack both OX40 and CD30 signals. Both the total numbers and percentages of 






 mice, with minimal 
changes observed in Tfh CXCR5
+
 populations (Figure 3.7 C, D, E). This once more has 





 replicated the results obtained in straight OX40
-/-
 mice.  
We next wanted to determine whether requirements for OX40 signals were also crucial in 







 mice at day 0 and then administered another dose 
of the Lm-2W1S at 42 dpi. The mice were then left for 4 days to enable for secondary 
expansion of 2W1S-specific CD4 T cells and were immunised again with 2W1S peptide 
adjuvanted with LPS to induce IFNg production, a method previously described (Marriott et 
al., 2014). The responses were assessed 4 hrs later. The enumeration of 2W1S-specific CD4 
T cells showed no significant differences between the mice comparable to the results 




clear dependency on the availability of OX40 signals at the time of secondary challenge. First 







 mice (Figure 3.8 A, C). The number of Tfh cells was again 
unaffected by the lack of OX40 and CD30 signals (Figure 3.8 D). 
The most notable results, defining the crucial role of OX40 signals in memory responses upon 
challenge emerged from the assessment of functional capabilities of the 2W1S-specific CD4 
T cells, namely their ability to produce IFNg. We compared the IFNg versus IL-2 production 
following the 2W1S peptide in vivo restimulation in WT, OX40-/- and CD30-/- x OX40-/- mice 
(Figure 3.8 E). The results showed a significant impairment in the production of IFNg in the 
absence of both OX40 and CD30 signals as represented by the reduction in total numbers 
as well as percentages of IFNg expressing 2W1S-specific CD4 T cells (Figure 3.8 F, G). 
Concluding, our analyses successfully demonstrated an OX40 dependent generation of 
2W1S specific CD4 effector T cell responses to Lm-2W1S which were diminished from the 
very early stages and maintained throughout the response. In particular, we were able to link 










































































Figure 3. 7 The defect in the generation of Th1 effector T cells is present later in the 
response  
The effect of OX40:OX40L interactions in the generation and survival of antigen-specific Th1 
effector CD4 T cells was determined at 14 days post infection with Lm-2W1S. The 2W1S 






 mice. (A) 
Expression of T-bet versus CXCR5 by 2W1S-specific CD44
hi
















 mice. (B) Enumeration of 2W1S-specific 
CD4 T cells. (C) Enumeration of T-bet+ 2W1S-specific CD4 T cells. (D) Percentage of T-bet+ 
2W1S-specific CD4 T cells. (E) Enumeration of CXCR5+ 2W1S-specific CD4 T cells. Data are 
pooled from two independent experiments, n=6. Values on flow cytometry plots represent 
percentages, bars on scatter plots represents the median. Statistical significance was tested 



































































































Figure 3. 8 The defect in the Th1 effector CD4 T cell numbers and function persist 
throughout the Lm-2W1S response  
The contribution of OX40:OX40L interactions to the survival of antigen-specific Th1 effector 
CD4 T cells at challenge responses to Lm-2W1S. The mice were infected i.v. with Lm-2W1S, 
followed by administration of a second dose of Lm-2W1S at day 42. At day 46 the mice 
received 2W1S peptide adjuvanted with LPS via i.v. route and were sacrificed 4 hrs later. The 






 mice. (A) 
Expression of T-bet versus CXCR5 by 2W1S-specific CD44
hi
















 mice. (B) Enumeration of 2W1S-specific 
CD4 T cells. (C) Enumeration of T-bet+ 2W1S-specific CD4 T cells. (D) Enumeration of 
CXCR5
+ 
2W1S-specific CD4 T cells. (E) Expression of IL-2 versus IFN!+ by 2W1S-specific 
CD44
hi






 mice. (F) Enumeration of IFN!+ 
2W1S-specific CD4 T cells. (G) Percentage of IFN!+ 2W1S-specific CD4 T cells. Data are 







Values on flow cytometry plots represent percentages, bars on scatter plots represents the 
median. Statistical significance was tested using Kruskal-Wallis one-way ANOVA with post 











3.2.4 Vaccine adjuvant AS01 requires OX40 pathway to promote efficient 
CD4 T cells responses to OVA-2W1S  
Costimulation plays a pivotal role in T cell biology, providing essential secondary signals 
which trigger activation and subsequent proliferation of antigen-specific T cells. What cells 
provide these signals and when is crucial for the development of new therapeutic approaches 
to better manipulate these responses. Vaccination is our most successful prophylactic 
approach for combatting infectious diseases, however vaccines containing recombinant 
antigen require the use of adjuvant to improve their immunogenicity. How adjuvants affect 
innate populations and which mechanisms and costimulatory pathways are required for 
generating effective responses remain unclear. 
Through an extensive collaboration with a British pharmaceutical company GlaxoSmithKline 
Biologicals (GSK), we were able to test one of the current adjuvant systems used in both 
Malaria and Zoster candidate vaccines and other vaccines in development (Didierlaurent et 
al., 2017). The Adjuvant System 01 (AS01) has been developed for over 20 years and has 
already proved to have some excellent immune enhancing qualities. It has been included in 
the Malaria vaccine RTS,S/AS01 which is used to induce long term protection against 
parasite Plasmodium falciparum. The design of the AS01 adjuvant improves the immune 
protection of this vaccine, however it has also been licensed for the use in Shingrix, vaccine 
used to prevent shingles caused by the varicella-zoster virus as a complication of past 
chickenpox infection, where it induced immunity in people over 50 years of age (Didierlaurent 
et al., 2017; Lal et al., 2015). Zoster vaccine has now been licensed and has been widely 
used in USA with now more than 10 million doses administered (personal communication, 
Arnaud Didierlaurent, Area Medical Director for Shingrix, GSK)  
AS01 belongs to a group of liposomes-based adjuvants. Those consist of lipid bilayer 
surrounding the vaccine mixture which also ensures the stability of the antigen (Coccia et al., 




21 (licensed by GSK from Antigenics Inc., a wholly owned subsidiary of Agenus Inc., a 
Delaware, USA corporation).  
Here we aimed to establish a model of intramuscular immunisation in mice to test the effects 
of AS01 adjuvant on antigen-specific CD4 T cell responses to OVA-2W1S and most 
importantly investigate the potential role of OX40 signals in the mechanisms used by the 
AS01 to elicit immune responses.    
Given the predominance of intramuscular delivery for vaccines in humans, initial experiments 
aimed to validate an intramuscular injection model. The mice were first anaesthetised with 
Isoflurane according to the Home Office regulations (Figure 3.9 A). Following the initial 
exposure to anaesthesia, the mice were transferred onto a platform where they continued to 
receive anaesthetic via a mouthpiece and had their hind legs shaved to expose the 
gastrocnemius muscle (Figure 3.9 B, C). The OVA-2W1S/AS01 was administered in a volume 
of 10 µL using a syringe with specially cut lid allowing only 3 mm of the needle to be exposed. 
This ensured the uniformity of the immunisations.    
To assess drainage from the injection site, injections of Evans blue dye into the 
gastrocnemius muscle of the hind leg were performed. The results showed a clear drainage 
into the iliac lymph node (LN), while the drainage to inguinal LN was absent (Figure 3.9 D).  
After initial pilot experiments, the model was refined by injecting into the gastrocnemius 
muscle of both hind legs, enabling collection of both iliac and inguinal LNs and obtaining 
sufficient cell numbers. For the purpose of analysis, the iliac and inguinal LNs of each mouse 
were pooled. Rather than pure 2W1S peptide, 2W1S peptide conjugated to OVA was used 
to better model peptide frequencies amongst protein antigens. Finally, OVA-2W1S was given 
alone (in PBS) or with ASO1 to directly assess the contribution of the adjuvant. The mice 










Figure 3. 9 AS01 model and its potential in tracking local responses 
Intramuscular injection in C57Bl/6 mice. (A-C) Set up of intramuscular injections under local 
anaesthetic. Mice were placed in an anaesthetic chamber filed with Isoflurane. Once under 
anaesthetic, mice were transferred onto a platform where they continued receiving 
anaesthetic via breather. Both hind legs were shaved to remove the hair, enabling 
visualisation of the injection site. Following the assessment of the pedal reflex, the mice were 
immunised in both hind legs in the gastrocnemius muscle. The orange lid was cut and placed 
back onto the syringe to expose only 3mm of the needle, ensuring the position of the needle. 
(D) Lymphatic drainage into the iliac LN following the intramuscular injection of Evans blue 


















We firstly carried out an assessment of the 2W1S-specific CD4 T cell responses in both iliac 
and inguinal draining LNs in which AS01 induced expansion of the 2W1S population as 
compared to the OVA-2W1S/PBS control mice (Figure 3.10 A). This was demonstrated 
further by statistically significant increase in the number of 2W1S-specific CD4 T cells within 
the draining LNs of mice immunised with OVA-2W1S/AS01 (Figure 3.10 B). Overall, 
immunisation with AS01 induced increase in the total number of CD4 T cells within the 
draining LNs with additional significant changes in their proportion in the iliac and minimal 
increase in the inguinal LNs (Figure 3.10 C, D).  
Interestingly we have consistently observed greater response in the inguinal rather than the 
iliac LNs at day 5 post immunisation with OVA-2W1S/AS01 which didn’t not correlate with 
our initial observations obtained in experiments with Evans blue dye. The initial action taken 
to understand this phenomenon involved testing the quality of the intramuscular injections as 
one of the suspected reasons included a possible subcutaneous administration of the 
antigen. This hypothesis was however rejected after the results for both subcutaneous and 
intramuscular injections did not show any significant differences (data not shown). The 
response in inguinal LN may result entirely from the lymphatic drainage pathway following 
the intramuscular injections. Despite the very limited literature on murine lymphatic drainage, 
there are data suggesting that both rear paw pad injections as well as injections to the base 
of the tail involve drainage to both inguinal and iliac LNs. In both of those cases however, 
there is a strong indication that the drainage might diverge and may not be necessarily 
sequential (Harrell et al., 2008). 
Although TCR:pMHC complexes are crucial stimulants of T cell function, other signals are 
required for full activation of T cells. To fully understand the mechanisms behind adjuvant 
function it is important to dissect different stages on the immune response, including the 
requirement for costimulatory molecules. We therefore carried out additional analyses to 
investigate whether AS01 induced CD4 T cell responses ‘obeyed’ the requirements for crucial 














































































Figure 3. 10 AS01 drives a robust CD4 T cell response to OVA-2W1S in draining LNs in 
a CD80 and CD86 dependent manner  




 mice. Mice were immunised with 20µg 
OVA-2W/PBS or 20µg OVA-2W/AS01 (1/50 HD) and sacrificed at D5 post immunisation. (A) 
Gating strategy showing identification of 2W1S-specific CD44
hi










) in control mice (OVA-2W1S/PBS) and immunised mice (OVA-2W1S/AS01). 
(B) Enumeration of 2W1S-specific CD4 T cells in iliac and inguinal dLNs. (C) Enumeration of 
total CD4 T cells in iliac and inguinal dLNs. (D) Percentage of total CD4 T cells in iliac and 
inguinal dLNs. Data pooled from three independent experiments OVA-2W1S/PBS n=8, OVA-
2W1S/AS01 n=10. (E) Gating strategy showing identification of 2W1S-specific CD44hi CD4 T 




 mice. Representative flow cytometry 
plots for iliac dLNs can be found in Appendix Figure 8.1 (F) Enumeration of 2W1S-specific 
CD4 T cells in iliac dLNs. (G) Enumeration of 2W1S-specific CD4 T cells in inguinal dLNs. 




 n=4. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 











This requirement is well established for infection/T cell response in general but not yet for 
AS01, although previous reports have shown upregulation of those costimulatory molecules 
on APCs post immunisation with AS01 (Coccia et al., 2017). These investigations involved 




 knockout mice with OVA-2W1S/AS01 and assessment 
of the resulting 2W1S-specific CD4 T cells response. As anticipated, lack of those two crucial 
costimulatory molecules had significant effect on stimulation of CD4 T cells with the total 




 knockout mice 
as represented by severely reduced total numbers of 2W1S-specific CD4 T cells (Figure 3.10 
E, F).   
We then focused on another costimulatory pathway, namely the OX40L-OX40 signalling, 
given the key role played in many other CD4 T cell responses (M.-Y. Kim et al., 2005; Withers 
et al., 2012). The efficacy of vaccines is often measured by the induction of efficient effector 
and memory responses, hence we investigated the potential role of OX40 signalling, as 
previous studies have linked OX40 signals to the robust memory responses (Gaspal et al., 
2005; Withers et al., 2011).  
For these analyses we immunised WT and OX40
-/-
 mice with OVA-2W1S/AS01 and assessed 
the antigen-specific CD4 T cell responses at day 7 in both iliac and inguinal draining LNs. 
First of all, we observed a significant reduction in the magnitude of the 2W1S-specific CD4 T 
cell response in iliac and inguinal LNs of OX40
-/-
 mice which correlated strongly with our 
previously discussed Lm-2W1S data (Figure 3.11 A, B, C). The differences between 
responses in iliac and inguinal LNs were minimal. Secondly, again identically to the Lm-2W1S 
model, we performed analyses of the T-bet versus CXCR5 expression to determine whether 
lack of OX40 signals had any effect on the generation of effector CD4 T cells. Similarly, to 
the Lm-2W1S model, also these analyses demonstrated the promotion of effector CD4 T cell 
responses by AS01 to be OX40 dependent, as represented by highly significant decrease in 
the number and proportion of T-bet expressing 2W1S-specific CD4 T cells in both iliac and 
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Figure 3. 11 CD4 T cell responses to OVA-2W1S in draining LNs at D7 post 
immunisation are OX40 dependent  
Intramuscular injection in C57Bl/6 and OX40
-/-
 mice. Mice were immunised with 20µg OVA-
2W/AS01 (1/50 HD) and sacrificed at D7 post immunisation. (A, B) Identification of 2W1S-
specific CD44
hi










) and expression of T-bet versus 
CXCR5 in inguinal dLNs of WT and OX40
-/-
 mice. Representative flow cytometry plots for iliac 
dLNs can be found in Appendix Figure 8.2. (C) Enumeration of 2W1S-specific CD4 T cells in 
iliac and inguinal dLNs. (D) Enumeration of T-bet+ 2W1S-specific CD4 T cells. (E) 
Percentages of T-bet
+ 
2W1S-specific CD4 T cells. (F) Enumeration of CXCR5+ 2W1S-specific 
CD4 T cells. (G) Enumeration of total CD4 T cells in iliac and inguinal dLNs. (D) Percentage 
of total CD4 T cells in iliac and inguinal dLNs. Data pooled from 4 independent experiments, 
WT n=13, OX40
-/-
 n=10. Values on flow cytometry plots represent percentages, bars on 
scatter plots represents the median. Statistical significance was tested using an unpaired, 














We observed a partial defect in the numbers of Tfh cells, defined by expression of CXCR5, 
in iliac LNs which was not apparent in inguinal LNs (Figure 3.11 F). Finally, we assessed the 
numbers and percentages of the total CD4 T cell population present in both draining LNs 
which were reduced in OX40
-/-
 mice, suggesting a fundamental problem with the expansion 
of the CD4 T cells in the absence of OX40 signals (Figure 3.11 G, H). 
In addition to assessing T-bet expression, we also aimed to extend our analysis of AS01 
driven effector T cell responses to include their function, namely production of cytokines. As 
AS01 is known for generating rapid IFNg responses, we decided to investigate the effect of 
OX40 deletion on the functional CD4 T cells responses, namely the production of IFNg at day 
7 post immunisation with OVA-2W1S/AS01. To have a more in situ view, our initial 
experiments focused on testing the AS01 model in Great x Smart17A (GS) dual IFNg reporter 
mice to determine whether they were suitable for future analyses of AS01 induced 2W1S-
specific CD4 T cell responses. Using control WT mice, expressing no eYFP, immunised with 
OVA-2W1S/AS01, we set the gates and assessed IFNg production in both iliac and inguinal 
draining LNs of GS mice immunised with either OVA-2W1S/PBS or OVA-2W1S/AS01 (Figure 
3.12 A). Unfortunately, despite sustainable 2W1S responses, we were unable to report for 
IFNg in GS mice immunised with OVA-2W1S/AS01, with the analysis showing a minimal 
increase in eYFP expression comparing to the PBS control mice (Figure 3.12 B, C, D).  
We therefore left the idea of using GS mice and moved towards an already existing approach 
for assessing T cell function ex vivo involving potent unspecific stimulation with phorbol 12-
myristate 13-acetate (PMA) and Ionomycin. PMA is an analog of diacylglycerol and together 
with Ionomycin they activate key signalling pathways and stimulate release of Ca
2+
































































Figure 3. 12 AS01 driven IFNg response is undetectable at D7 post immunisation with 
OVA-2W1S/AS01  
To determine the CD4 T cell derived IFNg (eYFP) production with no further manipulation, the 
GS mice were immunised with 20µg OVA-2W1S/AS01 (1/50 HD) or OVA-2W1S/PBS and the 
responses assessed 7 days later in draining iliac and inguinal LNs. (A) Identification of 2W1S-
specific CD44
hi










) and their expression of eYFP 
and IL-17A in inguinal LNs of WT control mice (no eYFP). (B) 2W1S-specific CD44hi CD4 T 
cell response and the expression of eYFP and IL-17A in inguinal LNs of GS mice immunised 
with OVA-2W1S/PBS. (C) 2W1S-specific CD44hi CD4 T cell response and the expression of 
eYFP and IL-17A in inguinal LNs of GS mice immunised with OVA-2W1S/AS01. (D) 
Percentage of eYFP
+ 
2W1S-specific CD4 T cells in iliac and inguinal dLNs. Data represents 
one experiment, n=3. Values on flow cytometry plots represent percentages, bars on scatter 
plots represents the median. Statistical significance was tested using an unpaired, non-














In this approach we immunised WT and OX40
-/-
 mice with OVA-2W1S/AS01 and sacrificed 
them 7 days later. The cell suspensions of the collected iliac and inguinal LNs were then ex 
vivo cultured in the presence of PMA and Ionomycin. Similarly, to previously discussed data, 
we observed a reduced magnitude of the 2W1S-specific CD4 T cell response in OX40
-/-
 mice 
as oppose to the WT mice (Figure 3.13 A, B, C). This reduction reached statistical significance 
in the analysis of the 2W1S response in inguinal LN (Figure 3.13 C). However, most 
importantly, total numbers of IFNg producing 2W1S-specific CD4 T cells were also reduced 
in both draining LNs in OX40
-/- 
mice following immunisation with OVA-2W1S/AS01 (Figure 
3.13 D). The enumeration of IL-2 only producing cells was not included in this analysis but 
can be found in the appendices. Past studies have shown that simultaneous production of 
IFNg and IL-2 could be used to define effector T cells generated upon secondary responses, 
while IL-2 is predominantly being produced by the central memory cells also often referred to 
as Tfh (Pepper et al., 2011).  
Collectively, these analyses provided strong evidence for OX40 dependency in AS01 induced 






























































Figure 3. 13 OX40 signalling is required for optimal functional CD4 T cell responses 
elicited by AS01  
To investigate the mechanisms through which AS01 induces robust CD4
 
T cell responses, 
WT and OX40
-/-
 mice were immunised intramuscularly with 20µg OVA-2W/AS01 (1/50 HD) 
and the draining LNs assessed 7 days later. The expression of IFNg was assessed following 
4hr ex vivo restimulation with PMA and Ionomycin (A) Identification of 2W1S-specific CD44hi 
CD4 T cells and their expression of IL-2 and IFNg in inguinal dLNs of WT mice. 
Representative flow cytometry plots for iliac dLNs can be found in Appendix Figure 8.3. (B) 
Identification of 2W1S-specific CD44
hi
 CD4 T cells and their expression of IL-2 and IFNg in 
inguinal dLNs of OX40
-/-
 mice. (C) Enumeration of 2W1S-specific CD4 T cells in iliac and 
inguinal dLNs. (D) Enumeration of IFNg+ 2W1S-specific CD4 T cells. Data pooled from three 
independent experiments, WT n=6, OX40
-/-
 n=6. Values on flow cytometry plots represent 
percentages, bars on scatter plots represents the median. Statistical significance was tested 














3.2.5 Antigen-specific responses to the intestinal pathogen Salmonella 
typhimurium are impaired in the absence of OX40 signals  
The gastrointestinal tract is a unique series of organs, primarily involved in digestion and 
uptake of nutrients. However, it also has the difficult task of maintaining immune homeostasis 
in an antigen-rich and bacteria dominated environment. The difficulty lies in establishing 
tolerance to commensal bacteria, self-antigens and food antigens, yet still recognising 
harmful pathogens and defending against their actions. To achieve these specialised 
functions, GI tract has evolved the largest and most advanced network of immune cell 
interactions.  
The intestinal immune system is highly compartmentalised and forms several levels of 
regulation, starting with GALT, like Peyer’s patches, scattered throughout the intestinal wall 
and the associated mesenteric lymph nodes (mLNs). Moreover, multiple lymphocyte 
populations residing in the small intestine lamina propria, including IgA-secreting plasma cells 
and T cells, also mediate defence and homeostatic mechanisms.  
The major population of intestinal T cells is represented by CD4 subset which can be found 
in all intestinal compartments, in either naive or effector states (Shale et al., 2013). Majority 
of naive intestinal T cells usually reside within the inductive sites like mLNs and Peyer’s 
patches, where they can easily interact with DC and undergo tissue-specific priming and 
activation. The costimulatory requirements of intestinal T cells in both steady state and during 
intestinal infections, however, have yet to be properly understood. Moreover, the limited 
number of experimental models tracking antigen specific CD4 T cells responses in intestinal 
infections has posed another challenge in trying to understand their function.  
We aimed to use one of the few models available Salmonella enterica serovar typhimurium, 
an intestinal pathogen, to track antigen specific CD4 T cell responses and investigate the role 
of OX40 signals in generating Th1 effector T cells. With the overall goal established, we firstly 
asked a simple question whether intestinal CD4 T cell responses to commensal bacteria 




Previous work in our laboratory provided evidence for the crucial requirement of OX40 and 
CD30 signals in intestinal CD4 T cell immunity, showing a significant reduction in the CD4 T 
cell compartment in small intestine lamina propria as well as impaired survival of the memory 
CD4 T cells generated in response to OVA and R848 (Withers et al., 2009).  
To determine the role played by OX40 and CD30 signals in generating Th1 and Th17 
responses to commensal bacteria we assessed CD4 T cells responses in small intestine 




 mice prior to and after weaning. As expected, 
the analysis prior to weaning in both strains showed no significant Th1 or Th17 responses, 
represented by minimal percentages of both IFNg and IL-17A respectively (Figure 3.14 A, B, 
C).  
In contrast, the analysis of CD4 T cell responses post weaning (5 weeks) showed a clear 




 mice (Figure 3.14 D). This 





 mice compared to GS mice (Figure 3.14 E, F).  
The above results highlighted the importance of OX40 signals in generation of CD4 T cell 
responses to commensal bacteria and to build on those initial observations we decided to 
investigate whether OX40 and CD30 signals were similarly required for generation of effector 
CD4 T cell response using Salmonella.  
Salmonella enterica serovar typhimurium (STM) is a gram-negative bacterium predominantly 
found in intestinal lumen. Non-typhoid serovars of Salmonella enterica are one of the most 
common causes of foodborne diseases around the globe (Balasubramanian et al., 2018; 
Graham et al., 2000; Hedberg, 2011). Bacterium can be ingested with food or water, causing 























































































Figure 3. 14 OX40 signalling is required for intestinal CD4 T cell response to 
commensal microbiota  
To investigate the role of OX40 signals in maintaining efficient responses commensal 





 reporter mice was analysed for the production of IFNg and IL-17A at steady state. (A) 





 reporter mice at 4 weeks of age, prior weaning. (B) Percentage of eYFP 
expressing intestinal CD4 T cells. (C) Percentage of IL-17A expressing intestinal CD4 T cells. 





 reporter mice at 5 weeks of age, post weaning. (E) Percentage of eYFP 
expressing intestinal CD4 T cells. (F) Percentage of IL-17A expressing intestinal CD4 T cells. 




n=4. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 












Over the years, several in vivo animal models have been established to study the host-
pathogen interaction. Initial studies showed murine STM to be especially pathogenic only in 
susceptible mice, where it caused a typhoid-like fever symptoms followed by the spread of 
bacteria to other organs (Santos et al., 2001). In specific- pathogen free mice, however, 
bacteria met with colonisation resistance, a process mediated by host and commensal 
bacteria to defend against pathogens (Van Der Waaij et al., 1971). As a result, current studies 
use antibiotic pretreatment method to prevent this phenomenon and allow assessment of 
intestinal responses to this potent pathogen (Barthel et al., 2003).  
As previously established, defensive mechanisms against infections with intracellular 
pathogens rely heavily on Th1-like CD4 T cell responses including production of IFNg and 
TNFα (Reiner and Locksley, 2003; Schaible et al., 2008). This is particularly apparent in 
studies using mice deficient in either MHCII (required for priming of CD4 T cells) or in TCRab 
chains, with mice becoming susceptible to the Salmonella infection (Hess et al., 1996). In 
contrast, mice lacking MHCI (required for priming CD8 T cells) or lacking TCRd chains, were 
resistant to the infection.  
Many initial studies provided evidence of in vivo CD4 T cells activation and expansion 
following infection with Salmonella, however these were obtained by performing TCR 
transgenic adoptive transfer (Chen and Jenkins, 1999). We decided to use an attenuated 
strain of STM, expressing 2W1S peptide (STM-2W1S) to aid tracking of antigen-specific CD4 
T cell responses following the infection. Additionally, we focused on assessing the 2W1S-
secific responses in mLN as well as colon to obtain broader understanding of the effect of 
STM infection on inductive and effector sites. Finally, despite previous reports on the 
importance of OX40 signals in generating CD4 Th1 responses to STM, we aimed to 
investigate in vivo, the requirements of 2W1S-specific CD4 T cells for generation of effector 








 dual reporter mice which enabled assessment of 
both IFNg and IL-17A expression without further ex vivo manipulation. The responses were 









, using same strategy as the one applied in Lm-2W1S model (Figure 3.15 A, B). The 
same strategy was used for both mLN and colon and showed the magnitude of the 2W1S 




 mice with a significant reduction in the total 
numbers of 2W1S-specific CD4 T cells (Figure 3.15 C, D, E, F). Overall, the 2W1S response 
was more robust in colon than mLN. There was no difference in the bacterial burden present 




 mice.  
Using WT control mouse, expressing neither eYFP nor hNGFR, we assessed the production 
of IFNg and IL-17A respectively, in mLNs of GS versus GS CD30-/- x OX40-/- mice (Figure 
3.16 A). We observed a definite upregulation in expression of IFNg by the 2W1S-specific CD4 
T cells in GS mice following infection with STM, compared to the hardly detectable production 
of IL-17A, consistent with Th1 driven program for pathogen clearance (Figure 3.16 A, B, C). 





 mice most probably partially reflecting the lower magnitude of the 
2W1S response (Figure 3.16 A, B, C). The Th17 responses were insignificant in both mouse 










 mice were further exacerbated in colon showing highly significant 
reduction in total numbers of IFNg (Figure 3.16 F, G). The differences in proportion of cells 
expressing IFNg were however minimal (Figure 3.16 H). Assessment of colonic IL-17A 
responses revealed statistically significant increase in the percentage of IL-17 expressing 




 mice, with no indicative changes found in 























































































































Figure 3. 15 Salmonella typhimurium-2W1S induces strong 2W1S specific responses 
in both colon and draining mesenteric LNs which are CD30 and OX40 dependent 





 reporter mice were infected with intestinal pathogen STM-2W1S via oral 
gavage 24 hrs post administration of streptomycin and the responses in colon and mLN 
assessed 7 days later. (A, B) Gating strategy showing identification of 2W1S-specific CD44hi 














) in mLN and colon, 
respectively. (C) Flow cytometry plots showing 2W1S-specific CD44hi CD4 T cell response in 




mice at D7 post infection. (D) Enumeration of 2W1S-
specific CD4 T cells in mLN. (E) Flow cytometry plots showing 2W1S-specific CD44hi CD4 T 




 mice at D7 post infection. (F) 
Enumeration of 2W1S-specific CD4 T cells in colon. (G) Bacterial burden present in feaces 




 mice. Data pooled from two independent experiments, n=7. 
Values on flow cytometry plots represent percentages, bars on scatter plots represents the 
median. Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney 


























































































Figure 3. 16 CD30 and OX40 are required for the generation of effector T cells in 
responses to Salmonella typhimurium-2W1S but not for their function 
To investigate the role of OX40 signals in the function of effector CD4 T cells generated post 




 reporter mice were 
assessed 7 days post infection. (A) Expression of eYFP and IL-17A on 2W1S-specific CD44hi 



















 reporter mice. WT mouse was used as a negative control for the eYFP 
expression. (B) Enumeration of eYFP expressing CD4 T cells in mLN. (C) Percentage of 
eYFP expressing CD4 T cells in mLN. (D) Expression of eYFP and IL-17A on 2W1S-specific 
CD44
hi



















 reporter mice. WT mouse was used as a negative control for the 
eYFP expression. (E) Enumeration of eYFP expressing CD4 T cells in colon. (F) Percentage 
of eYFP expressing CD4 T cells in mLN. Enumeration of IL-17 expressing CD4 T cells can 
be found in the Appendix Figure 8.4. Data pooled from two independent experiments, n=7. 
Values on flow cytometry plots represent percentages, bars on scatter plots represents the 
median. Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney 











Collectively, this data showed a clear requirement for OX40 and CD30 signals in generating 
antigen-specific effector CD4 T cells responses to acute intestinal infections. Comparing to 
the Lm-2W1S and AS01 models, which lack anatomical dissection of the generation and 
effector sites, STM-2W1S model enabled investigation of the two sites. We showed that 
effector cells CD4 T cells were predominantly found within the colon where their proved to be 
highly dependent on OX40 and CD30 pathways, however these results might have reflected 























3.3 Discussion  
Upon interaction with antigen-presenting cells, naïve CD4
 
T cells receive instructions which 
direct their further development into distinct and functionally diverse populations. Early work 
on CD4 T cell clonal cell lines has demonstrated a clear division between the IL-2 and IFNg 
producing CD4 T cells, known as Th1 cells and the IL-4 producing cells, belonging to the Th2 
population (Mosmann et al., 1986). Since then our understanding of different CD4 T cell 
subsets has improved greatly, in particular further characterisation of Th populations like Th17 
and Tfh cells. Despite those advances, the process of cell fate acquisition remains complex, 
with many factors influencing the course of CD4 T cell development either directly or 
indirectly. Furthermore, the costimulatory requirements of particular subsets of CD4 T cells 
to acquire their effector functions are still unclear. Costimulatory molecules, broadly defined 
as co-signalling receptors can transduce both positive and negative signals into T cells, 
ultimately altering their TCR activity.  
In this investigation we have investigated the role of OX40 is establishing CD4 T cell function 
across three different Th1 responses and have shown that it was particularly important for 
generation of effector T cell population. The three Th1 response models chosen for this 
investigation utilised the significance of 2W1S immunogenicity in C57BL/6 mice, with its 
sequence incorporated either into bacterial genome of L. monocytogenes and Salmonella 
typhimurium or used as an adjuvanted vaccine.  
 
3.3.1 The role of OX40 signalling in in vivo CD4 T cell responses to Listeria 
monocytogenes  
L. monocytogenes is an important model pathogen used to study innate and adaptive immune 
responses. When given a sub-lethal dose of this gram-positive bacterium, mice can generate 
efficient immune responses, resulting in bacterial clearance and resistance to future 
infections. This has been known since 1960s, when cellular immunity, in particular the role of 




susceptible to infection with L. monocytogenes (Mackaness, 1962). Moreover, T cell 
responses were undoubtedly required in generating effector and memory responses following 
infection with L. monocytogenes (Bhardwaj et al., 1998; Lara-Tejero and Pamer, 2004).  
With the advances in molecular biology and subsequent generation of bacterial strains 
carrying specific peptides, our understanding of T cell responses, against Listeria infections 
has vastly improved. Initial studies aimed to dissect the paramount antigen-specific CD4 T 
cell responses using TCR-transgenic models (C S Hsieh et al., 1993; C. S. Hsieh et al., 1993). 
However, taking into consideration all potential limitation of this approach, for instance T cell 
precursor frequencies and T cell competition for APCs, the evaluation and interpretation of 
resulting data could have ignored important aspects of the immune response (Smith et al., 
2000). Furthermore, the use of OVA as an antigen for transgenic T cells might have limited 
biological relevance and would never fully reflect T cell responses against a pathogen 
(Zinkernagel and Hengartner, 2001).  
Utilising already established model of Lm-2W1S we were able to track an endogenous, 
polyclonal antigen-specific population of CD4 T cells throughout the course of infection. 
Alongside the use of a highly reproducible infection method, we also took advantage of the 
IFNg reporter mice, GS and GS x CD30-/-OX40-/-, which allowed for accurate and 
unmanipulated assessment of IFNg production following the infection and revealed crucial 
importance of OX40 and CD30 signals in establishing effector T cell function.  
Following infection with Lm-2W1S, the pool of expanded antigen-specific CD4 T cells in GS 
or WT mice at 7 dpi acquired previously described phenotype, with a clearly distinct effector 
and Tfh (also known as central memory) populations (Pepper et al., 2011; Tubo et al., 2013; 
Yang et al., 2015). The absence of OX40 and CD30 ligation had a profound effect specifically 
on the effector T cell population, characterised by expression of IFNg, involved in the 
clearance of intracellular pathogen like L. monocytogenes, and T-bet, the key transcription 




We observed an approximately 8-fold reduction in 2W1S-specific CD4 T cells were 




 mice which reflected production of IFNg. With similar 
results observed at 4 dpi, the data indicate that OX40 and CD30 signals were pivotal to the 
generation of effector CD4 T cell function. At both timepoints, the level of IFNg production in 
GS mice translated into eYFP expression was detectable, however its level was relatively 
low. The double reporter mice used in this investigation have been produced by crossing 
Great (IFNg reporter) mice with Smart17A (IL-17A reporter) mice. The reporter gene construct 
used to make Great mice consisted of an IRES-eYFP reporter cassette which was inserted 
between the translational stop codon and 3' UTR/polyA tail of the Ifng gene. Previous studies 
have shown this construct to be highly functional and specific, showing no spontaneous off-
target expression of IFNg, unlike other IFNg reporter models (Reinhardt et al., 2015). For 
instance, Yeti mice show elevated levels of IFNg due to the stabilising BGH polyA tail 
contained within the reporter gene construct which enhances eYFP expression (Reinhardt et 
al., 2015; Stetson et al., 2002). Upon infection with Listeria or Leishmania, heterozygous and 
homozygous Yeti mice were resistant to the infection or failed to survive respectively, while 
Great mice and WT mice were both equally susceptible to the infection. However, most 
importantly, results of steady state analyses showed that Yeti mice generated significantly 
more IFNg than Great mice, with most of the IFNg being expressed by naïve T cells. In Great 
mice the main source of IFNg consisted of innate cells, specifically NK cells which was 
representative of IFNg regulation similar to the WT mice (Reinhardt et al., 2015). Therefore, 
the relatively low level of eYFP expression we observed was most likely reflecting the 
physiology of the immune response to Lm-2W1S which is heavily attenuated and usually 
cleared by 7 dpi.  
Fundamentally, the results obtained in IFNg analyses were more significant than the 
differences found in the expression of T-bet, however both could be used as an evidence of 
a defect in effector T cell population. Previous studies indicated that in T-bet
-/-




function of some effector CD4 T cells was unaffected and that in response to agonistic anti-
OX40, IL-2 signals were inducing production of IFNg rather than either T-bet or IL-12 (Williams 
et al., 2007). Despite this data the production of IFNg in mice lacking T-bet was still 
substantially diminished. Our data showed a significant reduction in the expression of T-bet 




 mice as compared to GS and WT controls, but although effective, 
those analyses could have camouflaged the substantial loss in the effector CD4 T cell 
function. The use of IFNg reporter mice have therefore developed further understanding of 
the costimulatory requirements of the effector T cell function following infection with Lm-
2W1S. Further improvements would involve reporting for IFNg combined with simultaneous 
assessment of T-bet expression, which was not possible in this investigation due to the 
unstable nature of eYFP under the action of the two fixative solutions used. Additionally, a 
brighter reporter construct would also be beneficial. Nevertheless, the use of T-bet as an 
effector T cell marker in Lm-2W1S model remained highly effective, allowing assessment of 
responses in all mouse strains described in later chapters.  
OX40 and CD30 receptors have previously been shown to share signalling pathways, being 
involved in upregulating antiapoptotic proteins, Bcl-2 and Bcl-xL (Rogers et al., 2001). Both 
pathways were shown to act in synergy at the memory T cell responses. These data suggest 
that OX40 and CD30 signals act together to control the development of memory T cells and 
their absence has a significant impact on secondary antibody production (Gaspal et al., 2005). 
Further studies also identified the crucial role of both signals in CD8 T cell activation and 
maintenance of the effector functions (Bekiaris et al., 2009a). However, in case of FoxP3 
deficient mice, which suffer from lethal autoimmune disease due to the absence of Tregs, 
OX40 signals were shown to play dominant role (Gaspal et al., 2011). In this investigation we 
have shown that generation of effector CD4 T cells responses to Lm-2W1S as well as their 
function were predominantly OX40 dependent, as shown by the comparisons of the effector 
















 mice supported the 
dominant requirement of the OX40 signals in the effector CD4 T cell responses, while the use 








 mice advanced our understanding of 
the costimulatory requirements for the functional properties of CD4 T cells responding to Lm-
2W1S.  
The crucial role of OX40 signals has been associated particularly with enhanced memory 
CD4 T cell responses, as shown by increased numbers of memory T cells after the treatment 
with agonistic anti-OX40 antibody (Gramaglia et al., 2000; Weinberg et al., 2000). 
Additionally, studies in OX40
-/-
 mice have demonstrated the significant impact of OX40 
deletion on the resulting pool of memory T cell, which was significantly reduced with the 
function of the effector memory T cell (Tem) population being predominantly affected 
(Soroosh et al., 2007). Our observations supported the requirement of OX40 for generating 
efficient memory responses to Lm-2W1S. The defect in effector T cell responses originating 
at the primary stages persisted throughout the course of immune responses, showing 
reduced numbers of effector T cells present at 14 dpi. Furthermore, we observed a clear 
expansion of Tem cells, expressing T-bet, following secondary challenge with Lm-2W1S in 
WT mice which was consistent with published data on secondary antigen exposures (Salek-
Ardakani et al., 2003). Furthermore, mice lacking either OX40 or OX40 and CD30 signals 
failed to generate functional effector CD4 T cell responses shown by the reduced IFNg 
production. Together, this data indicates that the cells that made it past the initial OX40-
dependent stages persist but are fundamentally impaired in cytokine production.  
As previously stated, antigen-specific CD4 T cells generated in response to Lm-2W1S can 
be phenotyped as effector and Tfh populations. The Tfh cells, specialized in providing help 
to B cells, were distinguished from the effector T cells on the basis of the chemokine receptor 
CXCR5 expression. This chemokine enables the cells to migrate into the B cell follicle and 




Production of IFNg can positively regulate differentiation of Tfh cells as shown by overactivity 
of the germinal centres in sanroque lupus model (Lee et al., 2012). Mice homozygous for the 
‘san’ allele of Roquin gene, suffer from autoimmune responses caused by the accumulation 
of Tfh cells and lupus. Past studies have shown that development of lupus in 
Roquinsan/san mice could be prevented by abrogation of Tfh responses (Linterman et al., 
2009). Other types of interferons, for instance IFNa and IFNb, are involved in inducing Tfh 
formation, however the resulting population fails to complete the entire developmental 
programme (Nakayamada et al., 2014).   
Past studies highlighted the importance of OX40 signals in the optimal generation of the Tfh 





 mice were responsible for defective secondary antibody responses (Gaspal et 
al., 2005). This however, seemed to be highly infection-specific with conflicting reports 
suggesting that increased signalling via the OX40 receptor was important for reduction of Tfh 
function and thereby controlling malaria clearance and LCMV infections but on the other hand 
in L. monocytogenes infections OX40 signalling was dispensable, with its increased 
expression or its absence having no effect on Tfh formation (Boettler et al., 2013; Marriott et 
al., 2014; Zander et al., 2015). Consistent with this previously published data, our 
observations showed the Tfh population to be formed independently of OX40 signals. The 







throughout the Lm-2W1S response.  
 
3.3.2 AS01 induced CD4 T cells responses and its dependency on OX40 
signalling 
The significance of OX40 in vaccine immunology has not yet been fully understood. Induction 
of strong effector T cell responses is crucial to generating effective and long-lasting immunity. 
As shown in this investigation and other studies, antigen-specific T cells require OX40 signals 




a potent stimulant, inducing increased activity of the CD4 T cells. For instance, administration 
of agonistic OX40 alongside synthetic long peptide vaccines during booster vaccination 
resulted in significantly higher numbers of polyfunctional T cells and improved efficacy against 
mouse CMV infection (Panagioti et al., 2017). Furthermore, OX40L was identified as one of 
the costimulatory molecules which in combination with Fc portion of human immunoglobin 
served as a treatment for murine gliomas significantly increasing the cure rates (Murphy et 
al., 2012). Further studies have also shown that vaccination with irradiated granulocyte 
macrophage colony stimulating factor (GM-CSF)-expressing GL261 cells (GVAX) alongside 
the agonistic OX40, increased the antitumor Th1 responses and subsequently prolonged the 
survival of glioma-bearing mice (Jahan et al., 2018). Altogether, those results supported the 
adjuvant-like function of OX40 signals in enhancing immune responses. We have however 
asked a different question of whether OX40 signals were indeed required for the optimal 
efficacy of adjuvanted vaccines. This project was developed in collaboration with GSK who 
kindly provided their licensed Adjuvant System 01 (AS01). The combination of the two 
immunostimulatory components of AS01 adjuvant, MPLA and QS-21, enabled investigation 
into the role of OX40 in local Th1 responses to OVA-2W1S as oppose to the systemic 
responses induced by Lm-2W1S. As previously described, the use of highly immunogenic 
2W1S antigen allowed for identification of the polyfunctional antigen-specific CD4 T cell 
responses using MHCII tetramers.     
To accurately model the antigen exposure route, the AS01 model involved intramuscular 
injections into the gastrocnemius muscle of both hindlimbs. The WHO recommends 
administration of adjuvanted vaccines via the intramuscular route in order to reduce or 
eliminate possible adverse effects like induration and inflammation which was supported by 
clinical trials (Diez-Domingo et al., 2015; WHO, 2019). Past studies have shown that muscle 
contain very low number of immune cells, particularly DC, yet delivery of vaccines into a 
muscles can optimise their immunogenicity due to the increased vascularity (Arnaud M 




cells but are very closely positioned to the dermis, which is rich in various types of immune 
cells like DC and macrophages (Dupasquier et al., 2004). However administration of certain 
vaccines subcutaneously have been shown to have increased side effects as well as for 
instance injection of hepatitis B vaccine subcutaneously resulted in lower antibody responses 
and vaccine failure as compared to the intramuscular route (Diez-Domingo et al., 2015; Shaw 
et al., 1989).  
In AS01 model, injections into both hindlimbs allowed for reduction in the volume of the 
vaccine administered and optimisation of the animal use.  
Following intramuscular injections, AS01 was highly efficient at inducing strong 2W1S-
specific CD4 T cells responses as well as increasing total numbers of the CD4 T cells in both 
iliac and inguinal draining LNs at 5 dpi. The presence of increased 2W1S responses in both 
draining lymph nodes validated the previously suggested cell trafficking between the muscle 
injection site and those two local LNs. Past studies indicated the possible simultaneous 
drainage from the injection site to both iliac and inguinal LNs, however the injections sites 
used in that study were either the base of the tail or a footpad which might have induced 
different draining patterns (Harrell et al., 2008). A very recent study using near-infrared 
fluorescence imaging demonstrated three lymphatic systems present in the hindlimb of mice, 
namely the deep medial, superficial medial and superficial lateral systems (Nakajima et al., 
2018). Most importantly, this study also detected a lymphatic system connecting inguinal and 
iliac LN.  
It is not clear whether this connection differs between species as previous studies on AS01 
induced responses in sheep focused entirely on the cannulation of the iliac LN post 
intramuscular immunisation (Neeland et al., 2016). Nevertheless, consistent with our data, 
AS01 immunisation in sheep induced significant increase in the number of HBsAg-specific 
CD4 T cells present at 3-7 dpi in the efferent lymphatics. This also coincided with higher 




In humans, vaccination with AS01 induced higher geometric mean frequencies of CD4 T 
cells present in peripheral blood following immunisation with either the gE (varicella zoster 
virus glycoprotein) or HBs (recombinant hepatitis B virus surface protein) antigens used in 
Zoster and RTS,S/AS01 Malaria vaccines respectively (Chlibek et al., 2013; Leroux-Roels 
et al., 2016). In case of the RTS,S/AS01 vaccine, the CD4 T cell stimulating effects were 
observed at 14 dpi, while in the Zoster vaccine the increase was recorded at 3 months 
post infection. The antibody titres were induced similarly in both vaccines at approximately 
30 dpi. Additionally comparisons between the AS01B and AS01E (AS01E contains reduced 
amount of MPLA and QS-21) showed no significant differences for both vaccines (Chlibek 
et al., 2013; Leroux-Roels et al., 2016). 




 mice we confirmed that AS01 induced CD4 T cell responses 
were CD28 signalling dependent. We found no 2W1S-specific CD4 T cells in the absence 
of the two ligands. The importance of this particular costimulatory pathway in adjuvant 
function has previously been described and it is simply a result of the critical role CD28 
signalling plays in antigen-driven T cell activation and subsequent proliferation. Similar 
results were observed in mice lacking CD28 receptor, where administration of LPS did not 
induce formation of the antigen-specific T cells (Khoruts et al., 1998). Additionally, 
immunisation of OVA in Incomplete Freund’s Adjuvant (IFA) in CD28
-/-
 mice showed highly 
reduced expansion of the antigen-specific CD4 T cells as oppose to and CD40L
-/-
 and WT 
mice (Howland et al., 2000). Ultimately our investigation provided further support to the 
already existing data, with the additional advantage of being conducted in vivo and with 
the use of clinically relevant adjuvant whereas two described studies relied on the use of 
transgenic T cells.  
The OX40 pathway has been of interest to adjuvant related research due to its enhancing 
effect on CD4 T cell function and memory cell formation. In our investigation, we have 
presented strong evidence supporting the OX40 dependent generation of the effector CD4 




immunisation with OVA-2W1S/AS01, 2W1S-specific CD4 T cell responses were 
significantly impaired in OX40
-/-
 mice as oppose to the WT controls. Most importantly, 
however, it was the total number and percentages of effector T cells (identified on the basis 
of T-bet expression) which were predominantly reduced in the absence of OX40 signals. 
This was consistent with our previous data showing a defect in the effector population 
generated in response to Lm-2W1S.  
Studies on Th2 responses demonstrated the significant role of OX40 signals in 
ameliorating adjuvant induced T cell responses. In particular, the TCR transgenic T cell 
responses to OVA in the presence of Complete Freund’s Adjuvant (CFA) or Alum were 
shown to be highly OX40L dependent when comparing the OX40L
-/-
 mice to the WT 
controls (Ishii et al., 2003). On the other hand, overexpression of OX40L signals resulted 
in augmented CD4 T cells responses in absence and presence of the two adjuvants, once 
again demonstrating the T cell stimulating nature of OX40 signals.  
An important mechanism of adjuvant action involves induction of antibody responses. 
Specifically, emulsion-based adjuvants, like MF59 oil-in-water adjuvant has been shown 
to promote potent Tfh responses and thereby enhancing GC B cell responses in 3 week 
old mice (Gavillet et al., 2015). Moreover in human trials, the inducing effects of MF59 









) present in peripheral blood at day 7 post administration of the 
A/California/7/2009 avian flu vaccine (Spensieri et al., 2016). Other adjuvants like Aluminium 
salts were shown to have limited Tfh polarisation properties as shown by the minimal 




population in murine draining LNs following immunisation with 
Aluminium hydroxide (Riteau et al., 2016). Our data indicated that in AS01 system, antigen-
specific CD4 T cells formed previously described population of effector and Tfh (CXCR5
+
) 
cells. Unlike Lm-2W1S data, the total numbers of Tfh in OX40
-/-
 mice were reduced. This 
however this could have been a result of the overall reduction in the magnitude of the 




Consistent with Lm-2W1S data, lack of OX40 signals has a significant effect on the functional 
properties of the effector CD4 T cells generated in responses to AS01 immunisation. Those 
analyses required the use of ex vivo stimulation with PMA/Ionomycin, as initial attempt with 
immunisation in GS mice showed hardly any IFNg production. This result was however 
unsurprising, considering previous studies showing a very rapid production of IFNg by CD4  
and CD8 T cells during the first 6-8 hrs post immunisation with AS01 which decreased shortly 
after (Coccia et al., 2017; Neeland et al., 2016). The levels of IFNg present in efferent 
lymphatics increased slightly again between day 5 and 7 post AS01 immunisation in sheep, 
however did not reach nearly as significant levels as detected at early timepoints (Neeland et 
al., 2016). Following ex vivo stimulation, we observed a significant reduction in the IFNg 
expression by the 2W1S-specific CD4 T cells in OX40
-/-
 mice immunised with OVA-
2W1S/AS01 as compared to immunised WT control mice, suggesting that OX40 pathway 
was required for AS01 efficacy in inducing effector CD4 T cell responses. Similar results were 
obtained in previous studies using TCR transgenic T cells, where OX40L
-/-
 mice had their 
IFNg responses significantly reduced following immunisation with both CFA and Alum (Ishii 
et al., 2003). Overall, future studies would benefit greatly from further investigation into the 
OX40 dependent generation of AS01 induced responses.  
 
3.3.3 The requirement for OX40 signals in responses to intestinal pathogen 
Salmonella enterica serovar typhimurium 
Finally, this investigation also examined the role of OX40 pathway in tissue specific responses 
following acute infection with Salmonella enterica serovar typhimurium. This particular 
pathogen, like in case of Listeria monocytogenes, is a facultative anaerobic intracellular 
bacterium which induces highly specific Th1 responses. Upon ingestion, it invades host gut 




between the two bacteria, is the structure of their cell walls, with Salmonella being classed as 
a Gram-negative bacterium.  
The possible dependency on OX40 signals in Salmonella induced infections was indicated 
by previously published data showing reduced Th1 CD4 T cell survival in the absence of 
OX40 or CD30 signals as well as significant impairment in the CD4 T cell responses to 
attenuated Salmonella enterica serovar typhimurium in mice lacking both costimulatory 
pathways (Gaspal et al., 2008). Although, highly suggestive, that particular study used an 
unphysiological route of infection, namely intraperitoneal injections. The resulting systemic 
infection was not representative of the usual transmission mode, where the bacteria are 
ingested with contaminated food and water. In humans, nontyphoidal Salmonella causes 
bloodstream infections only in 6% cases, affecting mostly immunocompromised patients 
(Parry et al., 2013; Vugia et al., 2004). Salmonella enterica serovar typhimurium is considered 
less invasive, yet hospitalisation rates following the infection are still significant (Jones et al., 
2008). As a result of intraperitoneal infections, dissemination of the bacteria might have been 
skewed and aberrant, in particular with recent reports showing significantly higher loads of 
bacterial colony forming units (CFU) present in mLN, ileum and cecum than spleen post oral 
gavage (Bravo-Blas et al., 2018; Nilsson et al., 2019). Furthermore, the lack of better 
identification system for the antigen specific CD4 T cells than the expression of CD62L, 
prevented delineation of functionally distinct CD4 T cell subpopulations (Gaspal et al., 2008). 
We therefore used a novel Salmonella enterica serovar typhimurium-2W1S (STM-2W1S), 
which was administered by oral gavage with a pre-treatment of streptomycin. Pre-treatments 
with antibiotics are not necessary but act to reduce variability between the mice as well as 
resulting colitis resembles human Salmonellosis (Griffin and McSorley, 2011; Nilsson et al., 
2019). 
Prior to those experiments, we observed an essential role of OX40 and CD30 signals in 
generating effective CD4 T cell responses to commensal bacteria which appeared absent 




it did highlight the requirement of those key costimulatory pathways in gut mucosal 
responses.  
Consistent with previously published data, antigen-specific CD4 T cell responses following 





 mice as opposed to WT controls. Interestingly, again like in the previous study, 
we also found that mice lacking both CD30 and OX40 signals had comparable numbers of 
CFU present in their faeces at 7 dpi. This might have been however a result of the bacteria 
entering the stationary phase where their growth plateaus for instance due to spatial 
requirements.  
The effector CD4 T cell responses following Salmonella infections were firstly studied using 
TCR transgenic adoptive transfer systems, where following the infection with Salmonella-
OVA, OVA-specific CD4 T cells expanded and begun secreting IFNg by day 5 of the response 
(Chen and Jenkins, 1999). With the use of reporter mice, we were able to accurately assess 
the function of effector CD4 T cells, which once again proved to be OX40 and CD30 
dependent. The requirement for those signalling pathways was particularly evident in CD4 T 
cells responses generated in the mesenteric LNs. Interestingly, the eYFP expression in GS 
mice observed in those experiments comparing to the Lm-2W1S model was significantly 
higher. This was most likely caused by the acute state of the STM-2W1S infection which is 
more invasive and not cleared, eventually being fatal for the mice.  
 
3.3.4 Summary  
Overall, data presented in this chapter, clarified the role of OX40 in supporting functional 
effector CD4 T cells. Across different Th1 infection and immunisation models, the 
requirements for OX40 signals were crucial for the efficient expansion of 2W1S-specific CD4 
T population. However, most importantly, the impairment in the functional properties of 




in the generation of effective immune responses and indicated that further research into their 
function would be beneficial in designing better immunotherapies. The following chapters will 
aim to provide better mechanistic understanding of how is OX40L expression regulated and 


























CHAPTER 4: REGULATION OF OX40L EXPRESSION ON DC POST 
INFECTION WITH LM-2W1S  
4.1 Introduction 
Disease causing pathogens entering the body are treated as threat and instantly challenged 
by the cells of the innate immune system, a collection of specialised cells often with sentry 
roles (Janeway and Medzhitov, 2002). These cells act promptly to recognise infectious 
agents, initiate measures to limit the spread and expansion of the invader and initiate adaptive 
immune responses that can clear the infection should the innate response prove insufficient. 
DC are critical cells in this regard, located in tissues throughout the body but particularly at 
barrier sites, which upon their activation transform into highly potent APCs. DC can become 
activated by both pathogen derived molecules as well as by the signals their receive from 
other innate immune cells, and can be involved in mediating both primary and memory 
responses (Hart, 1997; Zammit et al., 2005). It is widely accepted, that activated DC are 
critical initiators of T cell responses. Their exceptional potential has been shown by both in 
vitro and particularly the in vivo studies, in which conditional or constitutive ablation of DC 
function resulted in abrogation of T cell responses (Jung et al., 2002; Steinman and Witmer, 
1978).  Antigen experienced DC provide several signals to naïve T cells, including presenting 
foreign antigens via the MHCII complexes, and most importantly costimulatory and co-
inhibitory molecules which are also required for T cells activation. Interaction of T cells with 
DC via the pMHC in the absence of costimulatory signals leads to a peripheral tolerance 
(Hawiger et al., 2001). The repertoire of costimulatory molecules is versatile, with many of 
them inducible like OX40 or ICOS, becoming expressed later on during T cell priming (M. 
Croft et al., 1992; A Hutloff et al., 1999). Their diverse expression patterns can represent 
specific functions of individual costimulatory pathways at different phases of T cell responses. 
Furthermore, DC maturation, cytokine production and expression of costimulatory signals can 




some of the pathways may be modulated to aid the course of infection (Foti et al., 2006; 
Sallusto and Lanzavecchia, 2002). Additionally, for some of the costimulatory molecules, like 
OX40L, there is not enough evidence describing who expresses them in vivo and how it is 
regulated. Hence, the complexity of DC function in the process of T cells activation, has 
highlighted the importance of assessing roles of separate costimulatory pathways but also 
determining mechanisms involved in their regulation, specifically mechanisms behind their 
upregulation.  
Throughout the last 30 years of research, our understanding of the costimulation paradigm 
has improved greatly. Given the importance of CD28 signalling in T cell activation, many 
studies focused on costimulatory molecules belonging to the B7/CD28 family and TNFRSF 
which identified wide range of possible ligand-receptor interactions and revealed the 
requirement and necessity of certain pathways in generating efficient T cells responses, also 
highlighting their potential use in T cell mediated immunotherapies. For instance, it has been 
shown that in many cancer patients, costimulatory molecule CD80 was expressed in very low 
levels on circulating monocytes, suggesting a possible impairment in antigen presentation 
and T cell priming (Bella et al., 2003; Chaux et al., 1996). Low level of CD80 expression are 
usually associated with immune tolerance where ICOSL expression dominates and resulting 
stabilisation of IL-10 receptor and production of IL-10 cytokine induces differentiation of Tregs 
(Herman et al., 2004; Rottman et al., 2001). Previous work also unveiled a mutual function of 
certain costimulatory pathways like for instance CD40L which can induce activation of both T 
cells and DC and result in subsequent further enhancement of T cell responses (Cella et al., 
1996). The interaction between CD40 and CD40L promoted much greater production of IL-
12 than after stimulation with TNFa and LPS which then in turn led to enhanced DC activation 
and expression of other costimulatory molecules. Ligation through CD40 receptor enhances 
expression of CD80, CD86, OX40L, although other signals including proinflammatory 




has been shown to be particularly important in fighting pathogens by promoting antiviral and 
antimicrobial immune responses (Samuel, 2001). This family includes two types of 
interferons, namely type I IFNa/b and type II IFNg which bind their cognate receptors and like 
other cytokines receptors, signal via Jak/Stat pathway (Darnell et al., 1994; Stark et al., 1998). 
Both types of interferons have been specifically shown to induce expression of CD80 on 
primary monocytes cultured ex vivo, as shown by the increase in mRNA and protein levels 
(Bauvois et al., 2009). Furthermore, transcriptomic and proteomic analyses of JNK-specific 
inhibitor SP600125 (reversible ATP-competitive inhibitor which inhibits phosphorylation of c-
Jun and thereby expression of IL-2, IFNg, TNFa and COX-2) in human monocytic cell line 
revealed that expression of CD80 was also regulated by interferon regulatory factor 7 (B. L. 
Bennett et al., 2001; Lim et al., 2005). Additionally, another study on human monocytic cell 
line, linked IFNg to an enhanced expression of another member of the B7 family, the CD86 
molecule (Curiel et al., 1999). Innate immune cells produce proinflammatory cytokines in 
response to danger signals they receive from environment, particularly the invading 
pathogens. As mentioned before, bacteria and viruses can act to modulate the costimulation 
and impair T cell responses. Previous reports on infection with Mycobacterium leprae showed 
a downregulation in CD40 signalling, while in chronic mycobacterial infections CD40, CD80 
and CD86 expression was significantly lower in all infected cells, while PD-L1 and PD-L2 
expression increased (Murray et al., 2007; Sakai et al., 2010; Schreiber et al., 2010). In viral 
infections, caused by for example HIV, expression of CD80, CD86, 4-1BBL was 
downregulated (Chaudhry et al., 2005; Keersmaecker et al., 2011; Venkatachari et al., 2007).  
In CD4 T cell responses, the crucial OX40:OX40L interaction, in particular OX40L expression 
in vivo is poorly understood and there is little understanding of how such expression is 
regulated. In this chapter, we sought to understand the kinetics of OX40L expression on DC 






4.2.1 OX40L is upregulated on DC at 24hrs post infection with Lm-2W1S  
Having established the crucial role of OX40 signals in generating functional CD4 T cell 
responses to pathogens and vaccine adjuvants, we sought to determine how this key effector 
costimulatory pathway was regulated in vivo.  
The expression of OX40 and OX40L has been found primarily on activated T cells and APC, 
respectively. However, their inducible and transient nature has made it particularly difficult to 
understand the mechanisms behind their interaction and in particular the signals involved in 
the upregulation of OX40L.  
Previous reports in Rag
-/-
 mice, identified DC as one of the main cellular sources of OX40L 
signals alongside LTi-like cells (Kim et al., 2003). Furthermore, studies have also shown that 
OX40L expression on DC could be elevated upon stimulation  (Godfrey, 2004; Murata et al., 
2000a; Ohshima et al., 1997; Stüber et al., 1995). We therefore hypothesised that DC 
expression of OX40L was important for the CD4 T cell response, given the crucial role these 
play in T cell priming. There is a lack of any data describing OX40L expression in the response 
to L. monocytogenes, therefore we firstly decided to simply track the kinetics of OX40L 
expression on DC post infection with Lm-2W1S in order to provide foundation for better 
understanding of OX40:OX40L pathway in this infection.  
Therefore, WT mice were infected with Lm-2W1S and sacrificed at selected time points (24, 
48 and 72 hrs) post infection. The splenocytes from infected and control WT mice were 
cultured overnight and stained for OX40L. The culturing process was required to obtain 
optimal OX40L expression on DC, which is usually absent on freshly isolated splenic DC (M.-
Y. Kim et al., 2005). The assessment of OX40L expression on DC was controlled using 




 mice (ubiquitous OX40L deletion) which 
were used as negative controls, facilitating setting accurate gates.  
Initial phenotyping of splenic DC included cell surface proteins associated with all 
conventional DC, specifically CD11c, MHCII and CD86 (Figure 4.1 A).  



















































Figure 4. 1 OX40L is upregulated on DC in response to Lm-2W1S  
To investigate regulation of DC expression of OX40L, splenocytes were isolated from mice 













). (B) Expression of OX40L by DC from 
uninfected mice and mice infected with Lm-2W1S 24, 48 and 72 hrs previously. (C) Proportion 










, n=7 uninfected, n=9 24 hrs post Lm-2W1S, n=7 48 hrs post Lm-2W1S, 
n=6 72 hrs post Lm-2W1S infection. Values on flow cytometry plots represent percentages, 
bars on scatter plots represents the median. Statistical significance was tested using Kruskal-
















This particular gating strategy for splenic DC in untreated WT mice showed that 





 control mice (Figure 4.1 B, C). However, infection with Lm-2W1S resulted in 
significant upregulation of OX40L on DC which peaked at 24 hrs post infection, reaching a 
median of 45.3 %. This then gradually decreased with the percentage of DC expressing 
OX40L returning back to the baseline by 72hrs (Figure 4.1 B, C). Thus, DC appeared to 
rapidly upregulate OX40L expression after Lm-2W1S infection, however this expression was 
short lived.   
To determine the phenotype of the OX40L expressing DC, splenocytes from Lm-2W1S 
infected WT mice were further analysed. In particular, the expression of cell surface proteins 
characteristic for the two conventional DC subsets, cDC1 and cDC2 was assessed. The 
‘conventional’ group of DC includes all DC except for the plasmacytoid DC (pDC) and can be 
found in most lymphoid and nonlymphoid tissues. In the spleen they reside within marginal 
and T cell zones, screening for tissue and blood for foreign antigens. The two subsets have 
been associated with differential role in eliciting immune responses. The overall view presents 
cDC1 subset as important for efficient cross-present antigens to CD8
+
 T cells, while the 
cDC2s are involved in the stimulation of CD4
+
 T cells. However, there is some evidence 
suggesting that either DC subset can stimulate both types of T cells (den Haan and Bevan, 
2002; Dudziak et al., 2007).  
The identification of DC populations was first carried out in untreated WT mice and followed 
the previously described gating strategy used to recognize OX40L
+















 (Figure 4.2 A). Next, the OX40L
+
 DC 
were further phenotyped on the basis of CD24 and SIRPa expression, typical for cDC1 and 
cDC2, respectively. Additional analyses validated their anticipated phenotypes, with the 
CD24
+
 DC expressing CD8 and XCR1, while the SIRPa+ DC classed as CD4+ and CD11b+ 
















































































Figure 4. 2 Population of DC expressing OX40L at 24 hrs post Lm-2W1S can be 
phenotyped as type 2 conventional DC (cDC2)  
To determine the phenotype of DC expressing OX40L, WT mice were infected with Lm-
2W1S. The mice were sacrificed 24 hrs later and their splenocytes were cultured overnight. 
(A) Gating strategy used to identify splenic DC (B220-CD3-CD49b-, CD11c+, Ly6Clow, MHCII). 
(B) Phenotyping of splenic DC expressing OX40L from uninfected mice, showing cDC1 
(Green-CD24
+
SIRP#-CD8+XCR1+CD4-) and cDC2 (Yellow-CD24- SIRP#+ CD8-XCR1-CD4+) 
DC. (C) Phenotypes of DC expressing OX40L at 24 hrs post infection with Lm-2W1S. (D) 
Proportion of cDC1 versus cDC2 expressing OX40L in infected WT mice. Data pooled from 
two independent experiments, n=7. Values on flow cytometry plots represent percentages, 
bars on scatter plots represents the median. Statistical significance was tested using an 
















The cDC2 population was undoubtedly the dominant population of splenic DC expressing 
OX40L. This has remained true for the analyses conducted in WT mice infected with Lm-
2W1S 24 hrs prior the spleen harvest (Figure 4.2 C). The phenotypic analyses evidently 
identified the cDC2 population to account for the majority of the OX40L expressing splenic 
DC (Figure 4.2 D). 
The analyses of OX40L kinetics post infection with Lm-2W1S were extended to additionally 
include the dynamics of OX40 expression on antigen-specific 2W1S:I-A
b+ CD4 T cells 
measured within the same spleen. This assessment was particularly important, enabling 
broader understanding of the relative expression of the receptor to its cognate ligand.  
The expression of OX40 was assessed at day 2, 3 and 4 post infection with Lm-2W1S as 
previously published data showed OX40 expression to be detectable between 2 to 20 days 
depending whether the activation was induced by acute or chronic infection (Boettler et al., 
2013; Gramaglia et al., 1998). Additionally, previous work from our lab showed the OX40 
expression post Lm-2W1S infection to peak at day 3 (Marriott et al., 2014). MACS cell 
separation system was used to enhance the MHCII Tetramers facilitated detection of 2W1S:I-
A
b+ CD4 T cells.  
At day 2 post infection in WT mice there was a very small but evident population of 2W1S:I-
A
b+ CD4 T cells, as compared to uninfected controls (Figure 4.3 A, E). Among those cells 
approximately 40% had detectable expression of OX40 which was validated using OX40
-/-
 





 mice, which expressed comparable levels to the infected WT mice. 
Interestingly, majority of the OX40
+ 
cells also co-expressed CD25 (Figure 4.3 A-C). This 
receptor has been previously recognised as an important developmental requirement for the 
TH1 effector T cells and as a marker to aid their identification (Pepper et al., 2011).  





 mice maintained by approximately 45% of 2W1S:I-A












































































































Figure 4. 3 Kinetics of OX40 and OX40L expression in response to Lm-2W1S  
To understand the relationship between DC OX40L expression and CD4 T cell OX40 
expression, mice were infected with Lm-2W1S and T cells and DC from the same spleen 
















 control mice. (B) Expression of OX40 on 2W1S- specific CD4 
T cells at day 3 post infection with Lm-2W1S in WT and in uninfected and OX40
-/-
 and PGKCre 
x Ox40L
f/f 
control mice. (C) Expression of OX40 on 2W1S- specific CD4 T cells at day 4 post 







mice. (D) Enumeration of 2W1S-specific CD4 T cells at day 2, 3 and 4 post infection with Lm-
2W1S. (E) Percentage of 2W1S- specific CD4 T cells expressing OX40 at 2, 3 and 4 days 
post infection with Lm-2W1S. (F) Percentage of DC expressing OX40L at 2, 3 and 4 days 
post infection with Lm-2W1S. Data pooled from two idependent experiments, n=8. Values on 
flow cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using Kruskal-Wallis one-way ANOVA with post hoc 










First signs of a decline in OX40 expression on 2W1S:I-A
b+ CD4 T cells were observed at day 
4 post infection with Lm-2W1S where its percentages decreased to 20% (Figure 4.3 C, E). 
The expression of OX40 on 2W1S:I-A
b+ CD4 T cells was totally absent by day 7 post infection 
(data not shown, (Marriott et al., 2014)). Throughout this analysis the total numbers of 
2W1S:I-A
b+ CD4 T cells in infected WT mice were increasing steadily, following the course of 
infection (Figure 4.3 D).  
Overall, the kinetics of OX40 expression on 2W1S:I-A
b+ CD4 T cells post infection correlate 
strongly with the expression of OX40L on DC which begins a decline from day 2, reaching 
the baseline levels and being maintained by day 3 and 4 post infection (Figure 4.3 E, F).  
These analyses have shown that both OX40 receptor and its ligand are expressed early in 
the response to Lm-2W1S, and in parallel with previously published data, we showed that 
OX40 is expressed by a proportion of antigen-specific CD4 T cells being most likely linked to 
antigenic stimulation.   
 
4.2.2 Early production of IFNg promotes upregulation of OX40L on DC  
Following the observation that OX40L was rapidly upregulated on DC after infection with Lm-
2W1S, we sought to understand the signals that controlled this process. Past studies have 
shown that expression of OX40L on DC can be readily upregulated by in vitro stimulation 
through a CD40 receptor (Murata et al., 2000a; Ohshima et al., 1997; Stüber et al., 1995). 
CD40 belongs to the TNFRSF family of costimulatory molecules and is expressed on B cells 
and DC, while its ligand (CD40L) is induced rapidly on activated T cells. The transient 
expression of the CD40L ranges anywhere between 4 to 72 hrs following an in vitro aCD3 
mediated T cell activation (Lee et al., 2002). In fact, the expression of CD40 has been shown 
to be upregulated on DC among other maturation markers, like CD86 and CD80, at 24 hrs 
post infection with L. monocytogenes (Mitchell et al., 2011). However, there is no evidence of 




Lm-2W1S infection. Other cells like NK cells and macrophages could be providing CD40L at 
this time, however our observations have indicated that L. monocytogenes drives a 
significantly higher OX40L upregulation on DC as opposed to the one seen with in vitro CD40 
stimulation. This has led us to a hypothesis that other signals from innate immune cells could 
also be involved, aiding in the upregulation of OX40L on DC.  
Production of IFNg in L. monocytogenes induced infections and the following chain of cellular 
responses to this particular cytokine have been shown to be paramount for the effective 
clearance of the infection, as demonstrated in both mice treated with mAb to IFNg or IFNg-/- 
mice (Buchmeier and Schreiber, 1985; Dalton et al., 1993). We therefore aimed to investigate 
the role of IFNg in the upregulation of OX40L on splenic DC at 24 hrs post Lm-2W1S infection.  
Firstly, we examined the IFNg production at 24 hrs post Lm-2W1S infection, particularly 
focusing on the NK cell contribution as previous studies reported a rapid IFNg release by 
activated NK cells in response to adjuvanted vaccines (Coccia et al., 2017). We therefore 
sought to provide further data on NK derived IFNg production in vivo using the GS reporter 
mice.  
The GS reporter mice were infected with Lm-2W1S and responses assessed in spleens 24 
hrs later. The analyses revealed that comparing to the untreated GS controls, in GS mice 
infected with Lm-2W1S, NK cells were a source of substantial IFNg expression, which 
accounted for approximately 50-60% of all identified splenic NK cells (Figure 4.4 A, B). Next, 
we assessed the contribution of NK cells to the total IFNg expression present in GS mice at 
24 hrs post Lm-2W1S infection. Gating on total eYFP expression (proportionate to the total 
IFNg) showed that approximately 70% was represented by NK cells making them the 
dominant source of IFNg (Figure 4.4 C, D). Other cells accounted for remaining 30% of total 






























































Figure 4. 4. NK cells are main producers of IFNg 24 hrs post infection with Lm-2W1S 
To investigate the early innate cytokine response to Lm-2W1S, GS reporter mice were used 
to assess IFNg production at 24 hrs post infection. (A) Representative flow cytometry plots 
showing gating strategy and expression of IFNg by NK cells (CD3-NK1.1+.MHCII-) (B) 
Percentage of NK cells expressing IFNg (eYFP). (C) Representative flow cytometry plots 
showing expression of eYFP by different immune cells. (D) Percentage of total IFNg 
attributable to NK cells or other immune cell populations. Data pooled from two independent 
experiments, n = 5 uninfected and n=12 Lm-2W1S infected mice. Values on flow cytometry 
plots represent percentages, bars on scatter plots represents the median. Statistical 
significance was tested using an unpaired, non-parametric, Mann-Whitney two tailed T test: 















Having established that IFNg was rapidly expressed in response to infection with Lm-2W1S 
and its high expression correlated with OX40L upregulation, we then sought to determine 
whether IFNg was required for upregulation of OX40L on DC. This was especially important 
as past studies described a close relationship between NK and DC (Gerosa et al., 2002; 
Goldszmid et al., 2012).  
To test the requirement for IFNg in OX40L upregulation, WT and IFNg-/- mice were infected 
with Lm-2W1S and DC expression of OX40L assessed 24 hrs later. The exact gating strategy 
was used to identify splenic DC in WT and IFNg-/- mice (Figure 4.5 A). The analyses revealed 
an abrogation of OX40L upregulation on DC in the absence of IFNg, as represented by a 
significant reduction (approximately 50% or 1.4-fold) in the percentage of DC expressing 
OX40L at 24 hrs post infection (Figure 4.5 B, C). This led us to a conclusion that early IFNg 
plays an important role in the upregulation of OX40L on splenic DC. 
Production of IFNg is highly dependent on two important inducing cytokines, the interleukin 
12 (IL-12) and interleukin 18 (IL-18). Despite previous efforts in targeting their synergism, the 
relationship between the two cytokines remains unclear. Past studies have shown that IL-12 
upregulates the expression of IL-18 which is in turn required for IL-12 dependent activation 
of Th1 cells (Okamura et al., 1998). While IL-12 acts on NK cells and T cells, IL-18 is mainly 
a potent NK cell activation inducer (Micallef et al., 1997). Overall, the synergy between the 
two is required for the optimal production of IFNg due to their differential role in transcriptional 
regulation (Barbulescu et al., 1998). Preceding reports have described the importance of IL-
12 in responses to L. monocytogenes, showing that unlike live organisms, heat killed L. 
monocytogenes was only able to induce IFNg when administered with recombinant IL-12 
(Miller et al., 1995; Trinchieri, 1997). Additionally, neutralisation of IL-12 signals in vivo had a 
significant impact on the survivability of mice treated with sublethal dose of L. monocytogenes 




Therefore, we decided to focus on the role of IL-12 in inducing IFNg in responses to Lm-2W1S 
as well as its subsequent importance in upregulation of OX40L on DC at 24 hrs post infection. 
To investigate the requirement for IL-12, we infected IL-12p35
-/-
 mice with Lm-2W1S and 
measured both the NK cell derived production of IFNg as well as OX40L expression on splenic 
DC 24 hrs later.  
As IL-12p35
-/-
 mice did not express reporter properties, the assessment of IFNg production 
by NK cells required the splenocytes to be cultured for 3 hrs in the presence of a protein 
transport inhibitor, BFA. NK cells were identified on the basis of their NK1.1 and EOMES 
expression (Figure 4.6 A). As described previously, the infection with Lm-2W1S induced IFNg 
production by the NK cells, and expectedly the responses were absent in untreated WT 
controls (Figure 4.5 B). The impact of IL-12 deletion was evident as approximately 50% of 
the splenic NK cells failed to upregulate production of IFNg (Figure 4.6 B, C). More 
importantly, the residual IFNg expression by IL-12p35-/- NK cells was substantially lower than 
in WT NK cells, as evidence by a 3-fold reduction in the Mean Fluorescence Intensity (MFI) 
of IFNg (Figure 4.6 D). 
These data indicate that IL-12 plays an important role in NK expression of IFNg in response 
to infection with Lm-2W1S. To ask whether DC isolated from these mice showed impaired 
OX40L expression, which would be expected given the reduced IFNg production, DC isolated 
from spleens of infected WT controls and IL-12p35
-/-
 mice were compared. A significant 
decrease in the percentage of splenic DC upregulating and expressing OX40L at 24 hrs post 
Lm-2W1S infection was observed in IL-12p35
-/-
 mice (Figure 4.6 E, F).   
Thus these analyses provided strong support for the role of IL-12 mediated production of IFNg 
















































Figure 4. 5 Early production of IFNg is required for optimal expression of OX40L by DC 
24 hrs post infection with Lm-2W1S  
To test whether DC expression of OX40L was influenced by IFNg, splenocytes from WT and 
















). (B) Representative flow cytometry 
plots showing expression of OX40L on DC in WT and IFNg-/- mice. (C) Percentage of DC 




, UN, WT and IFNg-/- mice. Data pooled from two 




, n=7 uninfected, n=9 WT, n=7 IFNg-/-. Values 
on flow cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance as tested using an unpaired, non-parametric, Mann-Whitney two tailed 




















































































Figure 4. 6 OX40L is upregulated on DC in response to IL-12-mediated production of 
IFNg by NK cells  
To determine whether production of IFNg by NK cells is promoted by IL-12, the WT and IL-
12p35
-/-
 mice were infected with Lm-2W1S and responses were assessed 24 hrs later. (A) 
Gating strategy used to identify NK cells. (B) Representative flow cytometry plots showing 
production of IFNg by NK cells from uninfected WT and infected WT and IL-12p35-/- mice 24 
hrs post Lm-2W1S. (C,D) Proportion of NK cells producing IFNg and their MFI at 24 hrs post 











) in WT and IL-12p35
-/-
 mice 24 hrs post 
infection with Lm-2W1S. (F) Percentage of DC expressing OX40L in WT and IL-12p35-/- mice 
24 hrs post infection with Lm-2W1S. Data from 1 experiment, n=7 WT, n=6 IL-12p35
-/-
. Values 
on flow cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 













4.2.3 Production of IFNg by iNKT cells is not necessary for the upregulation 
of OX40L expression on DC 
NK cells can be activated by a variety of signals, including stimulation they receive from NKT 
cells. NKT cells represent a unique subset of T cells, which express rearranged TCR and also 
share properties with NK cells, like the expression of NK1.1 cell surface protein. Their TCR 
repertoire is extremely limited and specifically designed to bind glycolipids, lipids and some 
proteins presented by CD1d molecules (Park and Bendelac, 2000; Porcelli and Modlin, 2002). 
NKT cells are thought to be able to drive NK cell responses and the sequential activation of 
NK cells by NKT cells has been shown in studies using the glycolipid a-galactosylceramide, 
a-GalCer which in vivo resulted in NK cell activation measured by induction of CD69 





 mice, indicating the role of NKT cells in NK cell activation.       
Considering these findings, we hypothesised that NKT cells were involved in early activation 
of NK cells, their expression of IFNg and the upregulated OX40L on splenic DC.  
To investigate whether this crosstalk occurred, we first infected GS mice to compare the 
contribution of NKT cells and NK cells to the production of IFNg at 6 and 24 hrs post Lm-







 (Figure 4.7 A). Staining for the CD1d was validated using a control 
tetramer. The assessments at 6 hrs post Lm-2W1S failed to detect IFNg expression by NK 
cells (Figure 4.7 B, F). In contrast, the NKT cells showed small but evident upregulation of 
IFNg production, which accounted for 15 % (Figure 4.7 C, F). Interestingly, at 24 hrs post Lm-
2W1S infection, among both NK cell and NKT cell populations, approximately 50 % of the 
cells were reporting IFNg (Figure 4.7 D, E, G). Finally, we assessed the NK and NKT 
contribution to the total IFNg production at 6 hrs and 24 hrs post Lm-2W1S. Indeed, NKT cells 
were involved in IFNg production at 6 hrs as compared to the NK cells (Figure 4.7 H).  
 











































































C) IFNg production by NKT cell at 6 hrs 





















Figure 4. 7 NKT cells are among IFNg producers at 6 and 24 hrs post infection with Lm-
2W1S  
To investigate the possible contribution of the NKT cells to the production of IFNg by NK cells, 
the GS reporter mice were infected with Lm-2W1S and the responses assessed at 6 and 24 
hrs post infection. (A) Representative flow cytometry plots showing gating strategy to identify 
splenic NK and NKT cells. (B, C) Representative flow cytometry plots showing expression of 
IFNg by NK cells and by NKT cell at 6 hrs post infection. (D, E) Representative flow cytometry 
plots showing expression of IFNg by NK cells and by NKT T cells at 24 hrs post infection. (F) 
Percentage of NKT vs NK cells expressing eYFP at 6 hrs. (G) Percentage of NKT vs NK cells 
expressing eYFP at 24 hrs. (H) Percentage of total eYFP attributable to NK cells, NKT cells 
and other immune cell populations at 6 hrs. (I) Percentage of total IFNg attributable to NK, 
NKT cells and other immune cell populations at 24 hrs. Data represents one experiment, n 
=4 uninfected and n=4 Lm-2W1S infected mice. Values on flow cytometry plots represent 
percentages, bars on scatter plots represents the median. Statistical significance was tested 












However, other cells like for instance gd T cells contributed to the 80% of the total IFNg 
production (personal communication, Ameenah Zeglam, fellow PhD student). Furthermore, 
assessments of the total IFNg production at 24 hrs showed that despite 50% of the NKT cells 
were producing IFNg, comparing to the dominant NK cell population, the contribution from 
NKT cells was minimal (Figure 4.7 I).  
Having established that NK cells were the most numerous IFNg producing population, we 
asked whether the early NKT cell response was required to fuel NK cell activation.  
To answer this, we infected WT, CD1d
-/-
 and IFNg-/- mice with Lm-2W1S and assessed NK 
cell IFNg expression 24 hrs later. Similarly, to the previous experiments, the splenocytes were 
first cultured with BFA for 3 hrs to enhance and preserve the IFNg expression due to the lack 
of reporter mice. The identified NK cells from IFNg-/- mice were used as negative controls for 
the IFNg expression (Figure 4.8 A, B). Strikingly, the NK cells from WT and CD1d-/- mice 
showed comparable IFNg expression, fluctuating at around 90% for both strains (Figure 4.8 
B, C). Thus, these data strongly indicate that NKT cells are not absolutely required for the 
early IFNg response produced by NK cells after infection with Lm-2W1S. 
We further asked whether OX40L expression on DC was impaired in the absence of NKT 
cells. Consistent with normal expression of IFNg, no impairment in the expression of OX40L 
on DC was detected in the absence of NKT cells (Figure 4.8 D). Both WT and CD1d
-/-
 mice 
showed comparable percentage of DC upregulating OX40L at 24 hrs post Lm-2W1S (Figure 
4.8 E). Combined, these data demonstrate that crosstalk between NK and NKT cells and DC 






































































Figure 4. 8 NKT cells do not contribute to the NK derived IFNg production at 24 hrs post 
infection with Lm-2W1S and their absence has no effect on OX40L upregulation on DC  
To determine whether NKT cells were required for IFNg-/- production by NK cells, the CD1d-/- 
and WT mice were infected with Lm-2W1S and responses at 24 hrs post infection were 
assessed. The splenocytes were cultured for 3 hrs with BFA or overnight to assess IFNg and 
OX40L expression, respectively. (A) Gating strategy used to identify NK cells. (B) 
Representative flow cytometry plots showing expression of IFNg by splenic NK cells from 
IFNg-/-, WT and CD1d-/- mice at 24 hrs post infection with Lm-2W1S. (C) Percentage of NK 
cells expressing IFNg. (D) Expression of OX40L by DC (B220-CD3-CD49b-, CD11c+, Ly6Clow, 
MHCII
+
) from WT and CD1d
-/-
 mice at 24 hrs post infection with Lm-2W1S. (E) Percentage of 
DC expressing OX40L in WT and CD1d
-/-
 mice 24 hrs after infection with Lm-2W1S. Data 
from 1 experiment, n=4. Values on flow cytometry plots represent percentages, bars on 
scatter plots represents the median. Statistical significance was tested using an unpaired, 













4.2.4. IFNg signals directly via the IFNgR on DC to upregulate expression of 
OX40L  
IFNg, as an important immunomodulatory cytokine, provokes a wide range of biological 
effects on various cell types. Its role in modulating DC maturation and function has already 
been widely studied. For instance, in vitro and in vivo stimulation with recombinant IFNg has 
been shown to lead to an upregulation of CD86, CD80, CD40 and MHCII and provided 
assistance in TLR stimulation (Sheng et al., 2013a). Furthermore, an autocrine mechanisms 
for DC function has been observed, with the overexpression of IFNg leading to upregulation 
of CD40, CD54, CD80, CD86 and CCR7 as well as having enhancing effect on IL-1b and IL-
12 production, while the lack of IFNgR led to an impairment of DC function (Pan et al., 2004). 
Since responsiveness to IFNg is crucial for the clearance of L. monocytogenes infections and 
as shown in previous sections IFNg does play an important role in upregulation of OX40L on 
splenic DC, we were interested to explore the possible direct role of IFNg on the expression 
of OX40L by splenic DC via the interaction with IFNgR.   
Firstly, we aimed to recapitulate our previous findings in in vitro settings and assess whether 
recombinant IFNg could directly upregulate OX40L on DC. To do so, we cultured WT 
splenocytes in vitro with recombinant IFNg alongside anti-CD40 Abs as a positive control. As 
anticipated, stimulation with IFNg did have a profound effect on upregulation of OX40L on 
DC, significantly increasing the percentage of OX40L
+
 DC by approximately 50% as 
compared to the untreated controls (Figure 4.9 A, B). When compared to the splenocytes 
stimulated with aCD40, it was evident that IFNg enhanced further the upregulation of OX40L 
on DC, however the statistical tests used showed no significance. These analyses indicate 



























Figure 4. 9 Recombinant IFNg directly enhances OX40L expression on DC  
To determine the mechanisms of how IFNg contributed to the upregulation of OX40L on DC, 
in vitro experiments to test a direct interaction were performed. (A) Representative flow 











) isolated from WT mice and cultured with either #CD40 or recombinant IFNg. (B) 
Proportion of DC expressing OX40L after culture with recombinant IFNg. Data from 2 
independent experiments, n= 7 uninfected control (UN) and n = 7 #CD40 and n=7 IFNg. 
Values on flow cytometry plots represent percentages, bars on scatter plots represents the 
median. Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney 

















To test whether IFNg signalled directly to DC in vivo, CD11ccre x IFNgRf/f mice were generated 
to enable the conditional deletion of IFNgR on DC. To confirm the robust and specific deletion 
of the IFNgR on splenic DC, cells isolated from WT versus CD11ccre x IFNgRf/f mice were 




 and the analysis of their expression of 
IFNgR in WT mice showed that approximately 80% of all splenic DC were positive for IFNgR 
at steady state (Figure 4.10 A, B, C). FMO controls for the IFNgR were used to set accurate 
gates when analysing the data. In contrast to WT mice, the expression of IFNgR in CD11ccre 
x IFNgRf/f mice was severely reduced, indicating the successful incorporation of the gene 
construct and the predicted phenotype (Figure 4.10 B, C). We were however cautious about 
the NK cell expression of IFNgR due to the significant level of the CD11c expression found 





, expressed IFNgR at steady state as compared to the FMO controls 
(Figure 4.10 D, E, F). The analysis of the IFNgR expression on NK cells in CD11ccre x IFNgRf/f 
mice showed a significant and approximately 20% reduction in the percentage of IFNgR+ NK 
cells (Figure 4.10 D, E, F). Thus, whilst there was a modest reduction in the total proportion 
of NK cells expressing the IFNgR in CD11ccre x IFNgRf/f mice, this model did allow us to assess 
the requirement for DC expression of IFNgR which was very robustly deleted.  
To test the direct effect of IFNgR stimulation on the upregulation of OX40L on DC, we infected 
the CD11c
cre
 x IFNgRf/f alongside the CD11ccre and IFNg-/- controls with Lm-2W1S. Our 
observations revealed that, compared with control mice, splenic DC isolated from CD11c
cre
 x 
IFNgRf/f mice expressed significantly less OX40L on DC which was comparable to the defect 
we have previously reported in the IFNg-/- mice and recapitulated in this instance as well 










































































Figure 4. 10 Analysis of IFNgR expression in conditional IFNgR deficient mice  
To assess the DC specific deletion of IFNgR, splenocytes from CD11cCre x IFNgRf/f mice were 
stained for its expression on DC versus NK cells. (A) Gating strategy used to identify splenic 
DC. (B) Expression of IFNgR on splenic DC (B220-CD3-CD49b-, CD11c+, Ly6Clow, MHCII+) 
in WT and CD11c
Cre
 x IFNgRf/f mice. (C) Proportion of DC expressing IFNgR in WT versus 
CD11c
Cre
 x IFNgRf/f mice. (D) Gating strategy used to identify splenic NK cells. (E) Expression 
of IFNgR on splenic NK cells in WT and CD11cCre x IFNgRf/f mice. (F) Proportion of NK cells 
expressing IFNgR in WT versus CD11cCre x IFNgRf/f mice. Data representative of two 
independent experiments, n=4. Values on flow cytometry plots represent percentages, bars 
on scatter plots represents the median. Statistical significance was tested using an unpaired, 








































Figure 4. 11 Early IFNg directly enhances OX40L expression on DC via IFNgR  
In vivo experiments were performed to test a direct interaction between IFNg and the 
upregulation of OX40L on DC. (A) Representative flow cytometry plots showing expression 















IFNgRf/f and IFNg-/- mice 24 hrs after infection with Lm-2W1S. (B) Proportion of DC expressing 
OX40L at 24 hrs post infection with Lm-2W1S. Data pooled from three independent 
experiments, n = 14 CD11c
Cre
, n = 11 CD11c
Cre
 x IFNgRf/f, n=7 IFNg-/-. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using Kruskal-Wallis one-way ANOVA with post hoc 

















Finally, we stimulated splenocytes isolated from CD11c
cre
 x IFNgRf/f mice in vitro with 
recombinant IFNg. Like above, the result clearly indicated an IFNg dependent OX40L 
upregulation on DC via the IFNgR. In comparison to the WT mice undergoing the same 
treatment, the CD11c
cre
 x IFNgRf/f mice failed to upregulate OX40L on DC, represented by a 
significant reduction in the percentage of OX40L
+
 DC post overnight culture (Figure 4.12.A, 
B).   
In summary, here we have provided a detailed in vitro and in vivo analysis of the OX40L 
upregulation on DC post infection with Lm-2W1S as well as the mechanisms that are crucial 
for its optimal expression. We concluded that early IFNg, predominantly produced by the NK 
cells in an IL-12 dependent manner, is critical for optimal OX40L on DC and it acts directly 











































Figure 4. 12 DC can upregulate OX40L directly via IFNgR stimulation in response to 
recombinant IFNg  
In vitro experiments using recombinant IFNg were performed in CD11cCre x IFNgRf/f to further 
support evidence for the direct interaction between IFNg and upregulation of OX40L on DC. 
(A) Representative flow cytometry plots showing expression of OX40L by DC isolated from 
WT versus CD11c
Cre
 x IFNgRf/f mice and cultured with recombinant IFNg. (B) Proportion of 
DC expressing OX40L after culture with recombinant IFNg. Data from two independent 
experiments , n= 7 Control, n=7 WT and n = 4 CD11c
Cre
 x IFNgRf/f mice. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 


















The immune responses to bacterial infections involve a close interaction between the innate 
and adaptive immune systems. The adaptive immune system and its precision and 
immunological memory rely heavily on elements of the innate immune system for the efficient 
rapid sensing and recognition of pathogens, attempted control and for the initiation and 
direction of immune responses. One of the crucial properties of the innate immune cells is 
their ability to provide costimulatory signals which are particularly important for T cell 
activation. Despite the considerable amount of knowledge of how major costimulatory 
molecules influence the course of immune responses, it is crucial to investigate who 
expresses them and how they are regulated which would facilitate their careful manipulation 
therapeutically. 
In the previous chapter we have provided detailed analyses of the CD4 T cells responses in 
various infection models, demonstrating the crucial role of OX40 signalling in promoting 
effector T cell responses to a range of Th1 responses across multiple tissues and routes of 
antigen exposure. In this chapter we presented data which aimed to explore the mechanisms 
behind OX40L upregulation at early stages of Lm-2W1S responses and identify possible 
stimulatory signals which enhance this crucial signalling pathway. We found that OX40L was 
upregulated on DC at 24 hrs post infection with Lm-2W1S in IFNg and IL-12 dependent 
manner. The innate IFNg signalled directly via the IFNgR to the DC to induce OX40L 
expression. We also demonstrated that within that time period, the dominant producers of 
innate IFNg were NK cells.  
 
4.3.1 DC expression of OX40L post infection with Lm-2W1S  
We have focused our analyses on DC as they are one of the main providers of OX40L signals 
as well as being one of the myeloid cells responding at early stages of L. monocytogenes 




within the spleen where monocyte mediated phagocytosis takes place. The intravital 
snapshots of infected spleens have detected bacteria within the first 2 minutes of injection 
(Waite et al., 2011).  
In the marginal zones of the spleen, resident macrophages, DC and neutrophils facilitate the 
uptake of bacteria and subsequently begin the immune response. Neutrophils kill the bacteria 
by inducing production of reactive nitrogen and oxygen species, while resident red pulp 
macrophages as well as Kupffer cells in the liver can engulf the bacteria within the first 
minutes of the infection and are known to secrete TNFa and IL-12 which act synergistically 
to activate NK cells and induce their production of IFNg (Babior et al., 1973; Tripp et al., 1994). 
TNFa and IFNg are also important for the optimal activation of macrophages, as shown by 
impaired responses to L. monocytogenes post treatment with TNFa monoclonal antibodies 
and increase in MHCII expression post stimulation with IFNg (Denis, 1991; Dunn and North, 
1991; Higginbotham et al., 1992; van Furth et al., 1994).   
Once entered via the marginal zones, L. monocytogenes taken up by the myeloid cells which 
then migrate into the white pulps of the spleen, particularly the PALS, where it has been found 
in close association with splenic DC. The crucial role of DC in controlling L. monocytogenes 
infections has been demonstrated in CD11c-DTR mice, which upon diptheria toxin (DT) 
treatment lacked CD8
+
 DC and could not control the spread and proliferation of bacteria 
(Neuenhahn et al., 2006). Similarly experiments in Batf3
-/-
 knockout mice emphasised the 
importance of CD8
+
 DC in harbouring the bacteria and allowing its entry into the spleen, 
however have also been associated with increased resistance to the L. monocytogenes 
infection (Edelson et al., 2011).  
Being located within the T cell zones, Lm-activated DC are at the ideal position to present 
antigens and support the T cells activation via costimulatory pathways. Our investigation has 
shown that OX40L expression on DC was upregulated at 24 hrs post infection with Lm-2W1S, 




obtain OX40L expression on freshly isolated DC and therefore systematically throughout all 
analyses performed under this investigation OX40L expression was always analysed 
following an overnight culture. These observations correlate with previously published data 
showing a significant increase in OX40L and CD40 expression on lung DC, following isolation 
with additional adherence steps and overnight culturing (Wilkes et al., 2014). Past studies 
identified several reasons for this phenomenon, particularly the negative action of proteolytic 
enzymes, like collagense D or dispase which have been shown to affect expression of several 
surface proteins (Merad et al., 2013). Expression of CD40L, CD11c and CD8 is readily 
reduced by the action of dispase, while collagenase D can reduce CD27 expression 
(Autengruber et al., 2012). However, there is no evidence that any of those enzymes has any 
effect on OX40L expression. Similar results were previously observed by the Lane lab who 
showed that preparation of splenic DC in the absence of any enzyme did not rescue OX40L 
expression and that detection of OX40L on ILC3 is only possible after overnight culture (M. 
Kim et al., 2005; Kim et al., 2003). Therefore, the most probable reason for the culturing 
requirement was the enhancing effect of overnight culture on DC maturation. A potential 
technical solution to these issues would be a OX40L reporter mouse, which would enable 
tracking OX40L expression on any cell type with no further manipulation. 
The assessment of the type of DC expressing OX40L post infection with Lm-2W1S, revealed 
that this population predominantly consisted of cDC2 cells, showing a reduction in the 
proportion of cDC1 cells. The culture settings or digestion protocols had a minimal effect on 
the cDC1 population as shown by the significantly higher percentage in uninfected mice which 
were treated with the same enzymes and also cultured overnight. This contradicts the 
previously published data on CD8 DC involvement in the control of L. monocytogenes 
infections, yet other past reports have also observed a reduction in CD8 DC with some 
suggesting that they were prone to L. monocytogenes induced apoptosis (Edelson et al., 




observed by one of our collaborators (personal discussion with Dr Audrey Gerard – Senior 
Research Fellow at Kennedy Institute for Rheumatology, Oxford University). 
To fully understand the kinetics of OX40L upregulation on DC we have also conducted 
simultaneous analyses of OX40 expression on 2W1S specific T cells. Consistent with 
previous data from our lab, we have shown that approximately 40% of 2W1S specific T cells 
express OX40 at D2 and D3 post infection with Lm-2W1S which was significantly reduced by 
D4. The expression of OX40 is transient and heavily tied to TCR and CD28 signalling hence 
in this case most probably reflected the acute nature of the Lm-2W1S infection which is 
usually cleared by D7 (Flynn et al., 1998). The previous study demonstrated that this 
clearance coincided with the absolute loss of OX40 expression on 2W1S-specific T cells 
(Marriott et al., 2014). In more chronic infections, OX40 can be maintained for prolonged 
periods of time (Boettler et al., 2012). Our data also revealed that cells with the highest 
expression of OX40 were also positive for the CD25 expression, characteristic for Th1 effector 
T cells, which could explain some of our data from Chapter 3 where we showed a specific 
effector T cell defect in mice lacking OX40 receptor. Similar findings on expression of CD25 
by a portion of 2W1S-specific CD4 T cells and it co-expression with OX40 were previously 
published (Marriott et al., 2014; Pepper et al., 2011).  
 
4.3.2 Regulation of OX40L expression on DC 
Regulation of OX40L expression in vivo is not well understood, reflecting challenges in 
studying its expression without in vitro manipulation. Many reports have demonstrated the 
importance of CD40 signalling in upregulation of OX40L on DC in various experimental 
models (Dannull et al., 2005; Jenkins et al., 2007; Ohshima et al., 1997). Further reports also 
identified TNFa as a potent stimulant of DC maturation which also correlated with OX40L 
expression (Zaini et al., 2007a). Similarly a recent study showed that DC from GM-CSF 




et al., 2018). Our investigation, however, has revealed that other signals could also 
upregulate OX40L. We were able to demonstrate that optimal DC OX40L expression at 24 
hrs post infection with Lm-2W1S was dependent on the early IFNg signals, demonstrating the 
crucial role of IFNg in controlling primary responses to L. monocytogenes infection. Using 
IFNg-/- mice, we found that ex vivo OX40L expression on DC was impaired in the absence of 
IFNg signals. We have conducted further analyses using a reductionist approach of simply 
culturing splenocytes with recombinant IFNg which resulted in greater expression of OX40L 
on DC than the one induced by CD40 alone. This argues that as well as being IFNg 
dependent, IFNg might directly impact DC. Consistently, other past study also demonstrated 
a stimulatory effect of IFNg on DC maturation which induced expression of CD86, CD80, 
MHCII and CD40 aiding TLR stimulation (Sheng et al., 2013).  
 
4.3.3 Who provides IFNg in vivo in responses to Lm-2W1S 
To better understand the role of IFNg in DC OX40L expression we investigated the possible 
sources of this cytokine in vivo post infection with Lm-2W1S. Previous studies have shown 
that main sources of IFNg included mainly NK cells, but other cells like CD8 T cells and gdT 
cells, iNKT cells and DCs also contributed (Bancroft, 1993; Berg et al., 2005; Hiromatsu et 
al., 1992; Kang et al., 2008; S. H. Lee et al., 2013). Our studies also identify a number of 
possible sources of IFNg, although numerically NK cells are dominant IFNg producers at 24 
hrs post infection with Lm-2W1S. We additionally performed detailed analysis of the iNKT cell 
contribution to the total IFNg production, which in comparison to the NK cells, was 
insignificant. Although iNKT cells were dominant IFNg producers at 6 hrs post infection, their 
total contribution was still minimal. Those experiments benefited greatly from the use of GS 




assessing IFNg at the protein level in WT post ex vivo culture with BFA also showed 
consistent results.  
The effector function of NK cells can be mediated by many signals, although some studies 
highlighted the crucial role of iNKT cells and DCs in NK cells activation. In vivo stimulation 
with a-GalCer have been previously shown to induced iNKT cells to promote activation of NK 
cells, as CD1d
-/-
 failed to generate responses (Carnaud et al., 1999). We demonstrated that 
in responses to Lm-2W1S, the iNKT cells were redundant in providing stimulatory signals to 
NK cells, as CD1d
-/-
 mice responded as well as the WT mice did, including showing no 
impairment in neither the NK cell IFNg expression nor upregulation of OX40L expression on 
DC. One past study investigating L. monocytogenes responses drew the same conclusions, 
demonstrating that iNKT cells were not essential for optimal responses (Ranson et al., 2005). 
The importance of DC in the activation of NK cell effector functions was shown by co-
migration of the two cell types into the PALS following infection with L. monocytogenes 
(Carnaud et al., 1999). At 24 hrs post infection with L. monocytogenes, myeloid cells and NK 
cells were found clustered together within the T cell zones of the white pulp with the formation 
of these clusters being crucial for the NK derived production of IFNg (Kang et al., 2008). 
Similarly, depletion of DC also resulted in the loss of IFNg expression by NK cells. Other 
studies showed that in vitro co cultures of bone marrow derived DCs infected with Lm and 
naïve splenic NK cells induced IFNg production by 12 hrs (Humann and Lenz, 2010). This 
would suggest that direct DC and NK cell contact is pivotal to the innate responses against 
L. monocytogenes, however other signals may also be involved. First of all, other cytokines, 
like IL-12 and IL-18 have been shown to induce activation of NK cells (Bellora et al., 2012; 
Metzger et al., 1997). Previous studies demonstrated that neutralisation of IL-12 expression 
with the use of monoclonal antibodies led to reduction in the NK cell mediated IFNg production 
(Humann and Lenz, 2010). Furthermore, in mice lacking IL-12 subunit p40, the IFNg 




monocytogenes (Kang et al., 2008). We have shown similar results in IL-12p35 knockout 
mice in which the p35 subunit is unique to IL-12, unlike the p40 subunit which is shared with 
IL-23 and can affect both IFNg and IL-17 (Oppmann et al., 2000). Our results revealed that in 
the absence of IL-12 signals, IFNg expression by NK cells was significantly reduced post 
infection with Lm-2W1S. Not surprisingly, the IL-12 signals were also required for the optimal 
expression of OX40L on DC which related back to the importance of innate IFNg in regulation 
of OX40L expression on DC. Further investigations should explore the possible sources of 
IL-12 signals to determine the specific role of DC in NK cell activation.  
The results on both IFNg and IL-12 dependent OX40L expression on DC led to a hypothesis 
that innate IFNg responses to Lm-2W1S could also signal back to DC and induce their 
expression of OX40L. Expression of IFNgR on DC has previously been associated with an 
autocrine signalling whereby DC can induce their own maturation, as mice deficient in IFNgR 
had reduced DC expression of CD86, CD54 and IL-12 (Pan et al., 2004). Furthermore, some 
early studies have suggested that possible alternative ligands for IFNgR could mask the 
severity of responses in IFNg-/- mice (Cantin et al., 1999). We therefore utilised the CD11cCre 
x IFNgRf/f mice to specifically prevent IFNg signalling to DC. Our analyses showed that 
phenotypically the mice indeed lacked the expression of IFNgR on DC and that although 
CD11c expression has been shown in NK cells, we saw a minor defect in their effector 
function post infection with Lm-2W1S. Moreover, we also showed that OX40L expression on 
DC at 24 hrs post Lm-2W1S was reduced in these mice and in the IFNg-/- controls, as 
compared to the optimal expression found in WT mice. Similarly, further in vitro analyses with 
recombinant IFNg demonstrated requirement of IFNg signalling via the IFNgR for the 
upregulation of OX40L on DC. One other study investigated the effect of DC specific loss of 
IFNgR expression on the responses to L. monocytogenes and showed that these mice were 
most susceptible to the infection (S. H. Lee et al., 2013). They found that this was related to 




4 production in these mice was increased and its abrogation enhanced L. monocytogenes 
specific immune responses. This result is particularly interesting as we have also observed 
that in vitro stimulation with IL-4 significantly downregulated of OX40L expression on splenic 
DC (personal observations, Gajdasik and Gaspal, UoB).   
 
4.3.4 Summary 
This Chapter provided detailed analysis of OX40L upregulation on splenic DC in both in vivo 
and in vitro settings, highlighting the importance of innate IFNg and IL-12 in the costimulatory 
function of DC. This investigation is however not fully complete. The results obtained in IFNg-
/-
 mice showed a partial reduction in OX40L expression and therefore the role of other signals 
in regulating OX40L expression on DC post infection with Lm-2W1S should be explored. For 
instance, blocking of IL-18 and TNFa signals in vivo as well as stimulation of splenocytes with 
those signals in vitro could provide valuable information. Moreover the previously described 
NK independent sources of IFNg in L. monocytogenes infections, like CD8 T cells should also 
be considered, as they were able to maintain innate responses (Andersson et al., 1998). 
Similarly, CD8 T cell and DC interactions were shown to be more detailed analyses of the 
IFNg induced OX40L expression would be beneficial in order to understand its relationship 
with the CD40 signalling. 
Overall, this data set a strong basis for the further investigations into the requirement of 
OX40L provision by DC in CD4 T cell responses to Lm-2W1S which will be explored in the 







CHAPTER 5: CELLULAR SOURCES OF OX40L IN RESPONSES TO 
LM-2W1S 
5.1 Introduction 
A simple question of “what a specific gene does” has led to major advances in the field of 
molecular biology. Ultimately, the best way to determine specific gene’s function is to see 
what effect its ablation has on the whole organism. However, often selected genes can be 
differentially expressed or their transcripts post-translationally modified, resulting in cell 
specific expression. Additionally, often proteins encoded by those genes, like for instance 
receptor ligands, might be expressed in several cell types, making it extremely difficult to 
target specific cell type expression with a simple gene knockout. Since 1990s, our 
understanding of cellular and molecular interactions in vivo has improved tremendously. 
Rajewsky and colleagues introduced a new versatile genetic tool for producing genetically 
modified mice in which any gene could be deleted in a cell- or tissue-specific manner (Gu et 
al., 1994, 1993). The use of Cre- loxP system allowed immunologists to study the impact of 
specific gene deletions in various disease models but also assess the function of particular 
genes at steady state. This powerful technology involves the use of bacteriophage P1 derived 
Cre recombinase. This 38 kDa protein catalyses a site-specific recombination between two 
34 bp long loxP sites. The loxP sequences are made of two 13 bp inverted repeats and an 8 
bp nonpalindromic region. Depending on their orientation, opposite or the same, loxP sites 
mediate inversion or excision of the specific DNA sequence found between the sites by Cre 
recombinase, respectively (Orban et al., 2006; Sauer and Henderson, 1988; Sternberg and 
Hamilton, 1981). The Cre recombinase was shown to be highly compatible with eukaryotes, 
as represented by this prokaryotic system being expressed under the cadmium induced 
metallothionein I gene promoter in mammalian cells (Sauer and Henderson, 1988). One of 
the first reports of a mouse lines generated using Cre- loxP system, described a controlled 




Throughout the last 20 years, the Cre-recombinase system has been widely used by many 
immunologists to study conditional gene knockouts, conditional gene expression, fate 
mapping or the effects of germline. Additionally, it allows for genetic ablation within a  specific 
cell type which can also be induced at any time if Cre recombinase is for example fused with 
another ligand-binding domain, like estrogen (Feil et al., 1996).  
There is absolutely no doubt about the significance of costimulation in the activation and 
maintenance of T cell responses, yet some costimulatory pathways, like OX40-OX40L 
pathway still remain poorly understood in terms of the critical cellular provider, if there is one, 
in vivo.  
Since the discovery of OX40L and its binding properties, many studies focused on 
understanding the role of OX40L signalling in cell-cell interactions. This has proven somehow 
difficult, particularly because of its inducible nature but most importantly due to the 
identification of various cellular sources capable of providing OX40L signals. However, 
recently a floxed Tnfsf4 (OX40Lf/f) mouse has been described which was used to generate 
several mouse lines using the Cre- loxP systems, showing an essential role of B cell specific 
provision of OX40L for the generation of T follicular cell population and promoting systemic 
lupus erythematosus development (Cortini et al., 2017). 
In this chapter, we sought to answer the question of whether there was a critical cellular 
source of OX40L in the Th1 infection models used in Chapter 3, and if so what was the nature 
of that source. To do this we aimed to utilise a combination of the newly generated OX40L
f/f
 
mouse and several different Cre expressing mouse lines, each targeting a different accessory 










5.2.1 Novel conditional knockout mice enable assessment of OX40L 
provision in vivo  
In previous chapters, we focused on establishing the importance of OX40 signals specifically 
in antigen specific Th1 CD4 T cells responses utilizing various infection and immunisation 
models. Moreover, using the Lm-2W1S model, we also showed that early innate factors, 
namely the rapid production of IFNg can aid in the upregulation of OX40L expression by DC 
in an IL-12 dependent manner. Recently, role of OX40L provision by ILC2 was reported to be 
essential in Th2 and Treg responses in the lung (Halim et al., 2018). However, specific cellular 
provision of OX40L in Th1 responses has not yet been properly dissected. We therefore 
aimed to investigate further the relevance of OX40L signals provided by various accessory 
cells, including DC, to determine whether their provision was absolutely required for the 
generation of efficient effector CD4 T cell responses following infection with Lm-2W1S. 
Professional APCs, like DC, B cells and macrophages, have been considered as likely 
sources of OX40L within the secondary lymphoid tissues, but this has not been fully 
determined in vivo. These APCs have been reported to express OX40L within hours of their 
activation (Murata et al., 2000a; Stüber and Strober, 1996). Many signals, including LPS/ 
Endotoxin, CD40 signalling controlled by the CD28/B7 axis, IL-18 and TSLP can lead to an 
induction of OX40L on DC and B cells (Ito et al., 2005b; Maxwell et al., 2006; Rogers et al., 
2001). As previously described in Chapter 4, our data has now revealed that recombinant 
IFNg can also upregulate OX40L on DC following overnight in vitro stimulation.  
However, OX40L expression has also been found on other lymphoid and nonlymphoid cells 
like ILC3, NK cells, Langerhans, and mast cells and even non-hematopoietic populations 
such as endothelial cells, creating a wide range of interactions which potentially could play 




Considering all sources of OX40L, we decided to focus our investigation on four cell types, 
namely DC, ILC3, T cells, and B cells and determine whether their provision of OX40L during 
primary responses to Lm-2W1S was absolutely required for promoting effector T cell function.  
To dissect this, we have generated novel conditional knockout mice, by crossing previously 
described OX40L
f/f
 mice with cell type-specific Cre strains (Cortini et al., 2017) to target 
OX40L expression on DC (CD11c
Cre
), ILC and T cells (Rorc
Cre
) and only T cells (E8III
Cre
). B 
cell OX40L conditional knockout mice (Mb1
Cre
) were generated at later timepoints in the 
invetigation.    
To better understand the specificity of cre expression in these mice, we additionally cross 
these strains with mTmG mice, a double-fluorescent Cre reporters, expressing membrane-
targeted tandem dimer Tomato (mT) prior to Cre-mediated excision and membrane-targeted 
green fluorescent protein (mG) after excision (Muzumdar et al., 2007). Recent reports 
showed Cre systems to be particularly inclined to germline recombination or transient 
expression (Song and Palmiter, 2018).  
In the analysis, we identified splenic T cells as CD3
+
, B cells as B220
+









, IL-7Ra+, RORgt+ (Figure 5.1A, B, C). Expression of Cre was 
assessed in all those cell types with the comparison to the mTmG control splenocytes, which 
did not express any mG protein due to the lack of Cre (Figure 5.2 A).  
Analysis of CD11c
Cre 
x mTmG mice has shown a DC specific expression of the Cre construct, 
reaching approximately 90% of total splenic DC (Figure 5.2 A, B). B cells and ILC3 were 
minimally affected, showing significantly lower levels of mG protein present. However, the 
expression was more prominent in T cells showing approximately 15-20% cells expressing 
mG protein (Figure 5.2 A, B). Analysis of E8III
Cre
 x mTmG mice showed that levels of mG 
protein were significantly higher in T cells of the E8III
Cre
 x mTmG mice, comparing to the 






x mTmG was absolutely restricted to T cells and ILC3, reaching approximately 70-90% 








































































Figure 5. 1 Gating strategy used to identify different cell populations prior the analysis 
of the Cre induced mG (membrane tagged GFP) expression.  
(A) Gating strategy used to identify T and B cells. (B) Gating strategy used to identify DC (C) 
Gating strategy used to identify innate lymphoid cells (ILC). Values on flow cytometry plots 
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Figure 5. 2 Analysis of Cre expression in conditional OX40L deficient mice using 
mTmG fate-mapping mice.  
The fidelity of Cre expression in the Cre-expressing mouse strains used to selectively delete 
OX40L was assessed through crossing with mTmG ‘fate-mapping’ mice, where expression 
of mG (membrane tagged GFP) is induced by Cre expression. (A) Expression of mT vs mG 
in mTmG control mice, CD11c
Cre
 x mTmG, E8111
cre
 x mTmG, Rorc
cre
 x mTmG mice. (B) The 
percentage of mG+ T cells, B cells, DCs and ILCs in the spleen of CD11c
cre
 x mTmG mice. 
(C) The percentage of mG+ T cells, B cells, DCs and ILCs in the spleen of E8111cre x mTmG 
mice. (D) The percentage of mG+ T cells, B cells, DCs and ILCs in the spleen of Rorccre x 
mTmG mice. Data are pooled from 2 independent experiments, n=4 CD11c
cre
 x mTmG, 
E8111
cre
 x mTmG and n=5 for Rorc
cre
 x mTmG mice. Values on flow cytometry plots represent 
percentages, bars on scatter plots represents the median. Statistical significance was tested 















Alongside the analysis of Cre expression, we also sought to confirm the specific deletion of 
OX40L on the target cell populations. Here we used two separate protocols for inducing 
OX40L expression on DC, B cells and ILC3 which involved overnight stimulation with aCD40, 
and on T cells involving 72 hrs culture with aCD3 and CTLA4-Ig (Abatacept). The individual 
cell subsets were identified similarly to the previous data, with an exception to T cells which 
required TCRa staining due to the downregulation of CD3 in culture, and ILC3 which were 
identified on the basis of the CCR6 and CD4 expression (Figure 5.3 A, B, C, D).  
The OX40L expression on different cell types was assessed in comparison to expression 





mice, which expressed Cre recombinase ubiquitously (Figure 5.4 A). Collectively, these 
comparisons confirmed the validity of the models we had generated, with appropriate cell-
type specific deletion of OX40L. Results in WT mice showed an upregulated expression of 















 mice only T cells were affected, again with DC, B cells and ILC3 expressing normal 





 mice showed DC specific deletion, with minimal effect on other 





(Figure 5.4 A, D).   
The analyses provided valuable information about the precision of Cre expression in 
individual cell types, which was further supported by the protein level analysis showing the 
deletion of OX40L to be efficient in all conditional knockout mice. Combined these data 
demonstrated that we had developed appropriate tools to determine the cellular source of 







































































Figure 5. 3 Gating strategy used to identify different cell populations expressing 
OX40L.  
(A) Gating strategy used to identify DC. (B) Gating strategy used to identify B cells. (C) Gating 
strategy used to identify T cells. (D) Gating strategy used to identify innate lymphoid cells 














































































































































Figure 5. 4 Analysis of OX40L expression in conditional OX40L deficient mice.  
To confirm appropriate deletion of OX40L in novel OX40L conditional mouse strains, 
splenocytes were cultured overnight with aCD40 and OX40L expression of key cell types 
assessed. (A) Expression of OX40L by DCs (CD11c+, MCHII+), B cells (B220+), T cells 


















mice. (B) Expression of OX40L by DC in WT mice versus conditional OX40L deficient 
mice. (C) Expression of OX40L by B cells in WT mice versus conditional OX40L deficient 
mice. (D) Expression of OX40L by T cells in WT mice versus conditional OX40L deficient 
mice. (E) Expression of OX40L by ILC3 in WT mice versus conditional OX40L deficient mice. 
Data pooled from two independent experiments, n=4. Values on flow cytometry plots 
represent percentages, bars on scatter plots represents the median. Statistical significance 
was tested using an unpaired, non-parametric, Mann-Whitney two tailed T test: *p≤0.05, 














5.2.2 Provision of OX40L by LTI-like cells is redundant for generation of 
effector CD4 T cell responses 
Following the initial assessment of our Cre models, we focused our attention on investigating 
the role of different cellular providers of OX40L in generating effector T cell responses to Lm-
2W1S.  
Although there are no clear reports of other molecules binding to OX40 beyond OX40L, we 
began with testing the effects of total OX40L deficiency on antigen-specific CD4 T cell 





 mice, alongside PGK
Cre
 only controls and OX40
-/-
 positive 
controls with Lm-2W1S and assessed responses within spleens at 7 dpi. As previously, we 















and used T-bet versus CXCR5 expression to identify both effector and Tfh populations 
(Figure 5.5 A, B).   





 mice which was comparable with the response observed in mice deficient 







mice showed an impairment in the generation of effector CD4 T cells responses, with the 
numbers and percentage of T-bet
+
 cells significantly reduced (Figure 5.5 D, E). Although 






 mice, the enumeration of CXCR5
+
 
cells proved statistically nonsignificant when compared to PGK
Cre
 only control mice (Figure 
5.5 F). 
Having confirmed that the response in pan-OX40L deficient mice was comparable to mice 
lacking OX40, we sought to test the importance of OX40L provision by ILC3 on the effector 
T cells responses.  
Over the last decade, there has been an increasing number of reports suggesting that ILC3s 
could be involved in presenting antigens and providing costimulatory signals (Hepworth and 




located in the interfolicular spaces between T and B cells zones, and their help in splenic CD4 
T cells responses, supports the hypothesis of OX40L provision by the ILC3 to be required for 
functional Th1 responses (Mackley et al., 2015; von Burg et al., 2014).   






mice with Lm-2W1S and assessed 
the responses at 7 dpi, alongside OX40
-/-
 controls. The Rorc gene encodes two isoforms Rorg 
and Rorgt, with the latter being expressed in distinct immune cell population including ILC3, 
Th17, gdT cells (Eberl et al., 2004; Eberl and Littman, 2003; He et al., 1998). Our analyses 







mice (Figure 5.6 A). Although the reduction in 
the total number of 2W1S-specific CD4 T cells in OX40
-/-
 mice was non-significant, this was 
at odds with all the previous experimental data and likely reflected the surprising spread of 
data in the Rorc controls (Figure 5.6 B).  
Furthermore, total number and percentages of T-bet
+





mice as compared to the Rorc
Cre
 only controls, indicating that ILC3 provision of 
OX40L was not required for the generation of effector Th1 responses in the spleen (Figure 
5.6 C, D). These data were significantly different to OX40
-/-
 controls. Consistent with our 
previous data, we also demonstrated the expression of T-bet by 2W1S-specific CD4 T cells 
in OX40
-/-
 to be significantly impaired, while no differences were observed in the total numbers 
of CXCR5
+

























































































Figure 5. 5 Th1 responses in mice lacking OX40L mimic the defect observed in OX40-/- 
mice.  
To confirm that mice deficient in OX40L phenocopied mice deficient in OX40, expression of 
T-bet versus CXCR5 by 2W1S-specific CD44
hi









 mice was assessed. (A) Gating strategy used to identify 2W1S-specific CD44hi 










). (B) Expression of T-bet versus CXCR5 by 
2W1S-specific CD44
hi








 mice. (C) 
Enumeration of 2W1S-specific CD4 T cells. (D) Enumeration of T-bet+ 2W1S-specific CD4 T 
cells. (E) Percentage of T-bet+ 2W1S-specific CD4 T cells. (F) Enumeration of CXCR5+ 









. Values on flow cytometry plots represent percentages, 
bars on scatter plots represent the median. Statistical significance was tested using an 
unpaired, non-parametric, Kruskal-Wallis one-way ANOVA with post hoc Dunn’s test: 





































































Figure 5. 6 Expression of OX40L by ILC3 is not required for effector Th1 responses to 
Lm-2W1S.  
To investigate the critical cellular interaction for generation of Th1 effector T cells, conditional 
OX40L deficient mice, targeting ILC3 (Rorc
cre
) were generated. (A) Expression of T-bet 
versus CXCR5 by 2W1S-specific CD44
hi



















 mice. (B) Enumeration of CD44hi 2W1S-specific CD4 








 mice. (C) Enumeration of T-bet+ 2W1S-
specific CD44
hi
 CD4 T cells. (D) Percentage of T-bet+ 2W1S-specific CD4 T cells. (E) 
Enumeration of CXCR5
+ 
2W1S-specific CD4 T cells. Data pooled from three independent 
experiments, n=11 Rorc
cre




 and n=14 OX40
-/-
 mice. Values on flow 
cytometry plots represent percentages, bars on scatter plots represent the median. Statistical 
significance was tested using an unpaired, non-parametric, Kruskal-Wallis one-way ANOVA 















5.2.3 DC are the critical providers of OX40L in a primary CD4 T cell response  
Having demonstrated that ILC3 and T cell specific expression of OX40L were not absolutely 
required in the effector T cell responses to Lm-2W1S, we asked whether DC were the critical 
provider of OX40L in this response. Dendritic cells play a crucial role in inducing immune 
responses by processing and presenting antigens, providing costimulation to T cells and other 
inflammatory signals as well as being involved in inducing tolerance (Banchereau and 
Steinman, 1998; M Croft et al., 1992; Ronchese and Hausmann, 1993). They therefore 
interact with T cells from very early on in the response, and given past reports in Rag
-/-
 mice 
and our previous data showing a defect in the Th1 effector response at 4 dpi with Lm-2W1S, 
we hypothesised that OX40L provision by DC could be a critical step in generation of effector 
T cell responses (Kim et al., 2006). The significance of OX40L provision by DCs has been 
previously shown as an important factor in generating tumour-specific immunity in mouse 
tumour models (Zaini et al., 2007b).  





 mice, in which MHCII expression on DC was specifically targeted. As 
anticipated, in comparison to the typical responses in CD11c
Cre 





 mice was completely abrogated, showing significant 
impairment in the total numbers of 2W1S
+
 cells (Figure 5.7 A, B, C). Thus, in the response to 
Lm-2W1S, CD4 T cells must interact with DC to induce antigen-specific CD4 T cell responses.       
Next asked a question whether DC were the critical source of the OX40L signals required for 


























































Figure 5. 7 Dendritic cells are pivotal to generation antigen-specific CD4 T cell 
responses to Lm-2W1S.  
(A) Gating strategy used to identify 2W1S-specific CD44hi CD4 T cells. (B) Representative 
flow cytometry plots showing CD44
hi







 mice at 7 days post infection with Lm-2W1S. (C) Enumeration of 
CD44
hi










). Data pooled from two 
independent experiments, n=5 CD11c
cre




 mice. Values on flow 
cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 


















Results clearly indicated that DC provision of OX40L was undoubtedly required for generation 
of efficient 2W1S-specific CD4 T cell responses, as represented by a significant reduction in 
the total number of 2W1S
+




mice (Figure 5.8 A, B). The total 




 control mice were similarly 
affected.  
Most interestingly, assessment of the effector T cell responses, using expression of T-bet 
versus CXCR5, revealed substantial loss in the T-bet
+









 control mice 
(Figure 5.8 C, D). Similarly, to the previous findings, the total numbers of CXCR5
+
 cells were 
not affected by the lack of OX40L on DCs mice (Figure 5.8 E).  
These data support a model in which DC provision of OX40L is essential for the Th1 effector 
response to Lm-2W1S and furthermore indicate that loss of OX40L on DC, phenocopies the 
impact on CD4 T cells responding to Lm-2W1S in the complete absence of CD30 and OX40 



















































































Figure 5. 8 Expression of OX40L by DC is required for effector Th1 responses  
To investigate the critical cellular interaction for generation of Th1 effector T cells, conditional 
OX40L deficient mice, DC (CD11c
cre
) mice were generated. (A) Expression of T-bet versus 
CXCR5 by 2W1S-specific CD44
hi





















 mice. (B) Enumeration of 2W1S-specific CD44hi 
CD4 T cells. (C) Enumeration of T-bet+ 2W1S-specific CD44hi CD4 T cells. (D) Percentage of 
T-bet
+
2W1S-specific CD4 T cells. (E) Enumeration of CXCR5+ 2W1S-specific CD44hi CD4 T 
cells. Data pooled from three independent experiments, n=9 CD11c
cre









 mice. Values on flow cytometry plots represent 
percentages, bars on scatter plots represents the median. Statistical significance was tested 
using an unpaired, non-parametric, Kruskal-Wallis one-way ANOVA with post hoc Dunn’s 















5.2.4 Expression of OX40L by neither T cells nor B cells is required for 
generation of Th1 effector T cells in response to Lm-2W1S  
Finally, having established the important of DC in providing OX40L, we aimed to further 
investigate whether that other populations could not serve as additional sources of OX40L 
signals, being involved after the initial DC interactions. For instance T cells themselves are 
able to provide the OX40L as a feedback loop, further amplifying their responsiveness 




mice indicated this was unlikely to be 
critical in the response to Lm-2W1S, we wanted to further assess this in another mouse 
model. To target OX40L expression on T cells we utilised a T cell-specific conditional OX40L 





mice, and the responses in their spleens assessed at 7 dpi. The Lm-2W1S induced primary 




 mice were unaffected compared to the responses 
in E8III
Cre





 control mice (Figure 5.9 A, B). In regard to effector CD4 T cell responses, 
we found no significant defect in the T-bet
+




 mice as compared 
to E8III
Cre
 controls (Figure 5.9 C, D). There was, however, a significant reduction in total 
numbers and percentages of T-bet
+




 mice (Figure 5.9 C, D). The total 
numbers of Tfh cells again showed no differences between the mouse strains tested (Figure 
5.9 F).    
Having excluded a role for T cell expressed OX40L in the response, finally, we asked whether 
B cell expression of OX40L was required for optimal effector Th1 responses to Lm-2W1S. To 





 mice. In Mb1
Cre
 mice, Cre recombinase is expressed under a CD79a 
promoter which is a B cell antigen receptor, therefore enabling expression of Cre throughout 
B cell development (Hobeika et al., 2006). This strain of mice was not phenotyped using 
mTmG fatemapping method due to a lack of mTmG expressing mice at the time, however we 








 mice and their Mb1
Cre 
only controls 
overnight in the presence of aCD40 and assessed the expression of OX40L on DC, B cells, 
T cells and ILC3. We found the OX40L deletion to be specific to B cells, having no adverse 
effect on any other populations (Figure 5.10 A, B).  
To assess the requirement for B cell OX40L in generating normal primary Th1 effector 




 mice and their Mb1
Cre
 only controls and OX40
-/-
 
mice with Lm-2W1S. Analyses at 7 dpi revealed no significant differences in the magnitude 
of the 2W1S-specific CD4 T cells responses between Mb1
Cre





 mice (Figure 5.10 C, D). Furthermore, we observed no defect in the effector T cells 
responses, characterised by normal expression of T-bet (Figure 5.10 E, F). Analogous to our 
previous reports we found the 2W1S-specific CD4 T cell response and generation of the T-
bet
+
 cells to be significantly reduced in OX40
-/-
 mice, with no effect on total numbers of THF 
cells which were comparable between all three strains (Figure 5.10 E, F, G).   
In summary, this chapter contains a detailed analysis of differential sources of OX40L in vivo 
using novel Cre models to specifically target its expression on various cell types. Our 
observations provided evidence for the essential role of DC OX40L in promoting primary 












































































Figure 5. 9 Expression of OX40L by T cells is not required for generation of Th1 effector 
T cells in response to Lm-2W1S  
To investigate whether lymphocytes were key cellular sources of OX40L in vivo, the response 
to Lm-2W1S in T cell (E8111
Cre
) conditional OX40L deficient mice was assessed. (A) 














 x OX40Lf/f mice. (B) Enumeration of CD44hi 2W1S-
specific CD4 T cells. (C) Enumeration of T-bet+ 2W1S- specific CD44hi CD4 T cells. (D) 
Percentage of T-bet
+
2W1S-specific CD4 T cells. (E) Enumeration of CXCR5+ 2W1S-specific 
CD44
hi











 mice. Values on flow cytometry plots represent 
percentages, bars on scatter plots represents the median. Statistical significance was tested 





































































































Figure 5. 10 B cell provision of OX40L is not required for generation of Th1 effector T 
cells  
To assess the OX40L expression on B cells, splenocytes were cultured overnight with 









 mice. Data pooled from two independent 
experiments, n=4 Mb1
Cre




. To investigate whether B cells were key 
cellular sources of OX40L in vivo, the response to Lm-2W1S in B cell (Mb1cre) conditional 
OX40L deficient mice was assessed. (C) Expression of T-bet versus CXCR5 by 2W1S-
specific CD44
hi

















mice. (D) Enumeration of CD44hi 2W1S-specific CD4 T cells. (E) Enumeration of T-bet+ 
2W1S-specific CD44
hi





 CD4 T cells. Data pooled from two 
independent experiments, n=7 Mb1
Cre




 and n=5 OX40
-/-
 mice. Values 
on flow cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using Kruskal-Wallis one-way ANOVA with post hoc 












5.3 Discussion  
The mammalian immune system is highly dynamic, consisting of specialised cells organised 
in functional networks, interacting together to promote effective host defence. The broad 
spectrum of interactions supports all aspects of immune responses, stimulatory, regulatory 
and inhibitory. The in vivo cellular interactions, particularly via membrane proteins can 
determine the course of immune responses against invading pathogens.  
As described in previous chapters, the OX40 signalling pathway has been widely studied, 
particularly in the context of T cell activation and prolonged survival. Despite the years of 
research, the expression and function of its ligand in vivo remains poorly understood. In this 
chapter we conducted careful analysis of our novel OX40L conditional knockout mice, 
dissecting the cellular providers of OX40L and elucidating its in vivo provision in response to 
Lm-2W1S infection. We found that DC provision of OX40L in primary responses to Lm-2W1S 
was required for generating effector CD4 T cell population, leaving other known cellular 
sources of OX40L like T cell, B cells and ILC3 redundant.   
 
5.3.1 Cre loxP technologies 
All mice used in this investigation were generated using Cre-loxP technology, which has been 
the most widely used method for generating conditional knockout mice. In combination with 
the mTmG reporter mice, we were able to assess the efficiency of Cre expression in the target 





 accounted for approximately 20%. It is not uncommon for the Cre-loxP 
systems to produce off targets, whereby Cre is expressed in unwanted tissues or cells. In 
fact, it is actually one of the main criticisms of this powerful technology. The reduced 
specificity is caused by a transient expression of Cre in germline or during early development 
(Song and Palmiter, 2018). Due to increased occurrence of unintended and confound Cre-




immunological studies. A previous report on Cre characterisation method, revealed that 
majority of mouse strains in the Jax Cre Repository showed some degree of unexpected Cre 
recombinase activity, including impaired positioning in off target tissues (Heffner et al., 2012). 
This study developed a specific pipeline to histologically assess the efficiency of Cre 
expression using reporter mice to test Cre expression in various organs and tissues at both 
prenatal and postnatal stages. One of the reporter strains used was the exact mTmG reporter 
we have used in this investigation. Although not favourable in the described report, this strain 
was characterised by ubiquitous expression, strong robustness and good mouse breading 
properties. Additionally this reporter strain was used to verify the expression patterns 
observed in the preferred R26R-lacZ strain (Heffner et al., 2012). Other reporter strains 
tested, like R26R-GFP or R26R-YFP, showed deficiencies in certain areas, making them less 
suitable. According to JAX, CD11c
Cre
 has been found to be expressed in lymphocytes in low 
amounts, based on the original study in which the CD11c
Cre
 transgene was generated (Caton 
et al., 2007). Using R26-EYFP
+
 reporter mice, they showed that less than 10% of T cells and 
B cells expressed eYFP, compared to the 95% expression pattern in various types of DC, 
including their progenitors. Moreover, the expression seen in the T cells originated in early 
bone marrow progenitors and was not found in their activated states. On the other hand, there 




 T cells. Therefore, our analyses 
on CD11c
Cre
 expression could have also reflected the existence of such cells. The 




 T cell function have been challenging with conflicting 
reports implying that they played either regulatory or effector roles (Y. H. Kim et al., 2005; Lin 
et al., 2003; Vinay et al., 2009). They have been shown to become stimulated by the 4-1BB 
and antigen, producing high amounts of IFNg as well as have been shown to stimulate 
production of indoleamine 2,3-dioxygenase which induces immunosuppressive action of DC 




Assessment of the E8III
Cre
 showing 20% expression in ILC3 population were most likely a 
result of limited staining panel used to identify ILC3 and further analyses could increase its 
specificity. There is no Cre expression data available to verify it, however this Cre was chosen 
with the aim of specifically targeting T cells and not ILC3 given the lack of evidence showing 
a requirement for CD8 during their development (Melo-Gonzalez and Hepworth, 2017). 
Despite reports of an intermediate ILC population characterised by expression of CD8 in 
human fetal intestine and population of CD8
+
 ILC1 population found in human peripheral 
blood, murine splenic ILC have been shown not to express the CD8 receptor (Li et al., 2018; 
Magri et al., 2014; Roan et al., 2016). 
Overall, the phenotypic analyses conducted in this investigation demonstrated high efficiency 
of the Cre systems used and highlighted importance of systematic assessment of Cre 
expression to maximise and validate the use of this powerful and versatile technology.  
 
5.3.2 Assessing OX40L expression in conditional knockout mice  
Further analyses of OX40L expression on various cell types in all tested conditional knockout 
mice also served as a secondary checkpoint for the Cre activity and importantly confirmed 
deletion of expression in the target populations. Those analyses revealed that at the protein 
level all conditional Cre systems were fairly specific, abrogating OX40L expression on target 









 mice showed normal expression of OX40L on ILC3, which is not very high and 
minimally reduced expression of OX40L on T cells, respectively. 
Overall, stimulation with anti-CD40 allowed for optimal assessment of OX40L expression on 
APCs, as previously described (Ohshima et al., 1997). In our analyses, DC showed the 
highest expression of OX40L post in vitro stimulation with anti-CD40, while B cells the lowest. 
This result was consistent with previously published data where a treatment with anti-CD40 




IgM, led to its significant increase (Akiba et al., 1999). However, for the simple assessment 
of the OX40L deletion in different conditional knockout mice, anti-CD40 treatment was 
sufficient, showing activation of B cells by higher expression of CD86 and revealing significant 









 mice.  
Inducing signalling via the CD3 co-receptor and preventing signalling through the CD28 
receptor enabled assessment of T cell OX40L expression. To inhibit CD28 signalling, we 
used CTLA4Ig (Abatacept) which is an immunosuppressive agent and a CD28 receptor 
analog, showing strong affinities towards murine CD80 and CD86 ligands (Holt et al., 2017).  
This method of OX40L induction on T cells was optimised by a fellow PhD student in the Lane 
group, Dr Gwilym Webb, who observed that lymphocytes obtained from CTLA4
-/-
 mice and 
stimulated with anti-CD3, showed significantly lower expression of OX40L on CD4 T cells as 
compared to the littermate WT controls (Webb, 2017). On the other hand, the OX40 
expression was increased in these mice, suggesting that blocking CD28 signalling and 
subsequent T cell activation could lead to an upregulation of OX40L on CD4 T cells. Similar 
observations were previously described, where in vitro stimulation with anti-CD3 and anti-
CD28 led to an increase in OX40 and reduction in OX40L expression on splenic T cells (Akiba 
et al., 1999). This study also suggested that upregulation of OX40 on T cells could occur in 
CD28 independent manner as anti-CD3 stimulation in CD28
-/-
 mice showed no significant 
differences in OX40 expression when compared to WT controls. However, Gwilym’s 






 mice in which he showed 
that stimulation with anti-CD3 and anti-CD28 led to upregulation of OX40 while stimulation 
with anti-CD3 and CTLA4Ig led to upregulation of OX40L on CD4 T cells (Webb, 2017). In 
our investigation, this method proved highly effective at phenotyping T cell expression of 














5.3.3 Importance of OX40L signals in responses to Lm-2W1S infection  
The function of OX40L, this widely expressed 34 Kd glycosylated type II transmembrane 
protein, has been previously described in several studies, indicating its crucial role for 
instance in the pathogenesis of EAE and graft-versus-host disease (Nohara et al., 2001; 
Stüber et al., 1998; Weinberg et al., 1999). Moreover, constitutive expression of OX40L in 
OX40L-Tg mice has been linked to a development of spontaneous inflammatory diseases, 
like interstitial pneumonia presented with elevated numbers of neutrophils and macrophages 
(Murata et al., 2002). Responses to viral infections, like influenza have also been shown to 
exacerbate following OX40L signalling, with OX40L deficiency resulting in reduced 
susceptibility to the viral infection (Hirano et al., 2016). Furthermore, in tumour immunology 
OX40L has been associated with enhanced IFNg production and improved survival rates post 
vaccination with OX86 agonistic antibody (Shibahara et al., 2015).  
Since the generation of mice deficient in OX40L, the understanding of OX40L function has 
vastly improved. Past studies demonstrated that abrogation of OX40L signals had a 
significant effect particularly on the function of APCs as T cell stimulants, yet it played no role 
in their phenotype. Both DC and B cells isolated from OX40L
-/-
 mice showed no defect in their 
activation properties, characterised by expression of MHCII, CD40, CD80 and CD86, in the 
presence of anti-CD40 or at steady state (Murata et al., 2000a). However, their costimulatory 
properties as APCs were severely impaired, as shown by reduced antigen-specific CD4 T 
cell recall responses following immunisation with Keyhole Limpet Hemocyanin. Furthermore, 
in vitro cultures with CD4 T cells and APCs isolated and purified from either OX40L-/- or WT 
mice and assessed in different combinations, showed reduced T cell proliferation and priming 
when either CD4 T cells or APC came from the OX40L
-/-
 mice. Additionally, the effector 
functions of CD4 T cells were also defective as shown by reduced IFNg production (Murata 
et al., 2000a). Consistently, our data provided further evidence on the crucial role of OX40L 










, expressing Cre ubiquitously, as 
shown by efficient deletion of OX40L on all APCs, T cells and ILCs. We found that overall 
2W1S-specifc CD4 T cell responses and particularly their expression of T-bet
+
 (previously 
described as characteristic for effector population in Chapter 3) were highly impaired and 
mirrored the defect in generation of effector CD4 T cells found in OX40
-/-
 mice. Hence together 
this data reproduced the well-established concept of the importance of OX40:OX40L pathway 
in efficient antigen specific CD4 T cell responses.  
Additionally, past studies have identified the possible role of OX40L in generating primary 
and secondary antibody responses to a T cell-dependent antigen which could suggest that 
Tfh function was OX40L dependent (Kurche et al., 2010). In our investigation, the effect on 
Tfh population was not significant although further repeats could have strengthened the data. 
However, our group has previously demonstrated that blocking OX40L in vivo had no effect 
on numbers of Tfh cells (Marriott et al., 2014). Thus, it would seem that the requirement of 
different T cell subsets for OX40 signalling is likely dependent on the response and may 
reflect factors such as chronicity of antigen exposure which in turn helps control the timing of 
OX40 expression. 
 
5.3.4 Cellular providers of OX40L in vivo: ILC3 and T cells 
As previously mentioned, our investigations into the requirement of OX40L provision by 
different accessory cells focused on utilising the novel OX40L conditional knockout mice, 
establishing the requirement for OX40L provision by each cell type in the primary effector 





 accessory cells capable of interacting with T and B cells and lacking 
responsiveness to Flt3 ligand (Kim et al., 2003). In Rag
-/-
 mice, alongside DC, these cells had 
the highest expression of OX40L (Kim et al., 2006). Following these initial observations, many 




various stimulatory signals. They have been shown to be important for maintaining effective 
responses to microbiota (Hepworth et al., 2013). Additionally, deletion of MCHII on the 
surface of ILC3 had a profound effect on antigen-specific CD4 T cells and T cell dependent 
B cell responses, showing their direct role in antigen presentation (von Burg et al., 2014). In 
terms of provision of OX40L, current studies have shown that TL1A-induced expression of 
OX40L on ILC3 during colitis played beneficial role in barrier protection and T cell activation, 
while others showed it to be crucial in maintaining intestinal Treg homeostasis (Castellanos 
et al., 2018; Deng et al., 2019). Finally, previous reports from our lab also indicated that lack 
of ILC3 and their expression of OX40L could be linked to the reduced maintenance of memory 
CD4 T cells (Withers et al., 2012). Despite previous reports on the importance of ILC3 in 
providing costimulatory signals to T cells, we found that, alongside T cells, their provision of 





 on ILC3 contribution might be explained by the very limited number of ILC3 
in spleen in lymphoreplete mice (Baerenwaldt et al., 2016). Similarly, earlier and more recent 
studies relied on Rag
-/-
 mice where OX40L expression is much higher on ILC3 for reasons 
that are not completely clear (Castellanos et al., 2018; Kim et al., 2003). Perhaps, other 
models like for instance infections with Citrobacter rodentium or Salmonella serovar 
typhimurium, could be better suited for this type of analysis as ILC3 are predominantly 
associated with intestinal homeostasis and could play a clearer role in GALTs.  
Past studies have shown that T cells had the ability to acquire some of the APC associated 
molecules, like CD40 and CD86, which were crucial for generation of memory CD8 T cells 
and activation of naïve T cells, respectively (Bourgeois et al., 2002; Hakamada-Taguchi et 
al., 1998). OX40L expression on T cells has been associated with promoting and augmenting 
T cell responsiveness. In experiments with TCR transgenic CD4 T cells, following a transfer 
into WT or sublethally irradiated mice, OX40L-deficient T cells had reduced survival upon 
antigen stimulation (Soroosh et al., 2014). Our data, however, suggested that in Lm-2W1S 




on neither the magnitude of the response nor generation of effector population. Past studies 
on T cell OX40L function have used OT-II TCR transgenic mice which are often associated 







 mice, provision of OX40L by T cells and ILC3 was redundant 
in the primary response to Lm-2W1S.   
 
5.3.5 Cellular providers of OX40L in vivo: DC 
It is well established that OX40L expression is especially linked to APCs function as they 
represent primary group of accessory cells interacting with and providing costimulatory 
signals to naïve T cells (Ohshima et al., 1997; Stüber et al., 1995). DC in particular, as most 
efficient APCs, have the biggest potential to be crucial providers of OX40L signals. In fact, in 
L. monocytogenes induced infections, DC have been shown to be utterly required for entry of 
bacteria into the spleen and the consequent generation of immune responses (Neuenhahn 
et al., 2006). We demonstrated their crucial role in generating CD4 T cell responses using 
mice deficient in MHCII expression on DC, which did not respond to the Lm-2W1S infection 
in antigen-specific manner. Similar results were shown previously, where OVA-specific CD4 
T cell transfer into mice lacking MHCII on DC resulted in absence of antigen-specific CD4 T 
cell but not OT-I CD8 T cell responses following immunisation with OVA (Loschko et al., 
2016). Total knockout of MHCII in mice has been associated with impaired or even absent 
CD4 T cell development due to the lack of MHCII
+
 cTECs), mTECs and DC which mediate 
positive and negative selection in the thymus (Chen et al., 2017; Grusby et al., 1991). 
As previously described, studies involving the use of OX40L
-/-
 mice have been the main 
source of data supporting the critical role of OX40L expression on DC. They were based 
almost entirely on in vitro polarisation or adoptive transfer experiments, providing no evidence 
for the in vivo requirement of DC OX40L. With the documented wide expression patterns of 




of OX40L and their subsequent role in effective CD4 T cell priming and effector responses. 
One past study explored this in Th2 type of responses, where bone marrow derived DC from 
WT and OX40L
-/-
 mice where cultured with or without superantigen staphylococcal 
enterotoxin A (Jenkins et al., 2007). The antigen-experienced OX40L-deficient DC were 
transferred into WT mice and 7 days later, the harvested splenocytes were re-challenged in 
vitro with the SEA. The results of ELISA analyses, showed impaired Th2 responses, 
characterised by reduced production of IL-4, IL-5, IL-10 and IL-13 cytokines. Furthermore, 
this phenotype was rescued by intraperitoneal injections of the agonistic OX86 monoclonal 
antibody (Jenkins et al., 2007).  




 mice, our study provided even more specific 
analysis of the OX40L provision by DC in in vivo Th1 responses. Mice lacking OX40L on DC 
had their 2W1S-specific CD4 T cell responses significantly reduced. Our most striking 
observation however was the defect in the effector CD4 T cell population which was 
consistent with the similar reduction in mice lacking both CD30 and OX40 receptors. Once 
again, the Tfh population appeared to be unaffected by the lack of OX40L on DC, 




 mice.  
 
5.3.6 Cellular providers of OX40L in vivo: B cells 
The T cell-B cell contact via OX40:OX40L pathway has been particularly implicated in the 
development of T cell dependent humoral responses (Stüber et al., 1995; Stüber and Strober, 
1996). Those initial studies however, did not investigate in detail which of the cells was the 
actual OX40L provider, as both T and B cell can express OX40 and OX40L (Akiba et al., 
1999). Later reports demonstrated that adoptive transfer of OX40L deficient B cells along with 
WT T cells into Rag2
-/-
 mice, led to fewer memory B cells and lower alloantibody numbers, 
but CD4 T cell numbers were maintained (Kato et al., 2004). Moreover, another study has 
shown that WT B cells transferred into OX40L
-/- 




responses, while OX40L-deficient B cells transferred into immunoglobulin µ chain knockout 
mice (lack mature B cells) did not rescue the phenotype (Linton et al., 2003). Together, these 
studies highlighted the role of B cell OX40L, however, were limited to possible caveats 
resulting from their experimental designs. Most recent study on B cells provision of OX40L, 
has used the conditional knockout CD19
Cre
 x Tnfsf4fl/fl mice to specifically delete OX40L on B 
cells and demonstrated that it was absolutely required for optimal Tfh development and 
antibody affinity maturation (Cortini et al., 2017). We have received the Tnfsf4fl/fl mouse from 
this group and used them in generation of all of our OX40L conditional knockout mice. 
Interestingly, in responses to Lm-2W1S we found no defect neither in the 2W1S-specific CD4 
T cell responses nor in the generation of effector population at the primary stages of the 
infection. Similarly, the Tfh population was unaffected by the lack of OX40L on B cells. 
Although conflicting, the two sets of data reflect two very different immune responses and 
experimental designs, therefore should be analysed depending on their context. Additionally, 
we have used different Cre recombinase, Mb1
Cre
, to target B cells, which has been shown to 
present stronger B cell phenotype than the CD19
Cre
 (Hobeika et al., 2006).  
 
5.3.7 Summary 
Altogether, data presented in this Chapter explored the possible cellular providers of OX40L 
signals in primary responses to Lm-2W1S. Among many cells, DC were identified as 
absolutely required for the optimal Th1 CD4 T cell responses, once again emphasising the 
importance of DC: T cell interactions and the crucial role of OX40:OX40L pathway in 
promoting T cell function. Future studies should focus on providing detailed analysis of the 




 mice, particularly the cytokine profile as well 
as investigate the role of DC OX40L in memory T cell responses. Next chapter will assess 
the role of early IFNg signals in AS01 driven responses and determine whether DC OX40L 




CHAPTER 6: THE SIGNIFICANCE OF INNATE IFNg IN THE 
EFFICACY OF AS01 INDUCED RESPONSES  
6.1 Introduction 
The discovery of vaccination, almost 200 years ago, has transformed our lives, allowing us 
to prevent multiple infectious diseases establishing themselves within large swathes of the 
human population. We have observed a steady decrease in the morbidity and mortality rates, 
with many of the diseases closely controlled and some already or nearly eradicated like 
Smallpox and Polio.  
Initially, our understanding of how vaccine work was extremely limited, this however changed 
with 50 years of immunological research, leading to development of more advanced vaccine 
systems. One of such improvements involved the use of inactivated vaccines, which were 
combinations of attenuated live strains of pathogens and immunostimulants, called adjuvants.       
Over the last century, many adjuvants have been tested for use in human vaccines, however 
not many have actually been licensed. This has partially been caused by limited research 
methods and non-transferable results of animal research, with the mechanisms of action of 
many adjuvants lacking basic understanding. In recent years, however, further advances 
have been made and has led to generation of new adjuvant systems which have been 
optimized to be safe for human use. Typically, modern adjuvants act as delivery systems, 
usually consisting of emulsion or liposome core, carrying fragments of pathogens and other 
immunostimulatory agents. Over the years the focus of research has also shifted towards 
targeting other diseases like Malaria, flu and HIV which require generation of potent antigen 
specific Th1 immune responses. Previous generations of adjuvants, like aluminium salts,  
were known to induce poor responses, primarily and controversially of a Th2 phenotype 
(McKee et al., 2009; Petrovsky and Aguilar, 2004). Thus, many modern adjuvants, often 
referred to as PRR ligands, now include immunostimulants based on TLR agonists, 




One such modern adjuvant is the GSK licensed adjuvant AS01, described briefly in Chapter 
3. This system incorporates the use of liposome-based structure and TLR agonist to induce 
APC activation and maturation, resulting in elevated immune responses (Didierlaurent et al., 
2017). The TLR agonist used in AS01, as previously outlined, is MPLA. It is a TLR-4 agonist 
and is a LPS derivative, also used in another GSK licensed adjuvant, the AS04 which was 
incorporated into a hepatitis B vaccine, licensed in Europe since 2005 (Tong et al., 2005). 
MPLA is a detoxified version of lipid A from LPS of Salmonella minnesota obtained through 
controlled hydrolysis, which retains the immunostimulating activities of its parent molecule 
but with much lower toxicity rate (Ribi et al., 1979; Takayama et al., 1981; Vuopio-Varkila et 
al., 1988). In addition to MPLA, AS01 adjuvant also contains QS-21, a fraction of a saponin 
extract from soap bark tree Quillaja saponaria. First isolated in 1974, QS-21 has gained a lot 
of interest due to its inducing effects on the function of CD8 T cell as well as antibody 
production, in particular IgG1 and IgG2a (Dalsgaard, 1974; Katayama et al., 1999; Kensil et 
al., 1991; Kensil and Kammer, 2005). The combination of those two components has made 
AS01 into a particularly potent immune system inducer, which is currently being used in 
Zoster and Malaria RTS,S vaccines. The phase III trial for RTS,S took place between 2009 
and 2014 in several sub-Saharan African countries. The results of those trials proved 
promising particularly in children who received 4 doses, reducing malaria cases by 39% 
(RTS,S Clinical Trials Partnership, 2015). AS01 is also included in a number of other 
candidate vaccines against HIV and Mycobacterium tuberculosis (Dendouga et al., 2012; 
Leroux-Roels et al., 2013; Van Braeckel et al., 2011). All of these reports described increase 
in the number of antigen specific CD4 T cells as well as increased production of antibodies. 
No increase in antigen specific CD8 T cells have been reported across those studies. 
Although highly effective, the mechanisms behind AS01 functions are still being investigated. 
Recent reports on the RTS,S vaccine suggested a reduced efficacy of the vaccine over time 
with possible rebound in malaria cases, however more studies are necessary to fully 




to overcome age-related decline in immunity as in the case of the Zoster vaccine, however 
the mechanisms behind this function still remain unclear (Chlibek et al., 2016).   
Previous studies showed AS01 to play an important role in activating the innate immunity 
which in turn is critical for its adjuvant function (A. M. Didierlaurent et al., 2014). Investigations 
with gE (antigen used in Zoster vaccine)/AS01 vaccine with fluorescently labelled QS-21 and 
antigen showed the response to be notably rapid, with the drainage from the site of injection 
site, occurring within the first 24 hours post injections. Those analyses also concluded that 
the administration of antigen and adjuvant at the same location and same time was pivotal to 
efficient establishment of antigen specific immunity. The study also showed that immunisation 
with gE/AS01 increased the total numbers of innate cells, like Ly6C
high
 monocytes and 
neutrophils present within the dLNs, with majority of those found within the muscle just 3 hrs 
post injections, whereas in dLN the level of MHCII
high
 DC increased 16 hrs post injections (A. 
M. Didierlaurent et al., 2014). The resulting DC population included both tissue-resident and 
monocyte-derived cells. This suggests that AS01 promotes recruitment of innate cells into 
the site of injections and the dLNs. Furthermore, upregulation of costimulatory B7 molecules 
on DC and increase in CXCL9 and CXCL10 cytokines induced efficient T cell priming and 
enhanced Th1 programme.   
Recently, further research has focused on assessing the earliest stages of vaccination using 
the HBs antigen (used in RTS,S vaccine) and AS01 and successfully identified cell 
populations involved in producing early production of IFNg which is well known to be highly 
important in creating Th1 polarising milieu, thereby allowing establishment of antigen-specific 
CD4 T cells responses (Coccia et al., 2017). The assessment of early IFNg production in 
draining iliac LNs within the first 6hrs of immunisation revealed the main source of IFNg to 
include dLN resident NK cells and CD8 T cells which have been identified to respond in 
antigen-independent fashion. Additionally, the data clearly indicated that those early 




In this chapter we focused on exploring the mechanisms behind AS01 efficacy further, in 
particular its effect on innate cells and their subsequent role in promoting efficient adaptive 
responses. Building on existing data, we aimed to provide further insight into early IFNg 
production, induced by the AS01, and its role in promoting efficient T cell and B cell 


























6.2.1 AS01 induces rapid IFNg production in draining LNs 6hrs post 
immunisation  
Data presented in chapter 3, clearly demonstrated the efficiency of GSK licensed adjuvant 
AS01 in promoting antigen specific CD4 T cell responses. Moreover, we also showed that 
the adjuvant properties of AS01 are OX40 dependent, which prompted the question of 
mechanistically how does AS01 stimulate OX40L expression and which cells provide this 
signal to support effector CD4 T cell responses in vivo. We therefore made it paramount for 
us to understand the early actions of AS01, in particular early production of cytokines like 
IFNg which could promote upregulation of costimulatory molecules and thereby enhance 
immune responses.  
Most common adjuvants are characterised as having the ability to evoke innate signals which 
in turn activate antigen presenting cells, upregulating various molecules, including many 
costimulatory pathways, ensuring the efficacy and efficiency of antigen specific CD4 T cell 
responses. In particular, inflammatory cytokines, like IL-6 and IL-18 produced at the injection 
site form a link with enhanced antigen presentation (Li et al., 2004; S.-J. Park et al., 2004) . 
Notably, IFNg can generate a wide range of cellular events which include cell activation, 
upregulation of molecules, induction or stabilization of effector functions and especially 
promoting the Th1 polarizing milieu, enabling activation and expansion of antigen specific T 
cell populations. Due to the previous evidence showing importance of early IFNg in systemic 
responses to Lm-2W1S infections, we sought to understand what where the mechanisms 
behind AS01 function in local Th1 responses. 
Recent reports have shown that AS01 induced very rapid production of IFNg responses in 
WT mice (Coccia et al., 2017). As established earlier, all studies involving AS01 adjuvants 
were conducted in accordance with GSK guidelines. The injections were performed 
intramuscularly into the gastrocnemius muscle of both hind legs, with 10µL injections 




The WT mice were immunised with either 20µg OVA-2W/PBS or 20µg OVA-2W/AS01 and 
were culled 6hrs later (Figure 6.1 A). To identify IFNg producing cells in iliac and inguinal 
draining LNs we followed the GSK optimised protocol, where the isolated cells from draining 
LNs were cultured for 3 hrs in the presence of BFA (Golgi transport inhibitor) and Monensin 
(Golgi stop). Flow cytometry analyses revealed that AS01 indeed induced rapid production of 
IFNg 6 hrs post immunisation, evident by a clear population of CD45+IFNg+ cells in OVA-
2W/AS01 immunised mice and its minimal presence in control (OVA-2W/PBS) mice (Figure 
6.1 B, C). The results were true for both iliac and inguinal LNs and were further verified by 
the enumeration and proportion of CD45
+
 cells expressing IFNg which were found to be 
significantly higher in both iliac and inguinal draining LNs of OVA-2W1S/AS01 immunised 
mice as compared to their PBS controls (Figure 6.1 D, E).  
We next focused on assessing the phenotype of the CD45
+
IFNg+ cells, particularly the 
engagement of NK cells and their innate IFNg+ responses, which were previously reported 
(Coccia et al., 2017). Gating on CD45
+
IFNg+ cells, we assessed the expression of NK1.1 and 
CD3 amongst IFNg+ cells, enabling identification of NK cells (NK1.1+, red), putative NKT cells 




 cells (purple) 
(Figure 6.2 A). Immunisations with AS01 enhanced the total numbers of all identified 
population as compared to the PBS controls, however this was due to the overall increase in 
the cellularity of iliac and inguinal LNs post immunisation with OVA-2W1S/AS01 (Figure 6.2 
B, D). Further assessment of the proportional contribution of the individual populations 
showed most substantial changes, as compared to PBS controls, to be amongst the NK and 
T cell populations. (Figure 6.2 C, E). The increase in putative NKT cell population was more 
modest but still significant. These results were therefore consistent with previous data 
showing NK cells and T cells were the main source of IFNg after immunisation with AS01 




















20µg OVA-2W1S + 1/50HD AS01 or PBS
6hr Draining LNs 
























Figure 6. 1 AS01 induces rapid production of IFNg 
To investigate the early effects of AS01 on the immune response in the draining LNs, WT 
mice were injected intramuscularly with 20 µg OVA-2W/PBS or 20 µg OVA-2W/AS01, 
sacrificed 6hrs post immunisation and the IFNg response assessed in both the iliac and 
inguinal LNs following a 3 hrs culture with BFA and Monensin. (A) Experimental design. (B) 
Representative flow cytometry plots showing IFNg production at 6 hrs post immunization with 
OVA-2W/PBS and OVA-2W/AS01 in iliac dLNs. (C) Representative flow cytometry plots 
showing IFNg production at 6 hrs post immunization with OVA-2W/PBS and OVA-2W/AS01 
in inguinal dLNs. (D) Total number of CD45+IFN!+ cells in iliac and inguinal dLNs. (E) 
Percentages of CD45
+
IFN!+ cells in iliac and inguinal dLNs. Data pooled from 4 independent 
experiments, n=5 OVA-2W/PBS, n=11 OVA-2W/AS01. Values on flow cytometry plots 
represent percentages, bars on scatter plots represent the median. Statistical significance 













































































































































Figure 6. 2 AS01 immunisation have an effect of different cell subsets  
To further understand the early effects of AS01 on the immune response in the draining LNs, 
population of the IFNg+ cells were phenotyped. (A) Flow cytometry plots showing gating 
strategy used to identify different CD45
+
IFNg+ cell subsets (NK cells (NK) - RED, putative 
iNKT cells (NK1.1+ CD3+) - GREEN, T cells (T) - YELLOW, other cells (Other) - PURPLE) in 
iliac dLNs. These plots also show identification of ILC population within the NK cell subset. 
Representative flow cytometry plots for inguinal dLNs can be found in Appendix Figure 8.5. 
(B, C) Total numbers and percentages of different IFNg producing cells subsets identified at 
the 6hrs post immunisation in iliac LNs. (D, E) Total numbers and percentages of different 





 T cells present at 6 hrs post immunisation with OVA-
2W1S/AS01. Gating strategy and representative flow cytometry plots can be found in 
Appendix Figure 8.6 (G) Percentages of CD8+ versus CD4+ cells found within the CD62L+ T 
cell population at 6 hrs post immunisation with OVA-2W1S/AS01. (H) Total number of ILC 
population induced at 6 hrs post immunisation with OVA-2W1S/AS01. Data in B-E are pooled 
from four independent experiments, OVA-2W/PBS: n=5 and OVA-2W/AS01: n=11; data in F-
G are pooled from two independent experiments n=5; data in H are pooled from three 
independent experiments n=3 OVA-2W/PBS, n=6 OVA-2W/AS01; Values on flow cytometry 
plots represent percentage, bars on scatter plots represents the median. Statistical 
significance was tested using an unpaired, non-parametric, Mann-Whitney two tailed T test: 







We also observed T cell phenotypes induced by AS01 identified the IFNg+ T cells to be 
expressing conventional memory markers, including CD62L and being primarily CD8
+
 (Figure 
6.2 F, G). This suggests that early T cells responses resulted from reactivation of memory T 
cells, likely in TCR independent manner.   
Within the group of NK cells, we also assessed whether group 1 of innate lymphoid cells 
(ILC1) could be contributing to the production of IFNg. Despite the lack of conventional antigen 
receptors, ILC represent group of lymphocytes capable of producing wide range of effector 
functions which correspond closely to the function of individual helper T cell subsets (Spits 
and Cupedo, 2012). They are primarily tissue resident and highly abundant in lymph nodes. 
In recent years, ILC1 have been described to include classical NK cells as well as non-NK 
ILC1, with different transcriptional factor requirements. To differentiate between the classical 
NK cells and ILC1, we used expression of EOMES, a transcription factor which has been 
previously identified to be primarily expressed on NK cells (Figure 6.2 A) (Gordon et al., 
2012). Data showed that majority of the IFNg+ NK1.1 cells, approximately 85%, expressed 
EOMES
 
and therefore were undoubtedly characterised as classical NK cells. Interestingly, 
approximately 12% of cells were negative for EOMES, yet still expressed T-bet
 
and thus were 
most likely to be genuine ILC1 (Figure 6.2 H).  
We next sought to determine whether putative NKT cell population included genuine NKT 
cells. As in the case of Lm-2W1S model, we hypothesised that NKT cells might play an 





 cells among the IFNg+ population alone gave an indication for the possible 
involvement of NKT cells in AS01 induced responses. We were therefore interested to 
investigate if ablation of NKT cells would have an effect on the identified phenotype and 
potential of the IFNg producing cells. To do so, we immunised WT and CD1d-/- mice with OVA-
2W1S/AS01. The mice were sacrificed 6 hrs later and the AS01 induced responses analysed 






 mice indeed lacked NKT cells by staining for the CD1d tetramer which 
showed a significant reduction percentage of NKT cells present (Figure 6.3 B). Analysis of 





cells in WT and CD1d
-/-
 mice following immunisation with OVA-
2W1S/AS01 which was further represented by the absence of variation in their total numbers 
(Figure 6.3 D). Moreover, abrogation of NKT cell responses had no significant effect on the 
overall IFNg production at 6 hrs post immunisation with OVA-2W1S/AS01(Figure 6.3 E). 




 population should not be identified 
as putative NKT cells and that they most likely form a subset of T cells which acquire NK cell 
phenotype upon stimulation, in particular the expression of NK1.1. Our observations showed 




 cells were also positive for the CD8 expression (Figure 6.3 
C), validating previously published data on the potential of CD8 T cells in expression of NK 
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Figure 6. 3 The NK1.1+CD3+ population of IFNg+ cells cannot be identified as putative 
iNKT cells  
To investigate the phenotype of the NK1.1+CD3+ population of AS01 induced CD45
+
IFN!+ 
cells, WT and CD1d
-/-
 mice were immunised intramuscularly with 20 µg OVA-2W/AS01, 
sacrificed 6hrs post immunisation and the IFNg response assessed in both the iliac and 
inguinal LNs following 3hrs culture in the presence of BFA and Monensin. (A) Experimental 
design. (B) Representative flow cytometry plots showing CD1d-/- deletion in spleen of the 
mice tested and compared to WT mice. (C, D) Representative flow cytometry plots showing 
IFNg production in iliac dLN of WT and CD1d-/- mice 6 hrs post immunization with OVA-
2W/AS01. Representative flow cytometry plots for inguinal dLNs can be found in Appendix 
Figure 8.7 (D) Enumeration of NK1.1+CD3+ subset of IFN!+ cells in iliac and inguinal dLNs. 
(E) Total numbers of CD45+IFN!+ cells in iliac and inguinal dLNs. Data pooled from two 
independent experiments, n=4 WT, n=4 CD1d
-/-
. Values on flow cytometry plots represent 
percentage, bars on scatter plots represents the median. Statistical significance was tested 













6.2.2 AS01 promotes IFNg production by innate cells and antigen-specific 
CD4 T cells in response to OVA-2W  
Having established that AS01 induced early IFNg from different innate and memory cells, we 
next aimed to move on to developing the same approach in GS reporter mice to enable more 
dynamic assessment of IFNg expression which could be further explored also in prime boost 
approach. We have previously established the effectiveness of GS mice in reporting of IFNg 
(eYFP) and IL-17A (hNGFR). To confirm that our experimental approach would work with the 
GS mice, WT and GS mice were injected with OVA-2W1S/AS01 and their draining LNs 
analysed at 6hr post immunisation (Figure 6.4 A). WT mice immunised with OVA-2W/AS01 
served as negative controls for identifying eYFP expression (Figure 6.4 B). The gate set in 
the control mouse was then applied to the samples obtained from GS mice. The analyses 
showed a clear population of eYFP
+
 (proportional to IFNg expression) cells when compared 
to the background signal detected in the WT controls (Figure 6.4 C), identified in both iliac 
and inguinal draining LNs (Figure 6.4 D).   
The established surface staining panel allowed identification of the four IFNg producing 




 (green), T cells 




 cells (purple) (Figure 6.4 C). The results obtained from these 
analyses were comparable to those observed in WT mice with ex vivo culture, showing NK 
cells and T cells among the dominant population of IFNg cells (Figure 6.4 E, F). 
Having established more robust analysis that enabled direct ex vivo assessment with no 
further manipulation, we next sought to address two further questions, regarding the effect of 
a second booster injection of AS01 and whether responding CD4 T cells in the draining LN 







































































Figure 6. 4 Assessment of IFNg production induced by AS01 using IFNg reporter mice  
To directly assess IFNg production without further manipulation, GS mice dual reporter mice 
were injected intramuscularly with 20 µg OVA-2W/AS01, sacrificed 6hrs post immunisation 
and response was assessed in both iliac and inguinal dLNs. (A) Experimental design. (B) 
Representative flow cytometry plots showing eYFP expression in WT mice following the 
intramuscular injections and the gating strategy used to identify different cell subsets in iliac 
LNs. Representative flow cytometry plots for inguinal dLNs can be found in Appendix Figure 
8.8 (C) Representative flow cytometry plots showing eYFP expression GS mice following the 
intramuscular injections and the gating strategy used to identify different cell subsets in iliac 










cell subsets identified in inguinal dLNs. Data pooled from 2 independent 
experiments, n=4. Values on flow cytometry plots represent percentage, bars on scatter plots 
represents the median. Statistical significance was tested using an unpaired, non-parametric, 













To try to investigate this further, we established 4 treatment groups (Figure 6.5 A). The GS 
mice were injected at D0 with either OVA-2W/PBS or OVA-2W/AS01 or had no procedure 
carried out and then received a second dose of either OVA-2W/PBS or OVA-2W/AS01 at D7, 
anticipating that the early innate IFNg would have finished but new T cells from the initial 
immunisation might have formed effector population. A group of mice that received only OVA-
2W/PBS at D7 (group 1) served as a negative control for the effects of AS01 and helped with 
gating on both eYFP
+
 cells but also 2W1S-specific CD4 T cells. To assess the effect of boost 
on the innate responses, the analyses were conducted 6 hrs post second immunisation at D7 
in both draining LNs.  
Analysis of eYFP expression in the different mice revealed several interesting observations. 
First of all, the use of GS control mice (group 1) proved paramount to the accurate 
identification of the eYFP expressing cells. It indicated a presence of eYFP
low
 expressing cells 
which most probably reflected the impact of the injection procedure or more homeostatic 
levels in the LN (Figure 6.6 A). This population also appeared comparable between groups, 
with the eYFP
high
 population particularly apparent in mice that had received AS01 within last 
6hrs prior analysis (group 2 and 4) (Figure 6.6 A). This was further confirmed by the significant 
increase in the total number of eYFP
+
 cells in both iliac and inguinal draining LNs in mice 
belonging to treatment group 2 (Figure 6.6 B, C), revealing a clear enhancement of the innate 
response elicited by a second booster injection with AS01 present.  
To further assess whether boosting with AS01 altered the populations that produced high 
levels of IFNg, we phenotyped the eYFPhigh populations using previous gating strategy 
assessing expression of NK1.1 and CD3 in both iliac and inguinal draining LNs (Figure 6.7 
A, E). We then compared the individual cell subsets identified in draining LNs between the 
different treatment groups. Amongst the eYFP
+ 
population, total numbers of NK cells, NKT 
cells and T cells were significantly increased in mice that received OVA-2W/AS01 at D0 and 


















Figure 6. 5 Model for tracking AS01 induced recall responses in draining LNs  
To investigate the effects of AS01 on the efficacy of NK cell and T cell responses, the GS 
were immunised intramuscularly at D0 and D7 with either 20 µg OVA-2W/PBS or 20 µg OVA-
2W/AS01 according to 4 independent experimental conditions: 1= D7: 2W/PBS; 2= D0: 
2W/AS01➔D7: 2W/AS01; 3= D0: 2W/AS01➔ D7: 2W/PBS; 4= D0: 2W/PBS➔D7: 2W/AS01. 






























































Figure 6. 6 Boost with AS01 at D7 increases significantly NK derived IFNg production  
The production of IFNg was assessed using GS mice which were prior immunised either with 
20 µg OVA-2W/PBS or 20 µg OVA-2W/AS01 according to 4 independent experimental 
conditions: 1= D7: 2W/PBS; 2= D0: 2W/AS01➔D7: 2W/AS01; 3= D0: 2W/AS01➔ D7: 
2W/PBS; 4= D0: 2W/PBS➔D7: 2W/AS01. The mice were sacrificed 6hrs post immunisation 
at D7 and the response was assessed in both iliac and inguinal dLNs. (A) Representative 
flow cytometry plots showing eYFP expression in iliac and inguinal dLNs following the 
intramuscular injections. (B) Total numbers of CD45+eYFP cells in iliac dLNs. (C) Total 
numbers of CD45
+
eYFP cells in inguinal dLNs. Data pooled from 2 independent experiments, 
n=4 Condition 1 (iliac and inguinal LNs pooled); n=6 Condition 2, n=5 Condition 3, n=5 
Condition 4. Values on flow cytometry plots represent percentage, bars on scatter plots 
represents the median. Statistical significance was tested using an unpaired, non-parametric, 














Responses post boost were more prominent in iliac draining LNs than in inguinal LNs, 
however further repeats could reinforce sample size and provide sufficient statistical power 
to carry out further analyses. Here we showed that boost with AS01 enhanced innate IFNg 
production which supported better adjuvant effect.    
Our investigations revealed that approximately half the IFNg producing cells in the draining 
LN were T cells. Whilst these may be a mixture of previously activated or memory cells 
responding directly to the adjuvant or indirectly in response to other signals, we sought to test 
whether responding antigen experienced CD4
 
T cell within the draining LN were responsive 
to AS01. To do this, we assessed the endogenous CD4 T cell response to the OVA-2W1S, 
using MHCII tetramers. Consistent with previous experiments, administration of AS01 upon 
initial encounter of antigen resulted in a far more robust CD4 T cell response than the one 
detected in OVA-2W/PBS controls (Figure 6.8 A, B, C). Whilst boosting with OVA-2W/AS01 
did not result in a greater number of 2W1S-specific CD4
 
T cells, as might be expected given 
the 6hr time point assessed, interestingly, a significant increase in the IFNg production was 
detected versus mice that only received OVA-2W/PBS at boost (Figure 6.8 D, E). Thus, 
boosting with AS01 not only resulted in enhanced innate IFNg production but also by antigen-
specific CD4
 
T cells. At this stage, we do not know the impact of boost upon the resulting 
memory response, however, combined, these initial data indicate that a second booster 
injection with OVA-2W1S/AS01 induces an enhanced response compared with initial priming 
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Figure 6. 7 Analysis of IFNg-producing populations induced by AS01  
Phenotyping of the IFNg+ cells following immunisation with 20 µg OVA-2W/PBS or 20 µg 
OVA-2W/AS01 according to 4 independent experimental conditions: 1= D7: 2W/PBS; 2= D0: 
2W/AS01➔D7: 2W/AS01; 3= D0: 2W/AS01➔ D7: 2W/PBS; 4= D0: 2W/PBS➔D7: 2W/AS01. 
The mice were sacrificed 6hrs post immunization at D7 and the response was assessed in 
both iliac and inguinal dLNs. (A) Representative flow cytometry plots showing different 
CD45
+
eYFP cell subsets in iliac dLNs following the intramuscular injections. (B) Total 
numbers of NK cells identified in iliac dLNs. (C) Total numbers of NK1.1+CD3+ cells identified 
in iliac dLNs. (D) Total numbers of T cells identified in iliac dLNs. (E) Representative flow 
cytometry plots showing different CD45
+
eYFP cell subsets in inguinal dLNs following the 
intramuscular injections. (F) Total numbers of NK cells identified in inguinal dLNs. (G) Total 
numbers of NK1.1+CD3+ cells identified in inguinal dLNs. (H) Total numbers of T cells 
identified in inguinal dLNs. Data pooled from 2 independent experiments, n=4 Condition 1 
(iliac and inguinal LNs pooled), n=6 Condition 2, n=5 Condition 3, n=5 Condition 4. Data 
assessed by Mann-Whitney, two tailed, non-parametric test, *p<0.05, ** p<0.005, 



























































































3= D0: 2W/AS01➔ D7: 2W/PBS 4= D0: 2W/PBS➔D7: 2W/AS01













Figure 6. 8 AS01 promotes IFNg production by responding CD4 T cells in the draining 
LN  
To test whether AS01 induced IFNg production by responding CD4+ T cells in the draining LN 
GS mice were injected intramuscularly at D0 and D7 with either 20 µg OVA-2W/PBS or 20 
µg OVA-2W/AS01 according to 4 independent experimental conditions: 1= D7: 2W/PBS; 2= 
D0: 2W/AS01➔D7: 2W/AS01; 3= D0: 2W/AS01➔ D7: 2W/PBS; 4= D0: 2W/PBS➔D7: 
2W/AS01. The mice were sacrificed 6hrs post immunization at D7 and the 2W1S-specific 
response assessed in both iliac and inguinal dLNs using MHCII tetramers (I-A
b
:2W1S). (A) 










) and showing eYFP (IFNg) expression in iliac dLNs for the tested experimental 
conditions. Representative flow cytometry plots for inguinal dLNs can be found in Appendix 
Figure 8.9 (B) Total numbers of 2W1S-specific CD4 T cells in iliac dLNs. (C) Total numbers 
of 2W1S-specific CD4
 
T cells in inguinal dLNs. (D) Total numbers of eYFP+ 2W1S-specific 
CD4 T cells in iliac dLNs. (E) Total numbers of eYFP+ 2W1S-specific CD4 T cells in inguinal 
dLNs. Data pooled from 2 independent experiments, n=4 Condition 1 (iliac and inguinal LNs 
pooled); Condition 2: n=6; Condition 3: n=5; Condition 4: n=5. Values on flow cytometry plots 
represent percentage, bars on scatter plots represents the median. Statistical significance 










6.2.3 AS01-dependent germinal centres formation requires interaction 
between T and B cells but not IFNg  
So far, our data showed that AS01 induced rapid IFNg from both innate and adaptive immune 
cell populations. We next began studies assessing how AS01 elicits B cell responses to build 
on our understanding of the mechanisms through which this adjuvant supports establishment 
of robust adaptive immunity and whether they were IFNg dependent.  
The role of IFNg in creating the environment for effector T cells and regulating both T cell-
independent and T cell-dependent B cell differentiation has been already well established 
(Abed et al., 1994; Berg et al., 2005; Huang et al., 1993). Induction of long-term immune 
responses is paramount to the efficacy of vaccines, especially, generation of memory B cells 
and antigen responses. However, antigen-specific B cell responses are still not well 
understood. Previous studies identified MF59 oil-in-water emulsion adjuvant as an effective 
inducer of HlaH35L, a Staphylococcus aureus Ag, specific B cell responses (Salvatore et al., 
2015). To assess antigen-specific B cell responses following AS01 immunisation, mice were 
immunised intramuscularly with 10 µg PE/AS01, a method previously shown to allow 
detection of endogenous antigen-specific B cell populations (Pape et al., 2011). In these initial 
experiments, we sought to ask whether the B cell response induced by AS01, assessed 
simply by the formation of PE-specific GCs was a) dependent on T cells and b) dependent 
upon IFNg, given the prominent role this plays in supporting the CD4 T cell response. We 
planned to do this in vivo using mice lacking ab T cells or IFNg.  
The assessment involved immunisation of WT, TCRa-/- and IFNg-/- mice with either 10 µg 
PE/PBS or 10 µg PE/AS01 and the responses in a pool of iliac and inguinal draining LNs 
assessed at D10 of the response (Figure 6.9 A).  
In WT mice immunised with AS01/PE, a distinct and expanded population of PE specific B 
cells was identified, with this population nearly absent in PE/PBS control mice consistent with 




was significantly decreased in TCRa-/- mice indicating that in absence of ab T cells, the 
enhanced B cell response was blocked (Figure 6.9 D, E, F). We observed no difference in B 
cells response in IFNg-/- mice which argued that IFNg was not required for generation of robust 
B cells responses post immunisation with AS01 adjuvant (Figure 6.9 D, E, F).  




, as previously described (Oliver et al., 1997; Taylor 





was evident in AS01 immunised WT mice, but not PE/PBS controls 
nor TCRa-/- mice (Figure 6.10 A, B, C). In IFNg-/- mice, this population was not diminished, 
indicating this was independent of IFNg mediated effects of AS01 (Figure 6.10 A, B, C). 
Data described above, defined the function of AS01 adjuvant as an effective 
immunostimulatory agent and its role in mediating the CD4 T cell and B cell responses in 
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Figure 6. 9 AS01-induced B cell responses to PE are T cell dependent  
To investigate the mechanisms through which AS01 induces robust B cell responses, WT, 
IFNg-/- and TCRa-/- mice were injected intramuscularly with either PE/PBS or PE/AS01 and 
the draining LNs assessed 10 days later. (A) Experimental design. (B) Gating strategy used 
to identify PE specific B cells. (C) Representative flow cytometry plots showing B cell 
responses in dLNs (iliac and inguinal combined) of PE/PBS control WT, IFNg-/- and TCRa-/- 
mice. (D) Representative flow cytometry plots showing B cell responses in dLNs (iliac and 
inguinal combined) of PE/AS01 immunised WT, IFNg-/- and TCRa-/- mice. (E) Percentages of 
PE
+
 B cells in dLNs. (F) Total numbers of PE+ B cells in dLNs. Data pooled from two 
experiments, PBS control: n=5 C57Bl/6; n=4 IFNg-/- and n=6 TCRa-/-; AS01 immunised: n=6 
C57Bl/6; n=5 IFNg-/- and n=8 TCRa-/-.Values on flow cytometry plots represent percentage, 
bars on scatter plots represent the median. Statistical significance was tested using an 














































Figure 6. 10 AS01-induced germinal centre formation is T cell dependent  
To investigate the AS01 induced germinal centre formation WT, IFNg-/- and TCRa-/- mice were 
injected intramuscularly with either PE/PBS or PE/AS01 and the draining LNs assessed 10 





 at D10 post immunisation in dLNs (iliac and inguinal combined) of PE/PBS 
control WT and PE/AS01 immunised WT, IFNg-/- and TCRa-/- mice. (B) Percentages of GC+ 
B cells in dLNs. (C) Total numbers of GC+ B cells in dLNs. Data pooled from two experiments, 
PBS control: n=5 C57Bl/6; n=4 IFNg-/- and n=6 TCRa-/-; AS01 immunised: n=6 C57Bl/6; n=5 
IFNg-/- and n=8 TCRa-/-. Values on flow cytometry plots represent percentage, bars on scatter 
plots represents the median. Statistical significance was tested using an unpaired, non-















6.2.4. Provision of OX40L by DC is moderately important for generation of 
effector CD4 T cells responses following immunisation with AS01 and OVA-
2W1S  
Following our previous findings, we then aimed to investigate the effect of AS01 on the DC 
function in particular whether it had the potential to upregulate OX40L on DC and moreover 
whether this interaction could feed into the antigen- specific CD4 T cell responses.  
As described in chapter 4, OX40L upregulation on DC in response to Lm-2W1S follows 
specific pattern, occurring early in the response and being partially dependent on early IFNg 
production. We hypothesised that due to the rapid IFNg production post AS01 immunisation, 
there was high probability that similar mechanisms could be involved in the OX40L 
upregulation on DC in draining LNs.  
We first aimed to track OX40L expression on DC in draining LNs, contralateral LNs and 
spleen of WT mice, assessing it at 24, 48 and 72 hrs post immunisation with OVA-
2W1S/AS01 followed by the overnight culture, like in the case of the Lm-2W1S model (Figure 
6.11 A). Assessment of contralateral LNs and spleen ensured for thorough investigation of 
AS01 induced effects. Additionally, we used identical gating strategy to identify DC in draining 






 (Figure 6.11 B) and 
untreated WT mice were used to set accurate gates to assess OX40L at individual time 
points. Flow cytometric analyses revealed AS01 induced upregulation of OX40L on DC which 
reached a peak expression on LN and splenic DC at 24 hrs post immunisation with AS01 
(Figure 6.11 C, 6.12 A, B, C), as compared to the untreated controls. Following the initial 
upregulation, the proportion of DC expressing OX40L gradually decreased at 48 hrs and was 
maintained at approximately 10% and 8% at 72 hrs in draining and contralateral LNs, 
respectively (Figure 6.12 A, B). In the spleen, the decline in OX40L on DC was less prominent 



























































Figure 6. 11 Tracking OX40L expression on DC in draining LNs post intramuscular 
immunisation with AS01 adjuvant  
To investigate the effects of AS01 on the expression of OX40L on DC, mice were injected 
intramuscularly with 20 µg OVA-2W/AS01, sacrificed 24hrs post immunisation and the pool 
of iliac and inguinal LNs were cultured overnight. (A) Experimental design. (B) Gating strategy 








, MHCII). (C) 
Representative flow cytometry plots showing OX40L expression on DC in draining LNs (iliac 
and inguinal combined) at 24, 48 and 72 hrs post post immunization with OVA-2W/AS01. 





































































Figure 6. 12 AS01 upregulates OX40L expression on DC in draining LNs  
(A) Percentages of DC expressing OX40L in dLNs at 24, 48 and 72 hrs post post 
immunization with OVA-2W/AS01. (B) Percentages of DC expressing OX40L in contralateral, 
cLNs at 24, 48 and 72 hrs post post immunization with OVA-2W/AS01. (C) Percentages of 
DC expressing OX40L in spleen at 24, 48 and 72 hrs post post immunization with OVA-
2W/AS01. (D) Representative flow cytometry plots, showing DC (B220-CD3-CD49b-, 
CD11c+, Ly6C
low
, MHCII). expressioin of OX40L in dLN at 24 post post immunization with 
OVA-2W/AS01 in WT and IFNg-/- mice. (E) Percentages of DC expressing OX40L in dLN at 
24 post post immunization with OVA-2W/AS01 in WT and IFNg-/- mice.  Data in A-C are 
pooled from two independent experiments, n=4 UN; n=7 24 hrs; n=8 48 hrs and n= 7 72 hrs. 
Data in D represents one experiment, n=4. Bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 















Interestingly, identical analysis performed in IFNg-/- mice showed no significant differences 
between WT mice with regards to the OX40L expression on DC at 24 hrs post immunisation 
with AS01 (Figure 6.12 D, E). Here we provided novel data on AS01 induced upregulation of 
OX40L on DC, showing the importance and efficiency of AS01 adjuvant in stimulating 
costimulatory signals as previously shown for CD86, CD50 and CD40 (A. M. Didierlaurent et 
al., 2014). To investigate whether these signals were required for potent T cell responses, we 
decided to repeat our previous experiments using AS01 model combined with our conditional 
knockout mice targeting specifically OX40L on DC in vivo. The CD11cCre x OX40Lf/f mice 
alongside the CD11c
Cre
 only controls and OX40
-/-
 negative control mice were immunised with 
OVA-2W1S/AS01 and the responses assessed in draining iliac and inguinal LNs 7 days later 






 T cells, 2W1S-specific responses were 
measured using MHCII Tetramers (Figure 6.13 B, C). Moreover, we assessed T-bet versus 









) (Figure 6.13 D). Analyses unveiled a definite OX40 
dependency of 2W1S specific responses post AS01 immunisation, represented by a 
significant reduction in the number of 2W1S-specific CD4 T cells in both iliac and inguinal 
LNs in OX40
-/-
, compared to the CD11c
Cre
 only control mice (Figure 6.13 C; 6.14 A, E). 





 mice showed that they were not significantly affected by the lack of 
OX40L on DC (Figure 6.13 C; 6.14 A, E). However, further assessment of T-bet expression 





 mice. Although not statistically significant, the effect observed was reflected in 
reduction of T-bet
+
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Figure 6. 13 AS01 induced 2W1S-specific CD4 T cell responses require OX40 and are 









 mice were immunised with OVA-2W1S/AS01 
and sacrificed at D7 when the responses in both iliac and inguinal dLNs were assessed. (A) 
Experimental design (B) Gating strategy used for identification and expression of 2W1S-
specific CD44
hi










) in iliac LNs. (C) Expression of 
specific CD44
hi
















 mice. Representative flow cytometry plots for inguinal dLNs 























 mice did not recapitulate the defect in the total absence of OX40 signals, 
as the effector T cell responses post OVA-2W1S/AS01 immunisations were further abrogated 
in OX40
-/-
 mice in both iliac and inguinal LNs. These analyses gave strong indication for other 
possible providers of OX40L in vivo. Moreover, AS01 induced generation of Tfh cells was 
heavily impaired by the ablation of OX40 signals as shown by the significant decrease in the 
total number on CXCR5
+
 cells in iliac and inguinal draining LNs in OX40
-/-
 mice (Figure 6.14 
D, H). These results are particularly interesting as were not previously observed in the Lm-
2W1S model and could indicate the possible B cell-specific provision of OX40L.  
Altogether, data presented in this chapter outlined mechanisms of AS01 function, primarily 
its importance in promoting innate IFNg responses and their subsequent role in adaptive 
immunity as well as the role in upregulation of OX40L on DC which proved to be moderately 






































































































Figure 6. 14 Expression of OX40L by DC is partially required for efficient AS01 derived 
effector Th1 responses 
(A, E) Enumeration of 2W1S-specific CD44hi CD4 T cells CD11ccre, CD11ccre x OX40Lf/f and 
OX40
-/-
 mice. (B, F) Enumeration of T-bet+ 2W1S-specific CD44hi CD4 T cells in iliac and 
inguinal LNs (C, G) Percentage of 2W1S-specific CD4 T cells expressing T-bet in iliac and 
inguinal LNs. (D, H) Enumeration of CXCR5+ 2W1S-specific CD44hi CD4 T cells in iliac and 









. Values on flow cytometry plots represent percentages, 
bars on scatter plots represents the median. Statistical significance was tested using an 
unpaired, non-parametric, Kruskal-Wallis one-way ANOVA with post hoc Dunn’s test: 


















The initiation of an immune response to an infection is mediated through extensive 
collaboration between innate and adaptive immune cells. Both groups of cells possess 
specific recognition mechanisms to discriminate self from pathogens and initiate a chain of 
organised events leading up to the formation of long-term immunity. Vaccines mimic an 
infection to artificially induce protective immunity through stimulation of different parts of 
immune system. Modern adjuvanted vaccines are the most effective, exhibiting increased 
immunogenicity and speed as well as having minimal side effects. However, most importantly, 
the different types of adjuvants contained within these vaccines can modulate and promote 
specific phenotypes of T cell responses and antibody titers required to fight the infection.   
As presented in Chapter 3, part of this PhD project has been devoted to investigating the 
mechanisms of action of GSK licensed adjuvant AS01 in the context of Th1 immunity. In this 
chapter we have focused on trying to better understand how the adjuvants impact innate cells 
to enhance the adaptive responses and specifically investigate the aspects of control of 
costimulatory ligand provision. AS01 belongs to a class of novel and recently introduced 
combination adjuvants which have been shown to promote immunity through synergistic 
action of two or more components. In the case of AS01, these are the MPL and QS-21 which 
together induce potent antigen-specific CD4 T cell responses in vivo, as we have previously 
shown in Chapter 3 and others have already published (Leroux-Roels et al., 2013; 
Vandepapelière et al., 2008).  
The saponin QS-21 has been known to have agonistic function in activation of NLRP3 
inflammasome, promoting a NLRP3-Asc-caspase1 dependent release of IL-1b and IL-18 
(Marty-Roix et al., 2016). Contrarily, MPL has been shown to have reduced inflammatory 
properties but can induce production of IL-12 (Salkowski et al., 1997). The NLRP3 
inflammasome activation can be mediated by many pathways, but in the AS01 system it is 




predominantly expressed on the myeloid lineage of immune cells, including macrophages 
and dendritic cells (Ketloy et al., 2008; Lizundia et al., 2008; Rehli, 2002; Vaure and Liu, 
2014). Moreover, in mice, the Tlr4 transcripts have been found in many tissues, including 
lungs, heart and muscle (Qureshi et al., 1999). Both components of AS01 signal through the 
TLR4 receptor, as their stimulatory effects were reduced in TLR4
-/-
 mice (Marty-Roix et al., 
2016; Pouliot et al., 2014).  
The AS01 system relies on rapid activation of monocytes and other resident cells within the 
muscle and the draining LNs to induce TLR4 signalling and the subsequent release of 
proinflammatory cytokines like IL-1b, IL-6, TNFa which have been shown to be present at 
both sites within 3 hrs (A. M. Didierlaurent et al., 2014). In a recent study, these properties of 
AS01 have been identified as essential for the rapid production of IFNg observed within the 
first 6 hrs of AS01 administration (Coccia et al., 2017). Our data presented in this chapter, 
supported the recent findings, demonstrating early production of IFNg in WT mice in response 
to OVA-2W1/AS01 at 6 hrs post immunisation. Although, the original study showed the 
response to be specific only to the iliac draining LNs, as in our previous investigations, we 
have shown that inguinal LNs also displayed a significant increase in IFNg production. 
 
6.3.1 Early IFNg responses post immunisation with AS01  
The combined effects of IL-1b, IL-18, IL-6 and IL-12 have a significant effect on the type of 
cells becoming activated and acquiring their effector states. Consistent with the recently 
published study, we have shown that NK cells and T cells were the two dominant producers 
of IFNg at the 6 hrs post OVA-2W1S/AS01 immunisation. NK cell activation is highly 
influenced by the secretion of IL-12 and IL-18 (Bellora et al., 2012; Metzger et al., 1997). IL-
18 has been recognised as a key IFNg inducing factor and its mature form is mostly secreted 
by activated macrophages (Okamura et al., 1995). When cocultured in vitro with, CD16+ or 
CD16
-




of CCR7 and IFNg, which were abrogated with the addition of anti-IL18 monoclonal antibody 
(Bellora et al., 2012). Alongside IL-18 production, IL-12 is also critical for the induction of the 
early IFNg response, thereby promoting Th1 polarising environment for the differentiation of 
CD4 T cells (Scharton-Kersten et al., 1995; Seder et al., 1993). Moreover, NK cell activation 
and their effector functions can also be impaired by IL-12 signalling (Metzger et al., 1997). 
The other two proinflammatory cytokines, IL-6 and IL-1b, have been identified as both T cell 
and DC activation stimulants. In particular, IL-1b enhances the differentiation of monocytes 
into conventional DC and M0 (Schenk et al., 2014; Yakimchuk et al., 2011). For IL-6, the 
reports a more varying, with some suggesting a stimulatory role for IL-6 in DC maturation, 
while others presenting in vivo data on IL-6 mediated suppression of DC maturation (S.-J. 
Park et al., 2004; Su et al., 2008). Both cytokines promote CD4 T cell differentiation, with IL-
6 inducing Th17 phenotype following immunisation with IFA (Bettelli et al., 2006; Korn et al., 
2008). IL-1b has also been shown to induce CD8 T cell activation and function (Ben-Sasson 
et al., 2013). Similarly, IL-6 and IL-1b have been shown to suppress Tregs function by 
inhibiting TGFb (Bettelli et al., 2006; Ikeda et al., 2014). Together, these data are consistent 
with a model in which combined action of the two immunostimulant components of AS01 
induces the release of IL-12, IL-6, IL-1b and IL-18 which collectively drive early IFNg 
production from NK cells. 
In the recent study, the use of NKp46DTA mice enabled assessment of the NK cell specific 
contribution to the IFNg production, which showed a significant reduction in the proportion of 
IFNg produced by NK cells as opposed to other cells (Coccia et al., 2017). Those analyses 
however were flawed since both ILC1 and for instance NK cells can express NKp46 (Spits et 
al., 2013; Yu et al., 2011). Hence inducible deletion of NKp46 would affect both NK cells as 
well as ILC1 population. We therefore performed different type of analyses, including more 




proportion of the NK1.1+ IFNg producing cells. This data was used to support another PhD 
student’s paper on migratory properties of ILC subsets in peripheral LNs (Dutton et al., 2019).  
The observed significant increase in the population of cells expressing cell surface markers 
indicative of iNKT cell population, was assessed using CD1d
-/-
 mice. Those analyses 
disproved original assumptions of their possible phenotype. This was consistent with the 
previous data, presenting the iNKT cells to account for approximately less than 10% of IFNg 
producing cells following immunisation with AS01 (Coccia et al., 2017). We showed that those 
cells also had a low expression of EOMES, with a transient expression of CD8 markers, 
implying that they could indeed be CD8 T cells upregulating expression of NK1.1 as 





 effector T cells following infection with Plasmodium yoelli, which responded in 
MHCII restricted but CD1d independent manner (Wikenheiser et al., 2018). Overall, more 
detailed analyses were needed to provided better understanding with regards to the 
phenotype of this population, however considering that these cells are not dominant IFNg 
producers, their phenotype was not explored any further.    
During the direct detection of IFNg production, a large T cell population based on CD3 
expression was identified, which was surprising, yet further analyses demonstrated that they 
expressed a phenotype characteristic for central memory CD8 T cells. The previously 
described report showed that these cells expressed CD44, CD69 and CD25, associated with 
activation post antigen encounter (Budd et al., 1987; Kim et al., 2001; Ziegler et al., 1994). 
We have observed similar results, with respect to the CD44 staining, but have additionally 
characterised them on the basis of CD62L expression, showing a significant dominance of 
the CD62L
high
 population. The CD62L expression can be used to identify central memory 
population which are able to traffic into lymph nodes because of the elevated expression of 




were also shown to have strong proliferative potential and were mostly involved in recall 
responses to an antigen (Wherry et al., 2003).  
Previous studies have highlighted a potential role for memory CD8 T cells in rapid early 
cytokine production. Past study investigated the pool of endogenous B8R vaccina virus 
peptide and OVA-specific CD8 populations and found that unprimed mice averaged 
approximately 1,070 and 170 of each type of cells, respectively (Haluszczak et al., 2009). 





Interestingly, in in vitro settings, following an overnight culture with IL-2, IL-12 and IL-18, 
splenocytes isolated from unprimed animals showed that B8R-specific CD44
high
 CD8 T cells 
had an increased expression of IFNg (Haluszczak et al., 2009). Further evidence for the 
presence of memory CD8 T cells able to provide early cytokine expression in unimmunised 
animals was also reported by Lee et al., 2013. This study identified named ‘virtual memory’ 
(VM) cells, to distinguish them from the homeostatic populations found in previous 
investigation. These cells again expressed all memory phenotype markers, including CD62L, 
but were described as poor IFNg producers following in vitro stimulation with OVA. This result 
was however skewed by the use of true memory (TM) cells as a comparison. These TCR 
CD8 T cells, were purified, transferred and primed with Lm-OVA before being detected 30 to 
60 days later. Considering the time allowed for their development and expansion it was not 
surprising that they performed better at in OVA induced IFNg responses. Nevertheless, at 5 
hrs post of in vitro stimulation, approximately 30% of VM cells isolated from unprimed animals 
were shown to express IFNg in response to OVA (J.-Y. Lee et al., 2013). Together these 
reports are consistent with our data that a population of memory CD8 T cells can rapidly 
produce IFNg in vivo within hrs of AS01 immunisation. Particularly, the rapid secretion of IL-
18 and IL-12 post administration of AS01 could indeed promote activation of those cells. 
Further studies are required to fully investigate this phenomenon with improved staining 




have utilised GS mice which enabled assessment of the early AS01 induced IFNg responses 
with no further ex vivo manipulations, setting a foundation for the following experiments on 
adaptive immune responses. Once again, these IFNg reporter mice proved to be a highly 
valuable, as they fully supported the results obtained in experiments with WT mice. The rapid 
production of IFNg was observed at 6 hrs post AS01 immunisation in both iliac and inguinal 
draining LNs and moreover, the phenotype of the IFNg producing cells matched the previously 
described data.  
 
6.3.2 Early IFNg supports Th1 CD4 T cell responses 
The innate production of IFNg creates polarising environment required for differentiation of 
CD4 T helper cells into a fully functional Th1 subset capable of controlling the infection 
(Mosmann and Coffman, 1989). Additionally, also the level of IFNg induced during a response 
can affect the course of T cell differentiation (Scott, 1991).  
Expression of IFNg is induced following activation of Stat4 transcription factor which is in turn 
controlled by IL-12 signals, as shown by reduced Th1 differentiation in Stat4 deficient mice 
(Bacon et al., 1995; Kaplan et al., 1996). The produced IFNg activates another transcription 
factor Stat1, which leads to an upregulation of T-bet expression and subsequent 
reinforcement of the Th1 phenotype as well as IFNg production (Krause et al., 2006; Lighvani 
et al., 2001). The sources of polarising IFNg in many infections include NK cells and CD8 T 
cells which promote Th1 development (Das et al., 2001; Scharton and Scott, 1993). We have 
observed similar pattern in Lm-2W1S model described in Chapter 4 as well as in this 
investigation following immunisation with the AS01 adjuvant.  
In comparison to AS01, other adjuvants including Alum, and oil-in-water adjuvants like MF59 
(Novartis) and AS03 (GSK) show limited bias towards the Th1 immunity (Krause et al., 2006; 




signalling were upregulated, including Stat1 pathway, while responses post second dose at 
D14 showed increased number of polyfunctional IFNg, IL-2 and TNFa producing CD4 T cells  
(Coccia et al., 2017). Furthermore, tests for RTS,S/AS01 vaccine in rhesus monkeys showed 
elevated antibody titers and a strong Th1 profile as opposed to other adjuvants (Stewart et 
al., 2007). In particular comparisons of the vaccine efficacy between RTS,S/AS01 and 
RTS,S/AS02 in human trials showed significantly higher numbers of CSP-specific CD4 T cells 
and increased IFNg production (Kester et al., 2009).  
We investigated the AS01 induced T cell responses using GS mice which were assessed 6 
hrs post secondary (boost) immunisation with OVA-2W1S/AS01 or OVA-2W1S/PBS at D7. 
This method enabled assessment of innate and adaptive immune responses, which clearly 
demonstrated a significant increase in both responses in mice which received 2 doses of 
AS01. This emphasised the requirement for administrating booster vaccines, which has 
already been implemented in human trials with AS01 (RTS,S Clinical Trials Partnership, 
2015).   
Our findings showed that AS01 booster resulted in increased production of total IFNg with NK 
cells and T cells once again accounting for majority of it. The increase in the NK derived IFNg 
production post second dose of AS01 might be simply a result of an enhanced production of 
the inflammatory cytokines, however some reports suggested that NK cell activation by 
cytokines could favour generation of memory NK cells. For instance, preactivated NK cells, 
labelled with CFSE and transferred into a CFSE negative host, not only had higher 
proliferation rates but also produced much higher levels of IFNg upon restimulation with IL-12 
and IL-15 (Gillard et al., 2011). Consistently, during vaccinia virus challenge, T cell and B cell 
deficient mice receiving hepatic memory NK cells from vaccinia primed animals were more 
protected against secondary exposure (Gillard et al., 2011). Similar observations were made 
with regards to human trials, where adoptive transfer of memory NK cells significantly 




model, it would be beneficial to assess the NK cell responses post second boost at the later 
timepoints, in particular their localization within the LNs or other organs, for instance the liver.  
With the use of MHCII tetramers we were able to also assess the number of 2W1S-specific 
CD4 T cells and their production of IFNg. Interestingly, the secondary boost with AS01 had 
minor effect on the number of the 2W1S-specific CD4 T cells, as compared to mice 
immunised with only one dose at D0. However, the booster dose had definitely improved the 
effector function of those cells showing increased IFNg production.  
In human studies, a multi-parametric modelling study which compared data from controlled 
phase II trials of a cohort of 291 participants immunised with HBs antigen and different 
adjuvants, AS01B, AS01E, AS02 , AS03 and AS04,  found that any significant changes in the 
IFNg and interferon-inducible protein 10 levels were only observed after the second dose 
received at D30 (Burny et al., 2017). There were, however, some participants immunised with 
AS01B who showed much higher IFNg responses at 24 hrs post initial dose. At day 31, they 
observed a up to 3-fold increase in the magnitude of IFNg responses and levels of the IP-10 
as well as an increase in IL-6 production post immunisation with AS01B and AS01E as oppose 
to other adjuvants. This was further verified by a strong association found between the AS01 
and AS03 treatments and upregulation of Stat1, IRF1, MX1 and CXCL10 genes and the 
overall CD4 T cell responses.  
 
6.3.3 Early immune cell activation and how it drives robust adaptive immune 
responses 
The main goal of vaccinations is the establishment of immunological memory, which can be 
mediated by T cells but also B cells which are responsible for generation of antibody 
responses. In thymus-dependent development of GCs, B cells rely on interaction with T cells 
which is mediated by the CD40 signalling, resulting in class switching and antibody production 




by the absence of GCs and lower IgG antibody titers in Bcl6 deficient mice (Hollister et al., 
2013). However, in the absence of T cells, thymus-independent type II antigens, like 
polysaccharides can act directly on B cells engaging with their BCR and inducing formation 
of GC-like structures (de Vinuesa et al., 2000; Obukhanych and Nussenzweig, 2006). 
Previous reports have shown that T cell-independent GC formation is still highly conditioned 
on CD40 signalling but not the T cell derived provision of its ligand (Gaspal et al., 2006).   
Adjuvanted vaccinations with virus-like particles and polyICLC enhanced Th1 responses 
which led to an increased number of Tfh cells and B cell class switching (Martins et al., 2016). 
In the same experiments, mice lacking CD4 T cells failed to mount IgG responses post 
vaccinations suggesting they were T cell dependant.  
We have previously shown that AS01 induced high numbers of antigen-specific CD4 T cells 
which, can be phenotyped as effector T cells expressing T-bet and Tfh cells expressing 
CXCR5. Therefore, there an increased likelihood of them providing help to B cells and 
inducing formation of GCs. In this chapter we performed analyses of B cell responses post 
immunisation with phycoerythrin (PE) and AS01. The fluorescent nature of the PE antigen 
has been described in the past as a highly useful tool for identification of antigen-binding B 
cells (Hayakawa et al., 1987). We have shown that AS01 induced PE-specific B cell 
responses and GC formation in WT mice. In contrast, TCRa-/- mice, deficient in T cells 
showed abrogation of those responses, suggesting a T cell dependent mechanism of AS01-
induced B cell activation. With the respect to the early IFNg production being required in 
generation of adaptive responses post immunisation with AS01, we hypothesised that it could 
also be involved in generating PE-specific B cells responses. Previous research have shown 
that IFNgR expression on B cells was not required for generating primary responses and GC 
formation following treatment with foreign T cell-dependent antigens, however was crucial for 
controlling autoimmune antigens (Domeier et al., 2016). Similarly, in the AS01 model, IFNgR-
/-




that IFNg-/- mice generated efficient B cell responses post immunisation with AS01, showing 
no requirement for early IFNg production.  
Finally, in this chapter we have also assessed the role of early IFNg signals in upregulation 
of costimulatory OX40L signalling and its provisional requirements for effector CD4 T cells 
responses. We have previously demonstrated that DC OX40L was upregulated at 24 hrs post 
infection with Lm-2W1S, when the majority of innate IFNg was detected. Similarly, we showed 
that early IFNg signals were important for optimal upregulation of OX40L in in vivo and in vitro 
settings. In this investigation, immunisation with AS01 led to upregulation of OX40L on DC in 
draining LNs at 24 hrs. Interestingly and unlike in the Lm-2W1S model, when testing the 
responses in IFNg-/- mice, we observed no significant role of the early IFNg in upregulation of 
OX40L on DC. This suggested that other signals, like for instance IL-12, IL-18 and TNFa 
could be involved in its upregulation. All of those cytokines are being produced in the early 
responses to AS01 and some of them particularly IL-18 have already been shown to induce 
OX40L expression (Maxwell et al., 2006). One way of testing this would involve blocking IL-
18 or IL-12 signals in IFNg-/- mice and assess the OX40L expression on DC post immunisation 
with AS01.  
In Chapter 3, we have shown that efficient CD4 T cell responses post immunisation with AS01 





 mice to assess whether, similarly to the Lm-2W1S data, DC 
OX40L provision played a significant role in generation of effector CD4 T cell responses. 
However, considering its induction on DC at 24 hrs, our data showed that requirement for DC 
OX40L in AS01 induced responses was partial, implying that there could be another cellular 
provider, for instance B cells. Further experiments, assessing individual OX40L conditional 




 mice at both primary and boost or memory stages would 






Overall this chapter we have developed the mechanism of action of GSK licensed AS01 
adjuvant further. We showed that early IFNg was required for the effector T cell response, but 
not the B cell GC response. We enhanced the understanding of phenotype of the cells 
involved in early IFNg production. Finally, we revealed that OX40L expression on DC was 
























CHAPTER 7: GENERAL DISCUSSION 
7.1 Discussion 
Throughout the years of immunological research, our understanding of immune responses 
has greatly improved, however it has also become more complex. We have learnt that 
although T and B cells provide long term protection against reoccurring infections, their action 
is often dependent on the critical elements of the innate immune system, like the important 
ability to sense invading pathogens. The two immune systems are therefore no longer 
described as working independently and are viewed as complementary and integral.  
The CD4 T cell activation is one of the best examples of the cooperation between the innate 
and adaptive immune systems. The outcome of this highly complex and dynamic process is 
determined by several factors like the initial interaction with APC and signal strength, 
costimulatory and coinhibitory molecules as well as the cytokine profile. Collectively, these 
factors act together to activate and direct naive T cells to generate highly efficient antigen 
specific responses. However, the contribution of individual factors as well as mechanisms 
regulating their actions still remain unclear.  
One of the big challenges in studying T cell responses has been knowing the time frame of 
the response as well as the limited access to precise methods of tracking antigen-specific T 
cells in vivo, which has hampered our understanding of the mechanisms controlling 
generation and function of these cells. The development of MHCII tetramers has transformed 
our research, allowing to identify and track antigen specific CD4 T cells over time, including 
detection of endogenous populations and their subsequent development through the phases 
of the immune response. Moreover, this has provided a reliable method for assessing of all 
the previously mentioned driving forces responsible for induction of specific T cell mediated 
immunity.  
Immune responses generated against the 2W1S peptide incorporated into an infectious 




cells capable of recognising this peptide (Pepper et al., 2010; Rowe et al., 2012). Tracking of 
this stable 2W1S specific population with a half-life of 40 days enabled detailed in vivo 
assessment of mechanism involved in all phases of T cell responses including formation of 
memory population. Unfortunately, further advances are needed to fully understand the role 
of costimulatory and coinhibitory pathways in developing these specific CD4 T cell responses. 
Additionally, understanding of the exact time and duration of their costimulatory and 
coinhibitory effects as well as studying the cellular provision of these signals would be 
particularly useful for the development of modern immunotherapies which aim to manipulate 
various signalling pathways at different stages of the immune response to either promote or 
impede T cell function.  
Costimulation represents more than just an augmentation of the initial CD4 T cell-APC 
interaction through increasing TCR avidity. It involves a number of highly regulated signalling 
pathways which work synergistically alongside the TCR-pMHCII complex to activate T cells.  
Initial models of costimulation were based almost entirely on the concept of cytokine derived 
signals which would enhance T cell activation, however later it was discovered that specific 
ligand-receptor binding was instead essential for T cell activation. Some of the receptors, like 
CD28 are constitutively expressed, being involved in the initial binding and stabilisation of the 
TCR-pMHCII complex, however past reports also showed that in the absence of CD28 
receptor, mice were still able to develop immune responses against some viruses. 
Identification of CD28 prompt investigations into other possible genes involved in T cell 
costimulation, concluding in a discovery of multiple families of genes. 
Other costimulatory pathways like signalling through ICOS and members of the TFNRSF 
become induced after the primary costimulation and are thought to be particularly important 
for the function of the differentiated T cells like effector, memory or Tfh cells (Gramaglia et 
al., 1998; A Hutloff et al., 1999). For this reason, investigating the role of the latter signals has 
proven much more difficult due to their transient expression. In particular, the regulation and 




addressed yet it appears crucial for the precise understanding of the processes involved in T 
cell activation, differentiation and survival.  
This PhD project focused on the role of one particular costimulatory molecule, namely OX40 
which has been known as a primary enhancer of CD4 T cell activation and survival. Following 
the proposed hypotheses, its role was explored across different microenvironments using 
three different models generating immune responses against both pathogens and non-living 
immunostimulants (testing hypothesis 1). In addition, the mechanisms regulating its 
costimulatory potential on the basis of OX40L expression were assessed following the 
infection with intracellular pathogen Lm-2W1S and immunisation with AS01 adjuvant (testing 
hypothesis 3 and 4). Furthermore, due to a very limited number of previous studies, this 
investigation aimed to dissect the cellular providers of OX40L in vivo, utilising novel OX40L 
conditional knockout mice to target specific cell type provision of this ligand (testing 
hypothesis 2).   
OX40 signalling acts as a secondary costimulatory immune checkpoint, being expressed later 
in the response. The CD4 T cell requirement for OX40 signals refers mainly to the expansion 
of effector and memory populations.  
When investigating the costimulatory requirements of CD4 T cells, it is crucial to consider the 
type and the nature of the response. In acute infections, like L. monocytogenes, CD4 T cell 
response is shaped into the 3 known phases of expansion, contraction and memory 
formation. The expansion of the low frequency antigen specific T cells is highly OX40 
dependent with the OX40
-/-
 mice showing fewer primary effector T cells (Gramaglia et al., 
1998). The conventional TCR transgenic studies suggested that this was due to decrease in 
the CD4 T cell survival in the absence of OX40 signals, implying that the signals were 
important for maintaining T cells, particularly effector cells, through the late stages of the 
expansion phase, yet not many in vivo studies have been conducted (Rogers et al., 2001; 
Song et al., 2005; Soroosh et al., 2014). As mentioned, many times before, the TCR 




transferred into a mouse, which can skew their overall response, hence we used the in vivo 
Lm-2W1S model to generate an accurate representation of the CD4 T cell responses. We 
presented a strong evidence that OX40 signals were not only important for the maintenance 
of effector T cells but also their expansion and differentiation (Figure 7.1). As enhanced T cell 
division and survival have been considered to be the dominant features of the OX40 
signalling, it was even more striking that the lack of this molecule had such a profound effect 
on the function of effector T cells, specifically their ability to make IFNg in response to Lm-
2W1S. This would argue that this signalling pathway is most likely to be crucial and not 
redundant for the generation of optimal effector CD4 T cell responses, supporting hypothesis 
1 (Marriott et al., 2014; Soroosh et al., 2007). Similarly, in chronic viral infections which follow 
a completely a different response pattern, where the constant antigen stimulation maintained 
over longer periods of time ensures the appropriate control of pathogen’s replication, OX40 
signals have also proven to be vital for effector T cells (Boettler et al., 2012).  
Nevertheless, effector CD4 T cells in other types of infections, in particular intestinal 
pathogens have not yet been fully investigated and could follow differential requirement for 
OX40 signals. We showed that in chronic responses to STM-2W1S, the lack of OX40 did 
have an impact on the overall magnitude of the response, however production of IFNg by the 
existing/ surviving effector T cells appeared to be maintained. This once again emphasised 
the need for more infection specific studies to understand the nature of costimulatory signals 
















Figure 7. 1 Requirements for OX40 signals in Th1 responses. 
Different infectious diseases are associated with various innate immune responses which 
ultimately lead to T cell and B cell activation. The same innate signals could be involved in 
the regulation of inducible costimulatory signals, as we have seen in responses to Lm-2W1S 
where early production of IFNg was required for the optimal expression of OX40L on DC yet 
had no effect in responses to adjuvanted vaccines. Hence, mechanisms underpinning the 
costimulatory potential of individual pathways are as important as the direct effect of each 
pathway on the augmentation of T cell responses.      
Elucidating mechanisms involved in the generation of effector T cells and their subsequent 
survival is vital to the design and production of more efficient vaccines. With the majority of 
pathogens constantly evolving, modern vaccines can no longer rely on the stable antigens 
generating high affinity antibodies, instead include non-living immunostimulants which 








































(Didierlaurent et al., 2017). Mechanisms of action of many vaccine adjuvants have not been 
fully understood, partially because majority of studies were based on the empirical 
approaches. Nowadays, the emphasis on more advanced understanding of immunological 
and molecular processes requires more precise approaches which could improve the 
development of more effective vaccine strategies. We sought to use the detailed mechanistic 
insight from the Lm-2W1S model to investigate how AS01 influenced the CD4 T cell 
responses and whether early IFNg, previously identified as major innate signals induced by 
AS01, could be equally required for the optimal OX40L on DC (Coccia et al., 2017). Our work 
with AS01 adjuvant has demonstrated the enhancing effects on antigen specific CD4 T cell 
responses which were also highly dependent on OX40 signals. These results correlated with 
previously established adjuvant-like properties of immunisations with agonistic OX40 at the 
same time highlighting the crucial role of this pathway in generation of effector T cell 
responses. Further investigations into the importance of OX40 pathway could be key to 
refining the mode of action of AS01 adjuvant, however they should specifically take into 
consideration the regulation of OX40L expression post immunisation with AS01 and other 
innate signals influencing it, since the rapid production of IFNg was proved redundant. For 
instance, IL-18 which has been shown to be produced after the immunisation with AS01 could 
be one of the possible signals required for the optimal expression of OX40L on DC.  
Expression of OX40L is highly transient and not restricted to a specific cells type. With many 
potential cellular providers of the ligand, studying its function has been particularly difficult. 
Moreover, studies were limited to few models, mostly assessing the effect of total ablation of 
OX40L. Development of more advanced methods, like Cre-flox technology provided more 
sophisticated way of assessing cell specific deletion of genes. We have utilised this method 
to systematically dissect in vivo provision of costimulatory signal that is critical post CD28 
signalling. All together our data revealed the importance of early IFNg signals in the 




OX40L required for optimal CD4 T cell responses (Figure 7.2). This has fully supported 
hypothesis 3 stated prior the investigation as well as revised hypothesis 2, narrowing the 
cellular sources of OX40L to one specific cell type.  
With the results not being as clear in the AS01 model, our data once again highlighted the 
importance of assessing costimulatory requirements across different responses. In the AS01 
model, early IFNg was redundant for normal expression of OX40L on DC and similarly DC 
provision of OX40L in CD4 T cell responses was only partially required (Figure 7.3). This 
therefore provided an interesting new concept of an alternative OX40L provision or an idea 
of sequential provision in response to adjuvanted vaccines, despite the previously established 
role of DC in generating AS01 induced responses (Arnaud M Didierlaurent et al., 2014). 
Although these findings fully supported the hypothesis 4 stated previously, a further 
assessment specifically of B cell OX40L could provide more clear data, especially when 
taking into consideration its importance in Tfh function.  
Overall, this thesis represents just a tip of an iceberg of potential roles of OX40 signalling in 
promoting different effector CD4 T cell responses. Mechanisms behind the regulation of its 
ligand still need to be uncovered and could provide a valuable information about the function 
of innate immunity in enhancing T cell activation, however, similarly signals involved in the 












Figure 7. 2 Graphical summary of key findings in the investigation, outlining novel 
aspects of OX40-OX40L regulation and defining DC as specific cellular sources of 
OX40L in vivo required for generation of effector CD4 T cell responses in response to 




























Figure 7. 3 Graphical summary of key findings from the investigation, outlining the  
regulation of OX40-OX40L pathway following immunisation with AS01 adjuvant and 
defining potential cellular sources of OX40L required for efficient CD4 T cell 





































































































































Figure 8. 1 AS01 drives a robust CD4 T cell response to OVA-2W1S in draining LNs in 
a CD80 and CD86 dependent manner  
(A) Gating strategy showing identification of 2W1S-specific CD44hi CD4 T cells in iliac dLNs 





Figure 8. 2 CD4 T cell responses to OVA-2W1S in draining LNs at D7 post immunisation 
are OX40 dependent  
(A) Identification of 2W1S-specific CD44hi CD4 T cells and expression of T-bet versus CXCR5 
in iliac dLNs of WT mice. (B) Identification of 2W1S-specific CD44hi CD4 T cells and 
expression of T-bet versus CXCR5 in iliac dLNs of OX40
-/-
 mice. 
Figure 8. 3 OX40 signalling is required for optimal functional CD4 T cell responses 
elicited by AS01 
(A) Identification of 2W1S-specific CD44hi CD4 T cells and their expression of IL-2 and IFNg 
in inguinal dLNs of WT mice. (B) Identification of 2W1S-specific CD44hi CD4 T cells and their 
expression of IL-2 and IFNg in inguinal dLNs of OX40-/- mice.  
Figure 8. 4 IL-17 responses following infection with STM-2W1S  
(A, B) Enumeration and percentages of IL-17A (hNGFR) on 2W1S-specific CD44hi CD4 T 




 reporter mice. (C, D) Enumeration and 
percentages of IL-17A (hNGFR) on 2W1S-specific CD44
hi





 reporter mice. Data pooled from two independent experiments, n=7. Values 
on flow cytometry plots represent percentages, bars on scatter plots represents the median. 
Statistical significance was tested using an unpaired, non-parametric, Mann-Whitney two 





















































































































Figure 8. 5 AS01 immunisation have an effect of different cell subsets  
(A) Flow cytometry plots showing gating strategy used to identify different CD45+IFNg+ cell 
subsets (NK cells (NK) - RED, putative iNKT cells (NK1.1+ CD3+) - GREEN, T cells (T) - 
YELLOW, other cells (Other) - PURPLE) in inguinal dLNs. These plots also show 
identification of ILC population within the NK cell subset.  
Figure 8. 6 Phenotyping CD3 T cells found in dLNs at 6 hrs post immunisation with 
AS01  
(A) Gating strategy and representative flow cytometry plots showing proportion of CD62L+ 
and CD62L
-
 T cells present at 6 hrs post immunisation with OVA-2W1S/AS01 and their 
expression of CD4 and CD8. 
Figure 8. 7 The NK1.1+CD3+ population of IFNg+ cells cannot be identified as putative 
iNKT cells 
(C, D) Representative flow cytometry plots showing IFNg production in inguinal dLN of WT 
and CD1d-/- mice 6 hrs post immunization with OVA-2W/AS01. 
 
Figure 8. 8 Assessment of IFNg production induced by AS01 using IFNg reporter mice 
(B) Representative flow cytometry plots showing eYFP expression in WT mice following the 
intramuscular injections and the gating strategy used to identify different cell subsets in iliac 
LNs. (C) Representative flow cytometry plots showing eYFP expression GS mice following 





















































3= D0: 2W/AS01➔ D7: 2W/PBS 4= D0: 2W/PBS➔D7: 2W/AS01




























Figure 8. 9 AS01 promotes IFNg production by responding CD4 T cells in the draining 
LNs  











) and showing eYFP (IFNg) expression in inguinal dLNs for 
the tested experimental conditions. 
Figure 8. 10 AS01 induced 2W1S-specific CD4 T cell responses require OX40 and are 
moderately affected by the lack of OX40L on DC  
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